0001071739-23-000209.txt : 20231024 0001071739-23-000209.hdr.sgml : 20231024 20231023184857 ACCESSION NUMBER: 0001071739-23-000209 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 71 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231024 DATE AS OF CHANGE: 20231023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 231340799 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 10-Q 1 cnc-20230930.htm 10-Q cnc-20230930
0001071739--12-312023Q3FALSEhttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent00010717392023-01-012023-09-3000010717392023-10-20xbrli:shares00010717392023-09-30iso4217:USD00010717392022-12-31iso4217:USDxbrli:shares0001071739us-gaap:HealthCarePremiumMember2023-07-012023-09-300001071739us-gaap:HealthCarePremiumMember2022-07-012022-09-300001071739us-gaap:HealthCarePremiumMember2023-01-012023-09-300001071739us-gaap:HealthCarePremiumMember2022-01-012022-09-300001071739us-gaap:ServiceMember2023-07-012023-09-300001071739us-gaap:ServiceMember2022-07-012022-09-300001071739us-gaap:ServiceMember2023-01-012023-09-300001071739us-gaap:ServiceMember2022-01-012022-09-3000010717392023-07-012023-09-3000010717392022-07-012022-09-3000010717392022-01-012022-09-300001071739us-gaap:CommonStockMember2023-09-300001071739us-gaap:CommonStockMember2022-12-310001071739us-gaap:CommonStockMember2023-03-310001071739us-gaap:CommonStockMember2023-06-300001071739us-gaap:TreasuryStockCommonMember2023-09-300001071739us-gaap:TreasuryStockCommonMember2022-12-310001071739us-gaap:TreasuryStockCommonMember2023-03-310001071739us-gaap:TreasuryStockCommonMember2023-06-300001071739us-gaap:AdditionalPaidInCapitalMember2022-12-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001071739us-gaap:RetainedEarningsMember2022-12-310001071739us-gaap:NoncontrollingInterestMember2022-12-310001071739us-gaap:RetainedEarningsMember2023-01-012023-03-3100010717392023-01-012023-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001071739us-gaap:CommonStockMember2023-01-012023-03-310001071739us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001071739us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001071739us-gaap:AdditionalPaidInCapitalMember2023-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001071739us-gaap:RetainedEarningsMember2023-03-310001071739us-gaap:NoncontrollingInterestMember2023-03-3100010717392023-03-310001071739us-gaap:RetainedEarningsMember2023-04-012023-06-300001071739us-gaap:NoncontrollingInterestMember2023-04-012023-06-3000010717392023-04-012023-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001071739us-gaap:CommonStockMember2023-04-012023-06-300001071739us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001071739us-gaap:TreasuryStockCommonMember2023-04-012023-06-300001071739us-gaap:AdditionalPaidInCapitalMember2023-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001071739us-gaap:RetainedEarningsMember2023-06-300001071739us-gaap:NoncontrollingInterestMember2023-06-3000010717392023-06-300001071739us-gaap:RetainedEarningsMember2023-07-012023-09-300001071739us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001071739us-gaap:CommonStockMember2023-07-012023-09-300001071739us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001071739us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001071739us-gaap:AdditionalPaidInCapitalMember2023-09-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001071739us-gaap:RetainedEarningsMember2023-09-300001071739us-gaap:NoncontrollingInterestMember2023-09-300001071739us-gaap:CommonStockMember2022-09-300001071739us-gaap:CommonStockMember2022-03-310001071739us-gaap:CommonStockMember2022-06-300001071739us-gaap:CommonStockMember2021-12-310001071739us-gaap:TreasuryStockCommonMember2022-03-310001071739us-gaap:TreasuryStockCommonMember2022-06-300001071739us-gaap:TreasuryStockCommonMember2021-12-310001071739us-gaap:TreasuryStockCommonMember2022-09-300001071739us-gaap:AdditionalPaidInCapitalMember2021-12-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001071739us-gaap:RetainedEarningsMember2021-12-310001071739us-gaap:NoncontrollingInterestMember2021-12-3100010717392021-12-310001071739us-gaap:RetainedEarningsMember2022-01-012022-03-310001071739us-gaap:NoncontrollingInterestMember2022-01-012022-03-3100010717392022-01-012022-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001071739us-gaap:CommonStockMember2022-01-012022-03-310001071739us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001071739us-gaap:TreasuryStockCommonMember2022-01-012022-03-310001071739us-gaap:AdditionalPaidInCapitalMember2022-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001071739us-gaap:RetainedEarningsMember2022-03-310001071739us-gaap:NoncontrollingInterestMember2022-03-3100010717392022-03-310001071739us-gaap:RetainedEarningsMember2022-04-012022-06-300001071739us-gaap:NoncontrollingInterestMember2022-04-012022-06-3000010717392022-04-012022-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001071739us-gaap:CommonStockMember2022-04-012022-06-300001071739us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001071739us-gaap:TreasuryStockCommonMember2022-04-012022-06-300001071739us-gaap:AdditionalPaidInCapitalMember2022-06-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001071739us-gaap:RetainedEarningsMember2022-06-300001071739us-gaap:NoncontrollingInterestMember2022-06-3000010717392022-06-300001071739us-gaap:RetainedEarningsMember2022-07-012022-09-300001071739us-gaap:NoncontrollingInterestMember2022-07-012022-09-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001071739us-gaap:CommonStockMember2022-07-012022-09-300001071739us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001071739us-gaap:TreasuryStockCommonMember2022-07-012022-09-300001071739us-gaap:AdditionalPaidInCapitalMember2022-09-300001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001071739us-gaap:RetainedEarningsMember2022-09-300001071739us-gaap:NoncontrollingInterestMember2022-09-3000010717392022-09-300001071739cnc:CenturionMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-04-012023-06-300001071739cnc:MagellanSpecialtyHealthMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-200001071739cnc:MagellanSpecialtyHealthMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-202023-01-200001071739cnc:MagellanSpecialtyHealthMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-04-012023-04-300001071739us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercnc:ApixioMember2023-06-132023-06-130001071739us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercnc:SpanishAndCentralEuropeanBusinessesMember2023-04-012023-06-300001071739us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercnc:SpanishAndCentralEuropeanBusinessesMember2022-01-012022-12-310001071739us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembercnc:CircleHealthMember2023-09-300001071739us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembercnc:CircleHealthMember2023-07-012023-09-300001071739us-gaap:CurrencySwapMember2023-08-31iso4217:GBP0001071739us-gaap:CurrencySwapMember2023-09-300001071739us-gaap:USTreasuryAndGovernmentMember2023-09-300001071739us-gaap:USTreasuryAndGovernmentMember2022-12-310001071739us-gaap:CorporateDebtSecuritiesMember2023-09-300001071739us-gaap:CorporateDebtSecuritiesMember2022-12-310001071739cnc:RestrictedCertificatesOfDepositMember2023-09-300001071739cnc:RestrictedCertificatesOfDepositMember2022-12-310001071739cnc:RestrictedCashEquivalentsMember2023-09-300001071739cnc:RestrictedCashEquivalentsMember2022-12-310001071739us-gaap:BankTimeDepositsMember2023-09-300001071739us-gaap:BankTimeDepositsMember2022-12-310001071739us-gaap:MunicipalBondsMember2023-09-300001071739us-gaap:MunicipalBondsMember2022-12-310001071739us-gaap:AssetBackedSecuritiesMember2023-09-300001071739us-gaap:AssetBackedSecuritiesMember2022-12-310001071739us-gaap:ResidentialMortgageBackedSecuritiesMember2023-09-300001071739us-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMember2023-09-300001071739us-gaap:CommercialMortgageBackedSecuritiesMember2022-12-310001071739cnc:RatedSecuritiesMembercnc:InvestmentSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2023-01-012023-09-30xbrli:pure0001071739us-gaap:CommercialMortgageBackedSecuritiesMember2023-01-012023-09-30cnc:position0001071739us-gaap:InvestmentsMember2023-09-300001071739us-gaap:DepositsMember2023-09-300001071739us-gaap:InvestmentsMember2022-12-310001071739us-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Member2023-09-300001071739us-gaap:FairValueInputsLevel2Member2023-09-300001071739us-gaap:FairValueInputsLevel3Member2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-09-300001071739us-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:MunicipalBondsMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:BankTimeDepositsMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-09-300001071739us-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:EquitySecuritiesMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:EquitySecuritiesMemberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2023-09-300001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Member2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2023-09-300001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2023-09-300001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Member2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2023-09-300001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMember2023-09-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMember2023-09-300001071739us-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMember2023-09-300001071739us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DepositsMember2023-09-300001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Member2023-09-300001071739us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2023-09-300001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:DepositsMemberus-gaap:MunicipalBondsMember2023-09-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMember2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMemberus-gaap:MunicipalBondsMember2023-09-300001071739us-gaap:DepositsMemberus-gaap:MunicipalBondsMember2023-09-300001071739us-gaap:FairValueInputsLevel1Memberus-gaap:DepositsMember2023-09-300001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Member2023-09-300001071739us-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2023-09-300001071739us-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CurrencySwapMember2023-09-300001071739us-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CurrencySwapMember2023-09-300001071739us-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CurrencySwapMember2023-09-300001071739us-gaap:OtherCurrentAssetsMemberus-gaap:CurrencySwapMember2023-09-300001071739us-gaap:FairValueInputsLevel1Member2022-12-310001071739us-gaap:FairValueInputsLevel2Member2022-12-310001071739us-gaap:FairValueInputsLevel3Member2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:MunicipalBondsMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:BankTimeDepositsMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:EquitySecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:EquitySecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:DepositsMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DepositsMember2022-12-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2022-12-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:DepositsMemberus-gaap:MunicipalBondsMember2022-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMember2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMemberus-gaap:MunicipalBondsMember2022-12-310001071739us-gaap:DepositsMemberus-gaap:MunicipalBondsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:DepositsMember2022-12-310001071739us-gaap:DepositsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2022-12-310001071739cnc:MedicaidSegmentMember2021-12-310001071739cnc:MedicareSegmentMember2021-12-310001071739cnc:CommercialSegmentMember2021-12-310001071739us-gaap:AllOtherSegmentsMember2021-12-310001071739cnc:MedicaidSegmentMember2022-01-012022-12-310001071739cnc:MedicareSegmentMember2022-01-012022-12-310001071739cnc:CommercialSegmentMember2022-01-012022-12-310001071739us-gaap:AllOtherSegmentsMember2022-01-012022-12-3100010717392022-01-012022-12-310001071739cnc:MedicaidSegmentMember2022-12-310001071739cnc:MedicareSegmentMember2022-12-310001071739cnc:CommercialSegmentMember2022-12-310001071739us-gaap:AllOtherSegmentsMember2022-12-310001071739cnc:MedicaidSegmentMember2023-01-012023-09-300001071739cnc:MedicareSegmentMember2023-01-012023-09-300001071739cnc:CommercialSegmentMember2023-01-012023-09-300001071739us-gaap:AllOtherSegmentsMember2023-01-012023-09-300001071739cnc:MedicaidSegmentMember2023-09-300001071739cnc:MedicareSegmentMember2023-09-300001071739cnc:CommercialSegmentMember2023-09-300001071739us-gaap:AllOtherSegmentsMember2023-09-300001071739cnc:MedicaidSegmentMember2022-01-012022-09-300001071739cnc:MedicareSegmentMember2022-01-012022-09-300001071739cnc:CommercialSegmentMember2022-01-012022-09-300001071739us-gaap:AllOtherSegmentsMember2022-01-012022-09-300001071739cnc:MedicaidSegmentMember2022-09-300001071739cnc:MedicareSegmentMember2022-09-300001071739cnc:CommercialSegmentMember2022-09-300001071739us-gaap:AllOtherSegmentsMember2022-09-300001071739us-gaap:SeniorNotesMembercnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember2023-09-300001071739us-gaap:SeniorNotesMembercnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember2022-12-310001071739us-gaap:SeniorNotesMembercnc:A2300Million245SeniorNotsDueJuly2028Member2023-09-300001071739us-gaap:SeniorNotesMembercnc:A2300Million245SeniorNotsDueJuly2028Member2022-12-310001071739us-gaap:SeniorNotesMembercnc:A3500Million4625SeniorNotesDueDecember2029Member2023-09-300001071739us-gaap:SeniorNotesMembercnc:A3500Million4625SeniorNotesDueDecember2029Member2022-12-310001071739cnc:A2200Million375SeniorNotesDueFebruary2030Memberus-gaap:SeniorNotesMember2023-09-300001071739cnc:A2200Million375SeniorNotesDueFebruary2030Memberus-gaap:SeniorNotesMember2022-12-310001071739cnc:A2200Million300SeniorNotesDueOctober2030Memberus-gaap:SeniorNotesMember2023-09-300001071739cnc:A2200Million300SeniorNotesDueOctober2030Memberus-gaap:SeniorNotesMember2022-12-310001071739us-gaap:SeniorNotesMembercnc:A2200Million250SeniorNotesDueMarch2031Member2023-09-300001071739us-gaap:SeniorNotesMembercnc:A2200Million250SeniorNotesDueMarch2031Member2022-12-310001071739us-gaap:SeniorNotesMembercnc:A1300Million2625SeniorNotesDueAugust2031Member2023-09-300001071739us-gaap:SeniorNotesMembercnc:A1300Million2625SeniorNotesDueAugust2031Member2022-12-310001071739cnc:TermLoanCreditAgreementMember2023-09-300001071739cnc:TermLoanCreditAgreementMember2022-12-310001071739us-gaap:RevolvingCreditFacilityMember2023-09-300001071739us-gaap:RevolvingCreditFacilityMember2022-12-310001071739cnc:CircleHealthMember2023-09-300001071739cnc:ExcludingCircleHealthMember2023-09-3000010717392022-06-012022-06-3000010717392022-12-012022-12-310001071739us-gaap:SubsequentEventMember2023-10-012023-10-240001071739us-gaap:CommonStockMember2023-07-012023-09-300001071739us-gaap:CommonStockMember2022-07-012022-09-300001071739us-gaap:CommonStockMember2023-01-012023-09-300001071739us-gaap:CommonStockMember2022-01-012022-09-300001071739cnc:EmployeeStockCompensationPlanMember2023-07-012023-09-300001071739cnc:EmployeeStockCompensationPlanMember2022-07-012022-09-300001071739cnc:EmployeeStockCompensationPlanMember2023-01-012023-09-300001071739cnc:EmployeeStockCompensationPlanMember2022-01-012022-09-300001071739us-gaap:CommonStockMembercnc:AcceleratedShareRepurchaseAgreementMember2022-01-012022-09-300001071739us-gaap:CommonStockMembercnc:AcceleratedShareRepurchaseAgreementMember2022-07-012022-09-300001071739us-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMembercnc:MedicaidSegmentMember2023-07-012023-09-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2023-07-012023-09-300001071739cnc:CommercialSegmentMemberus-gaap:HealthCarePremiumMember2023-07-012023-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2023-07-012023-09-300001071739us-gaap:ServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-07-012023-09-300001071739us-gaap:ServiceMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300001071739cnc:CommercialSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300001071739us-gaap:ServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-07-012023-09-300001071739cnc:TotalPremiumAndServiceMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300001071739cnc:CommercialSegmentMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300001071739cnc:TotalPremiumAndServiceMember2023-07-012023-09-300001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-07-012023-09-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300001071739cnc:CommercialSegmentMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-07-012023-09-300001071739us-gaap:OperatingSegmentsMember2023-07-012023-09-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicaidSegmentMember2023-07-012023-09-300001071739cnc:MedicareSegmentMemberus-gaap:IntersegmentEliminationMember2023-07-012023-09-300001071739cnc:CommercialSegmentMemberus-gaap:IntersegmentEliminationMember2023-07-012023-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:IntersegmentEliminationMember2023-07-012023-09-300001071739us-gaap:IntersegmentEliminationMember2023-07-012023-09-300001071739cnc:MedicaidSegmentMember2023-07-012023-09-300001071739cnc:MedicareSegmentMember2023-07-012023-09-300001071739cnc:CommercialSegmentMember2023-07-012023-09-300001071739us-gaap:AllOtherSegmentsMember2023-07-012023-09-300001071739us-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMembercnc:MedicaidSegmentMember2022-07-012022-09-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2022-07-012022-09-300001071739cnc:CommercialSegmentMemberus-gaap:HealthCarePremiumMember2022-07-012022-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2022-07-012022-09-300001071739us-gaap:ServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2022-07-012022-09-300001071739us-gaap:ServiceMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739cnc:CommercialSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739us-gaap:ServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2022-07-012022-09-300001071739cnc:TotalPremiumAndServiceMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739cnc:CommercialSegmentMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739cnc:TotalPremiumAndServiceMember2022-07-012022-09-300001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2022-07-012022-09-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739cnc:CommercialSegmentMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739us-gaap:OperatingSegmentsMember2022-07-012022-09-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicaidSegmentMember2022-07-012022-09-300001071739cnc:MedicareSegmentMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300001071739cnc:CommercialSegmentMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300001071739us-gaap:IntersegmentEliminationMember2022-07-012022-09-300001071739cnc:MedicaidSegmentMember2022-07-012022-09-300001071739cnc:MedicareSegmentMember2022-07-012022-09-300001071739cnc:CommercialSegmentMember2022-07-012022-09-300001071739us-gaap:AllOtherSegmentsMember2022-07-012022-09-300001071739us-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMembercnc:MedicaidSegmentMember2023-01-012023-09-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2023-01-012023-09-300001071739cnc:CommercialSegmentMemberus-gaap:HealthCarePremiumMember2023-01-012023-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2023-01-012023-09-300001071739us-gaap:ServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-01-012023-09-300001071739us-gaap:ServiceMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001071739cnc:CommercialSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001071739us-gaap:ServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-01-012023-09-300001071739cnc:TotalPremiumAndServiceMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001071739cnc:CommercialSegmentMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001071739cnc:TotalPremiumAndServiceMember2023-01-012023-09-300001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-01-012023-09-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001071739cnc:CommercialSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-01-012023-09-300001071739us-gaap:OperatingSegmentsMember2023-01-012023-09-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicaidSegmentMember2023-01-012023-09-300001071739cnc:MedicareSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-012023-09-300001071739cnc:CommercialSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-012023-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:IntersegmentEliminationMember2023-01-012023-09-300001071739us-gaap:IntersegmentEliminationMember2023-01-012023-09-300001071739us-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMembercnc:MedicaidSegmentMember2022-01-012022-09-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2022-01-012022-09-300001071739cnc:CommercialSegmentMemberus-gaap:HealthCarePremiumMember2022-01-012022-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2022-01-012022-09-300001071739us-gaap:ServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2022-01-012022-09-300001071739us-gaap:ServiceMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739cnc:CommercialSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739us-gaap:ServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2022-01-012022-09-300001071739cnc:TotalPremiumAndServiceMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739cnc:CommercialSegmentMembercnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739cnc:TotalPremiumAndServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739cnc:TotalPremiumAndServiceMember2022-01-012022-09-300001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2022-01-012022-09-300001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739cnc:CommercialSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739us-gaap:OperatingSegmentsMember2022-01-012022-09-300001071739us-gaap:IntersegmentEliminationMembercnc:MedicaidSegmentMember2022-01-012022-09-300001071739cnc:MedicareSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300001071739cnc:CommercialSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300001071739us-gaap:AllOtherSegmentsMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300001071739us-gaap:IntersegmentEliminationMember2022-01-012022-09-300001071739us-gaap:PendingLitigationMember2021-09-30cnc:claim0001071739us-gaap:PendingLitigationMember2021-06-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
___________________________________________
FORM 10-Q
____________________________________________
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023

OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from  _____ to _____
____________________________________________
Commission file number: 001-31826
____________________________________________
CENTENE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware42-1406317
(State or other jurisdiction of(I.R.S. Employer
incorporation or organization)Identification Number)
7700 Forsyth Boulevard 
St. Louis,Missouri63105
(Address of principal executive offices)(Zip Code)

Registrant's telephone number, including area code: (314) 725-4477 
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock $0.001 Par ValueCNCNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days ☒ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) ☒ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act. 
Large accelerated filer☒Accelerated filer☐
Non-accelerated filer ☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒
As of October 20, 2023, the registrant had 534,201 thousand shares of common stock outstanding.


CENTENE CORPORATION
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
 PAGE
  
Part I
Financial Information
Item 1.
 
 
 
 
 
 
Item 2.
Item 3.
Item 4.
Part II
Other Information
Item 1.
Item 1A.
Item 2.
Item 6.


CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

All statements, other than statements of current or historical fact, contained in this filing are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue," and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in connection with completed and future acquisitions and dispositions, our investments, and the adequacy of our available cash resources. These statements may be found in the various sections of this filing, such as Part I, Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations," and Part II, Item 1. "Legal Proceedings."

These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments, and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive, and other factors that may cause our or our industry's actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions.

All forward-looking statements included in this filing are based on information available to us on the date of this filing. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this filing, whether as a result of new information, future events, or otherwise, after the date of this filing. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables, and events including, but not limited to:

•our ability to design and price products that are competitive and/or actuarially sound including but not limited to any impacts resulting from Medicaid redeterminations;
•our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth;
•our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates;
•competition, including our ability to reprocure our contracts and grow organically;
•the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods;
•our ability to manage our information systems effectively;
•disruption, unexpected costs, or similar risks from business transactions, including acquisitions, divestitures, and changes in our relationships with third parties;
•impairments to real estate, investments, goodwill, and intangible assets;
•changes in senior management, loss of one or more key personnel or an inability to attract, hire, integrate and retain skilled personnel;
•membership and revenue declines or unexpected trends;
•rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses;
•changes in healthcare practices, new technologies, and advances in medicine;
•increased healthcare costs;
•inflation;
•changes in economic, political, or market conditions;
•changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder;
•tax matters;
•disasters or major epidemics;
i
•changes in expected contract start dates;
•changes in provider, state, federal, foreign, and other contracts and delays in the timing of regulatory approval of contracts, including due to protests;
•the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE, or other customers);
•the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Centene Pharmacy Services (formerly Envolve Pharmacy Solutions, Inc. (Envolve)), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations will be brought by states, the federal government or shareholder litigants, or government investigations;
•challenges to our contract awards;
•cyber-attacks or other privacy or data security incidents;
•the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the terms of our contracts and the undertakings in connection with any regulatory, governmental, or third party consents or approvals for acquisitions or dispositions;
•any changes in expected closing dates, estimated purchase price, or accretion for acquisitions or dispositions, including due to the timing of regulatory approval for the pending sale of Circle Health Group (Circle Health);
•losses in our investment portfolio;
•restrictions and limitations in connection with our indebtedness;
•a downgrade of the credit rating of our indebtedness;
•the availability of debt and equity financing on terms that are favorable to us; and
•foreign currency fluctuations.

This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition, and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, other quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs.


ii

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures in this report as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measures internally in evaluating the Company's performance and for planning purposes, by allowing management to focus on period-to-period changes in the Company's core business operations, and in determining employee incentive compensation. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Specifically, the Company believes the presentation of non-GAAP financial information that excludes amortization of acquired intangible assets, acquisition and divestiture related expenses, as well as other items, allows investors to develop a more meaningful understanding of the Company's core performance over time.

The tables below provide reconciliations of non-GAAP items ($ in millions, except per share data):
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
GAAP net earnings attributable to Centene$469 $738 $2,657 $1,415 
Amortization of acquired intangible assets180 211 542 609 
Acquisition and divestiture related expenses16 30 52 149 
Other adjustments (1)
472 (222)345 1,225 
Income tax effects of adjustments (2)
(55)(2)(190)(521)
Adjusted net earnings $1,082 $755 $3,406 $2,877 
GAAP diluted earnings per share (EPS) attributable to Centene$0.87 $1.27 $4.85 $2.41 
Amortization of acquired intangible assets0.33 0.36 0.99 1.04 
Acquisition and divestiture related expenses0.03 0.05 0.09 0.25 
Other adjustments (1)
0.87 (0.38)0.63 2.09 
Income tax effects of adjustments (2)
(0.10)— (0.35)(0.89)
Adjusted diluted EPS$2.00 $1.30 $6.21 $4.90 
(1) Other adjustments include the following pre-tax items:
2023:
(a) for the three months ended September 30, 2023: Circle Health impairment of $251 million, or $0.46 per share ($0.50 after-tax), Operose Health impairment of $142 million, or $0.26 per share ($0.24 after-tax), real estate impairments of $47 million, or $0.09 per share ($0.09 after-tax), severance costs due to a restructuring of $22 million, or $0.04 per share ($0.03 after-tax), and a reduction to the previously recorded gain on the sale of Magellan Rx of $10 million, or $0.02 per share ($0.00 after-tax);

(b) for the nine months ended September 30, 2023: Circle Health impairment of $251 million, or $0.46 per share ($0.49 after-tax), Operose Health impairment of $142 million, or $0.26 per share ($0.24 after-tax), real estate impairments of $92 million, or $0.17 per share ($0.15 after-tax), gain on the sale of Apixio of $91 million, or $0.17 per share ($0.12 after-tax), gain on the sale of Magellan Specialty Health of $79 million, or $0.14 per share ($0.12 after-tax), severance costs due to a restructuring of $22 million, or $0.04 per share ($0.03 after-tax), gain on the previously reported divestiture of Centurion of $15 million, or $0.03 per share ($0.02 after-tax), an additional loss on the divestiture of our Spanish and Central European businesses of $13 million, or $0.02 per share ($0.01 after-tax), and a reduction to the previously recorded gain on the sale of Magellan Rx of $10 million, or $0.02 per share ($0.00 after-tax).

iii
2022:
(a) for the three months ended September 30, 2022: gain on the sale of PANTHERx Rare (PANTHERx) of $490 million, or $0.84 per share ($0.65 after-tax), impairment of assets associated with the divestiture of our Spanish and Central European businesses of $165 million, or $0.28 per share ($0.23 after-tax), real estate impairments of $127 million, or $0.22 per share ($0.16 after-tax), increase to the previously reported gain on the divestiture of U.S. Medical Management (USMM) due to the finalization of working capital adjustments of $13 million, or $0.02 per share ($0.01 after-tax), gain on debt extinguishment related to the repurchases of senior notes of $10 million, or $0.02 per share ($0.01 after-tax), and an adjustment to the costs related to the PBM legal settlement of $1 million, or $0.00 per share ($0.00 after-tax);

(b) for the nine months ended September 30, 2022: real estate impairments of $1,581 million, or $2.69 per share ($1.98 after-tax), gain on the sale of PANTHERx of $490 million, or $0.83 per share ($0.65 after-tax), impairment of assets associated with the divestiture of our Spanish and Central European businesses of $165 million, or $0.28 per share ($0.23 after-tax), gain on debt extinguishment of $23 million, or $0.04 per share ($0.03 after-tax), increase to the previously reported gain on the divestiture of USMM due to the finalization of working capital adjustments of $13 million, or $0.02 per share ($0.02 after-tax), and costs related to the PBM legal settlement of $5 million, or $0.01 per share ($0.01 after-tax).

(2) The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. In addition, the nine months ended September 30, 2023, include a one-time income tax benefit of $69 million, or $0.12 per share, resulting from the distribution of long-term stock awards to the estate of the Company's former CEO. The nine months ended September 30, 2022, also include an $18 million, or $0.03 per share, increase to the income tax benefit on the previously reported non-cash impairment of our equity method investment in RxAdvance.

Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
GAAP selling, general and administrative expenses$3,048 $2,846 $9,075 $8,391 
Less:
Acquisition and divestiture related expenses16 28 52 149 
Restructuring costs22 — 22 — 
Costs related to the PBM legal settlement— 1 — 5 
Real estate optimization— 3 7 7 
Adjusted selling, general and administrative expenses$3,010 $2,814 $8,994 $8,230 
iv
PART I
FINANCIAL INFORMATION

Item 1. Financial Statements.
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions, except shares in thousands and per share data in dollars)
September 30, 2023December 31, 2022
(Unaudited)
ASSETS  
Current assets:  
Cash and cash equivalents$18,190 $12,074 
Premium and trade receivables15,503 13,272 
Short-term investments2,241 2,321 
Other current assets5,471 2,461 
Total current assets41,405 30,128 
Long-term investments15,234 14,684 
Restricted deposits1,343 1,217 
Property, software and equipment, net2,004 2,432 
Goodwill17,558 18,812 
Intangible assets, net6,277 6,911 
Other long-term assets560 2,686 
Total assets$84,381 $76,870 
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY 
Current liabilities:  
Medical claims liability$17,141 $16,745 
Accounts payable and accrued expenses15,081 9,525 
Return of premium payable2,160 1,634 
Unearned revenue2,356 478 
Current portion of long-term debt113 82 
Total current liabilities36,851 28,464 
Long-term debt17,888 17,938 
Deferred tax liability577 615 
Other long-term liabilities3,649 5,616 
Total liabilities58,965 52,633 
Commitments and contingencies
Redeemable noncontrolling interests21 56 
Stockholders' equity:  
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2023 and December 31, 2022
— — 
Common stock, $0.001 par value; authorized 800,000 shares; 614,956 issued and 534,596 outstanding at September 30, 2023, and 607,847 issued and 550,754 outstanding at December 31, 2022
1 1 
Additional paid-in capital20,243 20,060 
Accumulated other comprehensive (loss)(1,122)(1,132)
Retained earnings11,998 9,341 
Treasury stock, at cost (80,360 and 57,093 shares, respectively)
(5,825)(4,213)
Total Centene stockholders' equity25,295 24,057 
Nonredeemable noncontrolling interest100 124 
Total stockholders' equity25,395 24,181 
Total liabilities, redeemable noncontrolling interests and stockholders' equity$84,381 $76,870 
The accompanying notes to the consolidated financial statements are an integral part of these statements. 
1
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except shares in thousands and per share data in dollars)
(Unaudited)
 Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Revenues:
Premium$33,866 $31,848 $101,404 $95,247 
Service1,101 1,878 3,353 6,679 
Premium and service revenues34,967 33,726 104,757 101,926 
Premium tax3,075 2,139 9,782 7,060 
Total revenues38,042 35,865 114,539 108,986 
Expenses:  
Medical costs29,479 28,111 88,260 83,261 
Cost of services856 1,571 2,603 5,658 
Selling, general and administrative expenses3,048 2,846 9,075 8,391 
Depreciation expense148 150 436 470 
Amortization of acquired intangible assets180 211 542 609 
Premium tax expense3,156 2,211 10,021 7,258 
Impairment440 289 478 1,739 
Total operating expenses37,307 35,389 111,415 107,386 
Earnings from operations735 476 3,124 1,600 
Other income (expense):  
Investment and other income214 692 992 786 
Debt extinguishment— 10 — 26 
Interest expense(181)(169)(542)(491)
Earnings before income tax768 1,009 3,574 1,921 
Income tax expense293 269 914 500 
Net earnings475 740 2,660 1,421 
(Earnings) attributable to noncontrolling interests(6)(2)(3)(6)
Net earnings attributable to Centene Corporation$469 $738 $2,657 $1,415 

Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$0.87 $1.29 $4.86 $2.44 
Diluted earnings per common share$0.87 $1.27 $4.85 $2.41 

Weighted average number of common shares outstanding:
Basic539,535 573,961 546,374 580,277 
Diluted541,270 580,607 548,412 587,084 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
2
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)
(In millions)
(Unaudited)
 Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Net earnings$475 $740 $2,660 $1,421 
Change in unrealized gain (loss) on investments(235)(503)(124)(1,664)
Change in unrealized gain (loss) on investments, tax effect56 120 29 397 
Change in unrealized gain (loss) on investments, net of tax(179)(383)(95)(1,267)
Reclassification adjustment, net of tax57 3 61 12 
Foreign currency translation adjustments, net of tax(22)(101)24 (216)
Net unrealized gain on cash flow hedge, net of tax20 — 20 — 
Other comprehensive earnings (loss)(124)(481)10 (1,471)
Comprehensive earnings (loss)351 259 2,670 (50)
Comprehensive (earnings) attributable to noncontrolling interests(6)(2)(3)(6)
Comprehensive earnings (loss) attributable to Centene Corporation$345 $257 $2,667 $(56)

The accompanying notes to the consolidated financial statements are an integral part of these statements.
3
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(In millions, except shares in thousands and per share data in dollars)
(Unaudited)
Three and Nine Months Ended September 30, 2023
 Centene Stockholders' Equity  
 Common Stock   Treasury Stock  
 
$0.001 Par Value Shares
AmtAdditional Paid-in CapitalAccumulated Other Comprehensive
Earnings (Loss)		Retained Earnings
$0.001 Par Value Shares
AmtNoncontrolling
Interest		Total
Balance, December 31, 2022607,847 $1 $20,060 $(1,132)$9,341 57,093 $(4,213)$124 $24,181 
Comprehensive Earnings:         
Net earnings— — — — 1,130 — — — 1,130 
Other comprehensive earnings, net of $61 tax
— — — 217 — — — — 217 
Common stock issued for employee benefit plans6,508 — 12 — — — — — 12 
Common stock repurchases— — — — — 5,548 (423)— (423)
Stock compensation expense— — 61 — — — — — 61 
Purchase of redeemable noncontrolling interest— — (12)— — — — — (12)
Balance, March 31, 2023614,355 $1 $20,121 $(915)$10,471 62,641 $(4,636)$124 $25,166 
Comprehensive Earnings:         
Net earnings (loss)— — — — 1,058 — — (3)1,055 
Other comprehensive loss, net of $(34) tax
— — — (83)— — — — (83)
Common stock issued for employee benefit plans388 — 9 — — — — — 9 
Common stock repurchases— — — — — 6,099 (408)— (408)
Stock compensation expense— — 56 — — — — — 56 
Purchase of non-redeemable noncontrolling interests— — (3)— — — — (24)(27)
Balance, June 30, 2023614,743 $1 $20,183 $(998)$11,529 68,740 $(5,044)$97 $25,768 
Comprehensive Earnings:
Net earnings— — — — 469 — — 3 472 
Other comprehensive loss, net of $(34) tax
— — — (124)— — — — (124)
Common stock issued for employee benefit plans213 — 11 — — — — — 11 
Common stock repurchases— — — — — 11,620 (781)— (781)
Stock compensation expense— — 50 — — — — — 50 
Purchase of non-redeemable noncontrolling interests— — (1)— — — — — (1)
Balance, September 30, 2023614,956 $1 $20,243 $(1,122)$11,998 80,360 $(5,825)$100 $25,395 
4
Three and Nine Months Ended September 30, 2022
 Centene Stockholders' Equity  
 Common Stock   Treasury Stock  
 
$0.001 Par Value Shares
AmtAdditional Paid-in CapitalAccumulated Other Comprehensive
Earnings (Loss)		Retained Earnings
$0.001 Par Value Shares
AmtNoncontrolling
Interest		Total
Balance, December 31, 2021602,704 $1 $19,672 $77 $8,139 20,225 $(1,094)$145 $26,940 
Comprehensive Earnings:         
Net earnings (loss)— — — — 849 — — (1)848 
Other comprehensive loss, net of $(171) tax
— — — (562)— — — — (562)
Common stock issued for employee benefit plans3,221 — 28 — — — — — 28 
Fair value of unvested equity awards in connection with acquisition— — 60 — — — — — 60 
Common stock repurchases— — — — — 846 (71)— (71)
Stock compensation expense— — 70 — — — — — 70 
Balance, March 31, 2022605,925 $1 $19,830 $(485)$8,988 21,071 $(1,165)$144 $27,313 
Comprehensive Earnings:         
Net (loss)— — — — (172)— — (3)(175)
Other comprehensive loss, net of $(106) tax
— — — (428)— — — — (428)
Common stock issued for employee benefit plans519 — 10 — — — — — 10 
Common stock repurchases— — — — — 4,249 (349)— (349)
Stock compensation expense— — 59 — — — — — 59 
Balance, June 30, 2022606,444 $1 $19,899 $(913)$8,816 25,320 $(1,514)$141 $26,430 
Comprehensive Earnings:
Net earnings (loss)— — — — 738 — — (2)736 
Other comprehensive loss, net of $(120) tax
— — — (481)— — — — (481)
Common stock issued for employee benefit plans487 — 24 — — — — — 24 
Common stock repurchases— — (200)— — 11,520 (1,043)— (1,243)
Stock compensation expense— — 51 — — — — — 51 
Reclassification to redeemable— — — — — — — 17 17 
Balance, September 30, 2022606,931 $1 $19,774 $(1,394)$9,554 36,840 $(2,557)$156 $25,534 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
5
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
(Unaudited)

 Nine Months Ended September 30,
 20232022
Cash flows from operating activities:  
Net earnings$2,660 $1,421 
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization978 1,079 
Stock compensation expense167 180 
Impairment478 1,739 
(Gain) loss on debt extinguishment— (26)
Deferred income taxes14 (682)
(Gain) loss on divestitures(172)(503)
Other adjustments, net158 164 
Changes in assets and liabilities  
Premium and trade receivables(2,329)(1,274)
Other assets(103)152 
Medical claims liabilities401 1,976 
Unearned revenue1,878 1,964 
Accounts payable and accrued expenses3,127 686 
Other long-term liabilities583 863 
Other operating activities, net(4)98 
Net cash provided by operating activities7,836 7,837 
Cash flows from investing activities:  
Capital expenditures(576)(771)
Purchases of investments(4,729)(5,118)
Sales and maturities of investments4,373 2,842 
Acquisitions, net of cash acquired— (1,457)
Divestiture proceeds, net of divested cash690 1,362 
Net cash (used in) investing activities(242)(3,142)
Cash flows from financing activities:  
Proceeds from long-term debt2,170 357 
Payments and repurchases of long-term debt(1,970)(1,202)
Common stock repurchases(1,602)(1,663)
Proceeds from common stock issuances32 62 
Payments for debt extinguishment— (14)
Purchase of noncontrolling interest(87)— 
Other financing activities, net— (5)
Net cash (used in) financing activities(1,457)(2,465)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash19 (37)
Net increase in cash, cash equivalents, and restricted cash and cash equivalents6,156 2,193 
Cash and cash equivalents reclassified from (to) held for sale(36)(192)
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period
12,330 13,214 
Cash, cash equivalents, and restricted cash and cash equivalents, end of period
$18,450 $15,215 
Supplemental disclosures of cash flow information:  
Interest paid$496 $462 
Income taxes paid$759 $448 
The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:
September 30,
20232022
Cash and cash equivalents$18,190 $14,987 
Restricted cash and cash equivalents, included in restricted deposits260 228 
Total cash, cash equivalents, and restricted cash and cash equivalents$18,450 $15,215 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
6
CENTENE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. Organization and Operations

Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2022. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2022 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2022 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2023 presentation, including reclassifications related to the Company's new segment reporting structure as outlined below. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

Segment Reporting

In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment, and (4) an Other segment.

The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind, or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans (D-SNPs), and Medicare Prescription Drug Plans (PDPs), also known as Medicare Part D. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.

Accounting Guidance Not Yet Adopted

The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.
7

2. Acquisitions and Divestitures

On January 5, 2023, the Company completed the divestiture of HealthSmart, its third-party health plan administration business.

On January 10, 2023, the Company signed and closed on a definitive agreement to divest Centurion, its prison healthcare business. During 2022, the Company recorded impairment charges related to goodwill and other current assets associated with the divestiture. During the second quarter of 2023, the Company recognized a $15 million gain on the divestiture of the Centurion business reflecting additional proceeds for contingent consideration, partially offset by net working capital adjustments. The gain is included in investment and other income in the Consolidated Statements of Operations.

On January 20, 2023, the Company completed the divestiture of Magellan Specialty Health for approximately $646 million in cash and stock, including an estimated working capital adjustment, and recognized a pre-tax gain of $79 million. The stock consideration was subsequently sold in April 2023 for cash proceeds of $245 million. The Company could also receive up to an additional $150 million in cash and stock in 2024 based on certain 2023 performance metrics. The Company will recognize the appropriate amount of contingent consideration related to the additional $150 million when realized or realizable.

On June 13, 2023, the Company completed the divestiture of its majority stake in Apixio. The Company recognized a pre-tax gain of $91 million, or $63 million after-tax, which is included in investment and other income in the Consolidated Statements of Operations.

During the second quarter of 2023, the Company recognized an additional $13 million expense related to the divestiture of its Spanish and Central European businesses, in addition to the previously recorded impairment charge of $163 million, or $140 million after-tax. The expense is included in investment and other income in the Consolidated Statements of Operations.

Circle Health Group Divestiture

On August 28, 2023, the Company signed a definitive agreement to sell Circle Health Group (Circle Health), one of the U.K.'s largest independent hospital operators, which is included in the Other segment. As of September 30, 2023, the assets and liabilities of Circle Health were considered held for sale resulting in $3,744 million of assets held for sale in other current assets and $2,947 million of liabilities held for sale in accounts payable and accrued expenses in the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as other long-term assets, goodwill and property, software and equipment. The majority of the liabilities were previously reported as debt and other long-term liabilities.

During the third quarter of 2023, the Company recorded an impairment charge related to goodwill associated with the pending divestiture of $251 million, or $269 million after-tax.

In order to manage the foreign exchange risk on the sale price associated with the pending divestiture of Circle Health, in August 2023 the Company entered into a foreign currency swap agreement for a notional amount of $931 million, to sell £740 million. The swap agreement was formally designated and qualified as a cash flow hedge. The swap expires on March 28, 2024. The gain or loss due to changes in the fair value of the foreign currency swap is recorded in other comprehensive income until the Circle Health divestiture closes, at which time the gain or loss will be recorded in earnings to the same line in the Consolidated Statement of Operations as the gain or loss on sale. The fair value of the swap agreement as of September 30, 2023 was $27 million, which was recorded in other current assets in the Consolidated Balance Sheet.

8
3. Short-term and Long-term Investments, Restricted Deposits

Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 September 30, 2023December 31, 2022
 Amortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair ValueAmortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair Value
Debt securities:
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$421 $— $(13)$408 $695 $— $(16)$679 
Corporate securities9,922 2 (750)9,174 10,127 12 (778)9,361 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
260 — — 260 256 — — 256 
Short-term time deposits
470 — — 470 204 — — 204 
Municipal securities3,931 1 (294)3,638 4,055 6 (280)3,781 
Asset-backed securities1,633 2 (52)1,583 1,396 — (70)1,326 
Residential mortgage-backed securities1,475 — (172)1,303 1,165 2 (121)1,046 
Commercial mortgage-backed securities
1,100 — (112)988 961 — (99)862 
Equity securities2 — — 2 5 — — 5 
Private equity investments
810 — — 810 529 — — 529 
Life insurance contracts
178 — — 178 169 — — 169 
Total$20,206 $5 $(1,393)$18,818 $19,566 $20 $(1,364)$18,222 

The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments, and life insurance contracts. Private equity investments include direct investments in private equity securities as well as private equity funds. The Company's investment policies are designed to provide liquidity, preserve capital, and maximize total return on invested assets with a focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of September 30, 2023, 99% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At September 30, 2023, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $144 million and $132 million at September 30, 2023 and December 31, 2022, respectively, and is included in other current assets in the Consolidated Balance Sheets.

The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AA+ and a weighted average duration of 4 years at September 30, 2023.

9
The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 September 30, 2023December 31, 2022
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair Value
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$(1)$161 $(12)$247 $(5)$342 $(11)$184 
Corporate securities(76)2,470 (674)6,393 (340)5,368 (438)3,400 
Municipal securities(44)1,308 (250)2,211 (142)2,437 (138)995 
Asset-backed securities(7)486 (45)946 (29)786 (41)486 
Residential mortgage-backed securities(23)517 (149)786 (55)629 (66)352 
Commercial mortgage-backed securities(11)228 (101)748 (49)513 (50)330 
Total$(162)$5,170 $(1,231)$11,331 $(620)$10,075 $(744)$5,747 

As of September 30, 2023, the gross unrealized losses were generated from 6,355 positions out of a total of 6,604 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.

For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.

In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates, and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit-related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.

The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 September 30, 2023December 31, 2022
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized CostFair ValueAmortized CostFair ValueAmortized CostFair ValueAmortized CostFair Value
One year or less$2,121 $2,091 $537 $534 $2,207 $2,179 $534 $532 
One year through five years7,421 6,906 531 496 7,651 7,147 524 490 
Five years through ten years3,931 3,501 312 282 4,066 3,613 224 195 
Greater than ten years123 113 32 31 135 129 — — 
Asset-backed securities4,208 3,874 — — 3,522 3,234 — — 
Total$17,804 $16,485 $1,412 $1,343 $17,581 $16,302 $1,282 $1,217 
 
Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments, and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem substantially all of the securities included in the greater than ten years category listed above at amortized cost.
10

4. Fair Value Measurements

Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at September 30, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$18,190 $— $— $18,190 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$81 $— $— $81 
Corporate securities— 9,142 — 9,142 
Municipal securities— 2,918 — 2,918 
Short-term time deposits— 470 — 470 
Asset-backed securities— 1,583 — 1,583 
Residential mortgage-backed securities— 1,303 — 1,303 
Commercial mortgage-backed securities— 988 — 988 
Equity securities— 2 — 2 
Total investments$81 $16,406 $— $16,487 
Restricted deposits:    
Cash and cash equivalents$260 $— $— $260 
U.S. Treasury securities and obligations of U.S. government corporations and agencies327 — — 327 
Corporate securities— 32 — 32 
Certificates of deposit— 4 — 4 
Municipal securities— 720 — 720 
Total restricted deposits$587 $756 $— $1,343 
Other current assets:
Foreign currency swap agreement$— $27 $— $27 
Total assets at fair value$18,858 $17,189 $— $36,047 

11
The following table summarizes fair value measurements by level at December 31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$12,074 $— $— $12,074 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$366 $5 $— $371 
Corporate securities— 9,328 — 9,328 
Municipal securities— 3,165 — 3,165 
Short-term time deposits— 204 — 204 
Asset backed securities— 1,326 — 1,326 
Residential mortgage-backed securities— 1,046 — 1,046 
Commercial mortgage-backed securities— 862 — 862 
Equity securities3 2 — 5 
Total investments$369 $15,938 $— $16,307 
Restricted deposits:    
Cash and cash equivalents$256 $— $— $256 
U.S. Treasury securities and obligations of U.S. government corporations and agencies308 — — 308 
Corporate securities— 33 — 33 
Certificates of deposit— 4 — 4 
Municipal securities— 616 — 616 
Total restricted deposits$564 $653 $— $1,217 
Total assets at fair value$13,007 $16,591 $— $29,598 
 
The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $988 million and $698 million as of September 30, 2023 and December 31, 2022, respectively.
12
5. Goodwill and Intangible Assets

As discussed in Note 1. Organization and Operations, in the first quarter of 2023, the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.

The following table summarizes the changes in goodwill by operating segment ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, December 31, 2021$10,194 $1,592 $5,424 $2,561 $19,771 
Acquisition and purchase accounting adjustments— — — 1,077 1,077 
Divestitures— — — (1,533)(1,533)
Reallocation4 — — (4)— 
Impairments— — — (370)(370)
Translation impact— — — (133)(133)
Balance, December 31, 2022$10,198 $1,592 $5,424 $1,598 $18,812 
Divestitures— — — (933)(933)
Impairments— — — (348)(348)
Translation impact— — — 27 27 
Balance, September 30, 2023$10,198 $1,592 $5,424 $344 $17,558 

The decrease in the Other segment goodwill in 2023 was primarily driven by the pending divestiture of Circle Health, which resulted in held for sale accounting and an impairment of $251 million as discussed in Note 2. Acquisitions and Divestitures, and an impairment of the Company's Operose Health business based on market indicators of fair value.

6. Medical Claims Liability

As discussed in Note 1. Organization and Operations, in the first quarter of 2023, the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.

The following table summarizes the change in medical claims liability for the nine months ended September 30, 2023 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2023$11,253 $3,431 $1,921 $140 $16,745 
Less: Reinsurance recoverable7 — 19 — 26 
Balance, January 1, 2023, net11,246 3,431 1,902 140 16,719 
Incurred related to:
Current year60,379 14,680 13,994 1,095 90,148 
Prior years(1,303)(326)(256)(3)(1,888)
Total incurred59,076 14,354 13,738 1,092 88,260 
Paid related to:
Current year50,774 12,069 11,575 984 75,402 
Prior years8,517 2,452 1,376 136 12,481 
Total paid59,291 14,521 12,951 1,120 87,883 
Balance, September 30, 2023, net
11,031 3,264 2,689 112 17,096 
Plus: Reinsurance recoverable4 — 41 — 45 
Balance, September 30, 2023
$11,035 $3,264 $2,730 $112 $17,141 

13
The following table summarizes the change in medical claims liability for the nine months ended September 30, 2022 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2022$9,845 $2,286 $2,014 $98 $14,243 
Less: Reinsurance recoverable23 — — — 23 
Balance, January 1, 2022, net9,822 2,286 2,014 98 14,220 
Acquisitions and divestitures— — — 249 249 
Incurred related to:
Current year57,074 14,624 10,609 2,150 84,457 
Prior years(966)(22)(193)(15)(1,196)
Total incurred56,108 14,602 10,416 2,135 83,261 
Paid related to:
Current year47,481 11,603 9,046 2,175 70,305 
Prior years7,343 1,963 1,580 82 10,968 
Total paid54,824 13,566 10,626 2,257 81,273 
Balance, September 30, 2022, net
11,106 3,322 1,804 225 16,457 
Plus: Reinsurance recoverable8 — — — 8 
Balance, September 30, 2022
$11,114 $3,322 $1,804 $225 $16,465 

Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of development within "Incurred related to: Prior years," the Company recorded $341 million and $121 million as a reduction to premium revenue in the nine months ended September 30, 2023 and 2022, respectively, for minimum health benefits ratio (HBR) and other return of premium programs.

Incurred but not reported (IBNR) plus expected development on reported claims as of September 30, 2023 was $11,661 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.

7. Affordable Care Act

The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions.

The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
September 30, 2023December 31, 2022
Risk adjustment receivable$1,130 $838 
Risk adjustment payable(2,312)(780)
Minimum medical loss ratio(90)(103)
Cost sharing reduction payable(104)(99)

In June 2023, the Centers for Medicare and Medicaid Services (CMS) announced the final risk adjustment transfers for the 2022 benefit year. As a result of and subsequent to the announcement, the Company increased its risk adjustment net receivables by $244 million from December 31, 2022. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was approximately $198 million in the nine months ended September 30, 2023.
14

8. Debt
 
Debt consists of the following ($ in millions):
 September 30, 2023December 31, 2022
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,395 $2,393 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,303 2,303 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,277 3,277 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,675 15,673 
Term Loan Facility2,142 2,183 
Revolving Credit Agreement309 58 
Finance leases and other3 253 
Debt issuance costs(128)(147)
Total debt18,001 18,020 
Less: current portion(113)(82)
 Long-term debt$17,888 $17,938 

In May 2023, the Company entered into a first amendment to the Company's Fourth Amended and Restated Credit Agreement. The amendment removed and replaced the interest rate benchmark based on the London Interbank Offered Rate (LIBOR) and related LIBOR-based mechanics applicable to U.S. dollar borrowings under the Amended and Restated Credit Agreement with an interest rate benchmark based on the Secured Overnight Financing Rate (SOFR) (including a customary credit spread adjustment) and related SOFR-based mechanics. Additionally, the amendment removed certain provisions which required the Company to make certain mandatory prepayments of the Term Loan Facility.

9. Leases

The following table sets forth the right-of-use (ROU) assets and lease liabilities ($ in millions):
 September 30, 2023December 31, 2022
Assets
ROU assets (recorded within other long-term assets)$430 $2,554 
Liabilities
Short-term (recorded within accounts payable and accrued expenses)$170 $180 
Long-term (recorded within other long-term liabilities)936 3,133 
Total lease liabilities$1,106 $3,313 

The decrease in ROU assets and lease liabilities in 2023 was primarily driven by divestiture related activity as discussed in Note 2. Acquisitions and Divestitures. Specifically, as of September 30, 2023, Circle Health was considered held for sale and accordingly the associated ROU assets and lease liabilities were reclassified to other current assets and accounts payable and accrued expenses, respectively, in the Consolidated Balance Sheet.
15

Additionally, in conjunction with ongoing real estate optimization initiatives, the Company recognized $35 million and $37 million of ROU asset impairments for the three and nine months ended September 30, 2023, respectively. The remainder of the $85 million real estate optimization impairment charge for the nine months ended September 30, 2023 was related to property, software and equipment.

As of September 30, 2023, the weighted average remaining lease term for the Company was 20.3 years. The average remaining lease term of the Circle Health portfolio is 26.5 years. Excluding Circle Health, the Company's portfolio average remaining lease term is 8.3 years. The lease liabilities as of September 30, 2023, reflect a weighted average discount rate of 5.8%, or 3.2% excluding Circle Health.

Excluding Circle Health, the Company had $51 million remaining in lease payments for 2023 as of September 30, 2023. Lease payments over the next five years and thereafter are as follows ($ in millions):
 Lease Payments
2024$201 
2025176 
2026151 
2027133 
2028113 
Thereafter441 
Total lease payments1,215 
Less: imputed interest(160)
Total lease liabilities$1,055 

10. Stockholders' Equity

The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. In 2022, the Company's Board of Directors authorized increases under the program including $3,000 million in June 2022 and an additional $2,000 million in December 2022. With these increases, the Company is authorized to repurchase up to $6,000 million, inclusive of past authorizations. As of September 30, 2023, the Company had a remaining amount of $1,256 million available under the stock repurchase program. In October 2023, the Company repurchased an additional 397 thousand shares for $27 million.

The following represents the Company's share repurchase activity ($ in millions, shares in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2023
2022 (2)
2023
2022 (2)
SharesCostSharesCostSharesCostSharesCost
Share buybacks11,609 $773 11,486 $1,040 22,489 $1,550 15,674 $1,384 
Income tax withholding11 1 34 3 778 52 941 79 
Total share repurchases (1)
11,620 $774 11,520 $1,043 23,267 $1,602 16,615 $1,463 
(1)
Excludes share repurchase excise tax of $10 million accrued as of September 30, 2023.
(2)
Includes 8.6 million shares delivered as part of an accelerated share repurchase (ASR) agreement, representing 80% of the $1,000 million notional amount. Remaining shares were delivered in the fourth quarter of 2022 upon the settlement of the ASR.
Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock.
16

11. Earnings Per Share

The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Earnings attributable to Centene Corporation$469 $738 $2,657 $1,415 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding539,535 573,961 546,374 580,277 
Common stock equivalents (as determined by applying the treasury stock method) (1)
1,735 6,646 2,038 6,807 
Weighted average number of common shares and potential dilutive common shares outstanding541,270 580,607 548,412 587,084 
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$0.87 $1.29 $4.86 $2.44 
Diluted earnings per common share$0.87 $1.27 $4.85 $2.41 
(1)
The reduction in common stock equivalents is primarily driven by the distribution of long-term stock awards to the estate of the Company's former CEO during the first quarter of 2023, which were fully dilutive prior to their distribution.

The calculation of diluted earnings per common share for the three months ended September 30, 2023 and 2022 excludes 1,313 thousand shares and 152 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.

The calculation of diluted earnings per common share for the nine months ended September 30, 2023 and 2022 excludes 1,383 thousand shares and 193 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.

12. Segment Information

In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. Prior year information has been adjusted to reflect the change in segment reporting.

The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.

Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.

17
Segment information for the three months ended September 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,619 $5,430 $6,451 $366 $33,866 
Service— — 2 1,099 1,101 
Premium and service revenues21,619 5,430 6,453 1,465 34,967 
Premium tax3,075 — — — 3,075 
Total external revenues24,694 5,430 6,453 1,465 38,042 
Internal revenues— — — 3,978 3,978 
Eliminations— — — (3,978)(3,978)
Total revenues$24,694 $5,430 $6,453 $1,465 $38,042 
Medical costs$19,607 $4,462 $5,089 $321 $29,479 
Cost of services$— $— $— $856 $856 
Gross margin (1)
$2,012 $968 $1,364 $288 $4,632 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the three months ended September 30, 2022, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,154 $5,639 $4,291 $764 $31,848 
Service— — 1 1,877 1,878 
Premium and service revenues21,154 5,639 4,292 2,641 33,726 
Premium tax2,139 — — — 2,139 
Total external revenues23,293 5,639 4,292 2,641 35,865 
Internal revenues— — — 6,420 6,420 
Eliminations— — — (6,420)(6,420)
Total revenues$23,293 $5,639 $4,292 $2,641 $35,865 
Medical costs$19,075 $4,730 $3,613 $693 $28,111 
Cost of services$— $— $— $1,571 $1,571 
Gross margin (1)
$2,079 $909 $679 $377 $4,044 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
18
Segment information for the nine months ended September 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$65,741 $16,971 $17,437 $1,255 $101,404 
Service— — 2 3,351 3,353 
Premium and service revenues65,741 16,971 17,439 4,606 104,757 
Premium tax9,782 — — — 9,782 
Total external revenues75,523 16,971 17,439 4,606 114,539 
Internal revenues— — — 11,634 11,634 
Eliminations— — — (11,634)(11,634)
Total revenues$75,523 $16,971 $17,439 $4,606 $114,539 
Medical costs$59,076 $14,354 $13,738 $1,092 $88,260 
Cost of services$2 $— $— $2,601 $2,603 
Gross margin (1)
$6,663 $2,617 $3,701 $913 $13,894 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the nine months ended September 30, 2022, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$62,763 $17,035 $12,977 $2,472 $95,247 
Service(1)— 2 6,678 6,679 
Premium and service revenues62,762 17,035 12,979 9,150 101,926 
Premium tax7,060 — — — 7,060 
Total external revenues69,822 17,035 12,979 9,150 108,986 
Internal revenues— — — 18,856 18,856 
Eliminations— — — (18,856)(18,856)
Total revenues$69,822 $17,035 $12,979 $9,150 $108,986 
Medical costs$56,108 $14,602 $10,416 $2,135 $83,261 
Cost of services$— $— $— $5,658 $5,658 
Gross margin (1)
$6,654 $2,433 $2,563 $1,357 $13,007 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

13. Contingencies

Overview

The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:

•periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to CMS related to risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;
19

•litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property and employment-related claims; and

•disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.

Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought.

The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.

As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits management (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the discussion below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.

Accellion

Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing, and at a mediation in September 2021, the Company reached a settlement with plaintiffs in three of the pending class actions which, if approved by court, should resolve most or all of the pending litigation related to this matter. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company's financial condition, results of operations and cash flows.

Pharmacy Benefits Management Matters

On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan. The Company has reached a no-fault settlement with the Ohio Attorney General regarding this matter and the complaint was dismissed.
20

The Company has reached no-fault settlement agreements with the Attorneys General in other states to resolve claims and/or allegations made by those states related to services previously provided by Envolve. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250 million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews or investigations relating to the Company's historical PBM business across products may be brought by other states, the federal government, or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial condition, results of operations and cash flows.
21

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this filing. The discussion contains forward-looking statements that involve known and unknown risks and uncertainties.

EXECUTIVE OVERVIEW

General

We are a leading healthcare enterprise, committed to helping people live healthier lives, with an established expertise in lower-income and medically complex populations. We provide access to high-quality healthcare, innovative programs, and a wide range of health solutions that help families and individuals get well, stay well, and be well. We believe that our local approach enables us to provide accessible, quality, culturally sensitive healthcare coverage to our communities.

Results of operations depend on our ability to manage expenses associated with health benefits (including estimated costs incurred) and selling, general and administrative (SG&A) costs. We measure operating performance based upon two key ratios. The health benefits ratio (HBR) represents medical costs as a percentage of premium revenues, excluding premium tax revenues that are separately billed, and reflects the direct relationship between the premiums received and the medical services provided. The SG&A expense ratio represents SG&A costs as a percentage of premium and service revenues, excluding premium taxes separately billed.

Value Creation Plan

We established our Value Creation Plan to drive margin expansion by leveraging our scale and generating sustainable, profitable growth. In addition to creating shareholder value, this plan is an ongoing effort to modernize and improve how we work in order to propel our organization to new levels of success and elevate the member and provider experiences. During the nine months ended September 30, 2023, we completed the following key milestones in our Value Creation Plan:

•Completed the divestitures of Magellan Specialty Health, Centurion (our prison healthcare business), HealthSmart (our third-party health plan administration business), and our majority stake in Apixio. In addition, in the third quarter of 2023, we entered into a definitive agreement to sell Circle Health Group (Circle Health).

•Completed $1.6 billion of common stock repurchases through our stock repurchase program, which were funded through divestiture proceeds and free cash flow generated from operations. In October 2023, we completed an additional $27 million of common stock repurchases.

•Completed operating model changes initiated in 2022, including streamlining call center management and utilization management.

•Initiated standardization of our pharmacy operating model and completed an RFP for pharmacy benefits management (PBM) services.

•Launched our next-gen clinical population health platform.

Segments Update

In the first quarter of 2023, and in conjunction with our updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, we revised the way we manage the business, evaluate performance, and allocate resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. We began reporting under this new segment structure in 2023. Prior year information has been adjusted to reflect the change in segment reporting.

22
Regulatory Trends and Uncertainties

The United States government, policymakers, and healthcare experts continue to discuss and debate various elements of the United States healthcare model. We remain focused on the promise of delivering access to high-quality, affordable healthcare to all of our members and believe we are well positioned to meet the needs of the changing healthcare landscape.

In contrast to previous executive and legislative efforts to restrict or limit certain provisions of the Affordable Care Act (ACA), legislation and regulations at the federal level over the last few years have contained provisions aimed at leveraging Medicaid and the Health Insurance Marketplace to expand health insurance coverage and affordability to consumers. The American Rescue Plan Act (ARPA), enacted in March 2021, initially enhanced eligibility for the premium tax credit for enrollees in the Health Insurance Marketplace, which was extended through the 2025 tax year by the Inflation Reduction Act, enacted in August 2022.

In addition, federal regulators for the Centers for Medicare & Medicaid Services (CMS) have finalized some regulations enhancing opportunities for beneficiaries dually enrolled in Medicare and Medicaid to receive integrated care through Medicare Advantage (MA) Dual Eligible Special Needs Plans (D-SNPs). Centene is positioned well given our overlapping Medicaid and MA footprints.

The COVID-19 pandemic has impacted and continues to affect our business as it relates to Medicaid eligibility changes and vaccines and treatments. The Families First Coronavirus Response Act, enacted in March 2020, increased federal matching rates for state Medicaid programs with a requirement that states suspend Medicaid redeterminations throughout the public health emergency (PHE). As a result, since the onset of the PHE through March 2023, our Medicaid membership increased by 3.6 million members (excluding new states North Carolina and Delaware and various state product expansions or managed care organization changes). The Consolidated Appropriations Act, 2023, signed into law on December 29, 2022, delinked the Medicaid continuous coverage requirements from the PHE and, as a result, some states began Medicaid disenrollments on April 1, 2023. Per the Act and clarifying CMS guidance, redeterminations related to the PHE should conclude during the second quarter of 2024. Redeterminations in certain states may move at a slower pace due to CMS compliance action to pause and/or complete corrective action prior to disenrolling beneficiaries. Some states could see redeterminations extend past the second quarter of 2024 given CMS compliance actions.

We are actively engaged to help ensure individuals take the state agency requested action to confirm eligibility in their Medicaid coverage or find other appropriate coverage that is best for themselves and their families. Our Ambetter Health product covers the majority of our Medicaid states, and we believe we are among the best positioned in the healthcare market to enroll those transitioning coverage through redeterminations. Although Medicaid continuous coverage requirements were decoupled from the PHE, we are working to address provisions that were tied to the end of the PHE which expired on May 11, 2023, including COVID costs related to vaccines and treatments, coverage requirements, and various other payment structures.

We also closely monitor state legislation across our markets and are advocating for and seeing adoption of coverage expansions for Medicaid adult populations (e.g. North Carolina), postpartum, foster care, children, among others, as well as mitigating adverse legislation addressing pharmacy, prior authorization, and other issues.

We have more than three decades of experience, spanning seven presidents from both sides of the aisle, in delivering high-quality healthcare services on behalf of states and the federal government to under-insured and uninsured families, commercial organizations, and military families. This expertise has allowed us to deliver cost-effective services to our government partners and our members. With trends in the personalization of healthcare technology, we continue the use of data and analytics to optimize our business. We continue to believe we have both the capacity and capability to successfully navigate industry changes to the benefit of our members, customers, providers, and shareholders.

23
Third Quarter 2023 Highlights

Our financial performance for the third quarter of 2023 is summarized as follows:

•Managed care membership of 28 million, an increase of 1.2 million members, or 5% year-over-year.

•Total revenues of $38.0 billion, representing 6% growth year-over-year.

•Premium and service revenues of $35.0 billion, representing 4% growth year-over-year.

•HBR of 87.0%, compared to 88.3% for the third quarter of 2022.

•SG&A expense ratio of 8.7%, compared to 8.4% for the third quarter of 2022.

•Adjusted SG&A expense ratio of 8.6%, compared to 8.3% for the third quarter of 2022.

•Operating cash flows of $1.0 billion for the third quarter of 2023.

•Diluted earnings per share (EPS) of $0.87, compared to $1.27 for the third quarter of 2022.

•Adjusted diluted EPS of $2.00, compared to $1.30 for the third quarter of 2022.

A reconciliation from GAAP diluted EPS to adjusted diluted EPS is highlighted below, and additional detail is provided above under the heading "Non-GAAP Financial Presentation":
Three Months Ended September 30,
20232022
GAAP diluted EPS attributable to Centene$0.87 $1.27 
Amortization of acquired intangible assets0.33 0.36 
Acquisition and divestiture related expenses0.03 0.05 
Other adjustments (1)
0.87 (0.38)
Income tax effects of adjustments (2)
(0.10)— 
Adjusted diluted EPS$2.00 $1.30 
(1) Other adjustments include the following pre-tax items:
2023:
(a) Circle Health impairment of $251 million, or $0.46 per share ($0.50 after-tax), Operose Health impairment of $142 million, or $0.26 per share ($0.24 after-tax), real estate impairments of $47 million, or $0.09 per share ($0.09 after-tax), severance costs due to a restructuring of $22 million, or $0.04 per share ($0.03 after-tax), and a reduction to the previously recorded gain on the sale of Magellan Rx of $10 million, or $0.02 per share ($0.00 after-tax).

2022:
(b) gain on the sale of PANTHERx Rare (PANTHERx) of $490 million, or $0.84 per share ($0.65 after-tax), impairment of assets associated with the divestiture of our Spanish and Central European businesses of $165 million, or $0.28 per share ($0.23 after-tax), real estate impairments of $127 million, or $0.22 per share ($0.16 after-tax), increase to the previously reported gain on the divestiture of U.S. Medical Management (USMM) due to the finalization of working capital adjustments of $13 million, or $0.02 per share ($0.01 after-tax), gain on debt extinguishment related to the repurchases of senior notes of $10 million, or $0.02 per share ($0.01 after-tax), and an adjustment to the costs related to the PBM legal settlement of $1 million, or $0.00 per share ($0.00 after-tax).

(2) The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment.

24
Current and Future Operating Drivers

The following items contributed to our results of operations as compared to the previous year:

Medicaid

•In September 2023, our subsidiary, Superior HealthPlan (Superior), commenced a new, six-year contract awarded by the Texas Health and Human Services Commission to continue providing youth in foster care with healthcare coverage through the STAR Health Medicaid program. Superior has been the sole provider of STAR Health coverage since the program launched in 2008.

•In April 2023, eligibility redeterminations related to the PHE began. We expect that these redeterminations will extend over a 14-month period, with the majority concluding in the second quarter of 2024. Eligibility suspensions from the onset of the PHE drove increased membership through March 2023.

•In April 2023, the state of New York removed pharmacy services for certain of our managed care contracts in connection with the state's transition of pharmacy services to Medicaid fee-for-service.

•In February 2023, our subsidiary, Buckeye Health Plan, commenced the Medicaid contract awarded by the Ohio Department of Medicaid to continue servicing members with quality healthcare, coordinated services, and benefits.

•In January 2023, our subsidiary, Delaware First Health, commenced its contract for the statewide Medicaid managed care programs.

•In January 2023, our subsidiary, Louisiana Healthcare Connections, commenced the Medicaid contract awarded by the Louisiana Department of Health to continue administering quality, integrated healthcare services to members across the state.

•In January 2023, our subsidiary, Managed Health Services, commenced the contract awarded by the Indiana Department of Administration to continue serving Hoosier Healthwise and Health Indiana Plan members with Medicaid and Medicaid alternative managed care and care coordination services.

•In October 2022, the state of Ohio removed pharmacy services in connection with the state's transition from managed care to a single PBM.

•In July 2022, our subsidiary, Home State Health, commenced the MO HealthNet Managed Care General Plan and Specialty Plan contracts. Under the General Plan, Home State Health continues to serve multiple MO HealthNet programs including Children's Health Insurance members and the state's newly implemented Medicaid expansion population, across all regions of Missouri. Additionally, as the sole provider of the newly awarded Specialty Plan, Home State Health now serves approximately 49,300 foster children and children receiving adoption subsidy assistance.

Medicare

•Medicare membership declined year-over-year due to lower enrollment during both the annual and open enrollment periods.

Commercial

•In 2023, our Health Insurance Marketplace product, Ambetter Health, expanded into Alabama and extended its footprint by more than 60 counties across 12 existing states. In total, the Marketplace plan is available in more than 1,500 counties across 28 states. Additionally, Marketplace membership increased year-over-year due to the expanded footprint, strong product positioning and open enrollment results, as well as overall market growth.

25
Other

•In June 2023, we completed the divestiture of Apixio, repositioning the business with a financial partner that can continue to invest in it. We maintain a close relationship with, and a minority interest in, the business.

•In January 2023, we completed the divestitures of Magellan Specialty Health, Centurion (our prison healthcare business), and HealthSmart (our third-party health plan administration business).

•In December 2022, we completed the divestiture of Magellan Rx, which was part of the Magellan Health, Inc. (Magellan) business acquired in January 2022.

•In November 2022, we completed the divestiture of our ownership stakes in our Spanish and Central European businesses, including Ribera Salud, Torrejón Salud, and Pro Diagnostics Group.

•In July 2022, we completed the divestiture of PANTHERx Rare (PANTHERx).

We expect the following items to impact our future results of operations:

Medicaid

•In July 2023, our subsidiary, Superior, announced it entered into a contract to continue to provide healthcare coverage to the aged, blind, or disabled (ABD) population in the state's STAR+PLUS program. The contract is anticipated to begin in September 2024 for a six-year term with a maximum of three additional two-year extensions.

•In June 2023, our subsidiary, Oklahoma Complete Health, was selected by the Oklahoma Health Care Authority for statewide contracts to provide managed care for the SoonerSelect and SoonerSelect Children's Specialty Plan programs. The contracts are anticipated to begin in April 2024 for a one-year term with five, one-year renewal options.

•In March 2023, the state of North Carolina passed legislation for Medicaid Expansion. We expect the program to commence in December 2023.

•In December 2022, the federal government's year-end spending bill was passed, including key coverage expansions for Medicaid and the Children's Health Insurance Program (CHIP). The provisions require states to provide 12 months of continuous coverage for children under Medicaid and CHIP effective January 2024 and made the state option to extend coverage for postpartum women for up to 12 months permanent.

•In December 2022, our subsidiary, Health Net of California, was selected by the California Department of Health Care Services for direct Medicaid contracts in 10 counties, including Los Angeles (in which a portion will be subcontracted). The contracts are anticipated to begin in January 2024.

•In September 2022, our subsidiary, Nebraska Total Care, was awarded the Nebraska Department of Health and Human Services statewide Medicaid managed care contract. Under the new contract, Nebraska Total Care will continue serving the state's Medicaid Managed Care Program, known as Heritage Health. The new contract term is five years and includes the option for two, one-year renewals. The contract is anticipated to begin in January 2024, subject to the resolution of third-party protests.

•In August 2022, our subsidiary, Magnolia Health Plan (Magnolia), was awarded the Mississippi Division of Medicaid contract. Under the new contract, Magnolia will continue serving the state's Coordinated Care Organization Program, which will consist of the Mississippi Coordinated Access Network and the Mississippi CHIP. The contract is anticipated to begin in July 2024, subject to the resolution of third-party protests.

•In August 2021, our subsidiaries, Carolina Complete Health and WellCare of North Carolina, were selected to coordinate physical and/or other health services with Local Management Entities/Managed Care Organizations under the state's new Tailored Plans. The Tailored Plans are integrated health plans designed for individuals with significant behavioral health needs and intellectual/developmental disabilities. The Tailored Plans are expected to commence no later than July 2024.

26
Medicare

•In October 2023, CMS issued 2024 Medicare Advantage Star Ratings on the Medicare Plan Finder. Based on the data, approximately 73% of membership is associated with contracts showing year-over-year unrounded score improvement, and approximately 87% of membership is associated with contracts rated 3.0 stars or better - compared to 53% in the prior year. While we have work to do to improve star scores, this demonstrates the first step towards our multi-year goals.

•We expect that the decrease in Star quality ratings in the 2023 rating year, which CMS published in October 2022, will adversely impact our 2024 Medicare revenue. The decrease in Star quality ratings is driven by the expiration of certain disaster relief provisions as well as deterioration in select metrics. Over the past year, our leadership team launched a multi-year plan to build and improve quality across the enterprise with a strong focus on enhanced patient experience and access to care.

Other

•In August 2023, Centene signed a definitive agreement to sell Circle Health Group, one of the U.K.'s largest independent hospital operators. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2024.

•We continue to execute on Value Creation Plan initiatives including the award of the new PBM contract commencing in 2024, portfolio review, real estate optimization, stock and debt repurchases, along with an ongoing focus on quality improvement actions. We expect these actions will drive future margin expansion, create shareholder value, and improve the experience for our members and providers.
27

MEMBERSHIP

From September 30, 2022 to September 30, 2023, we increased our managed care membership by 1.2 million, or 5%. The following table sets forth our membership by line of business:
 September 30, 2023December 31, 2022September 30, 2022
Traditional Medicaid (1)
13,470,900 14,264,800 14,000,100 
High Acuity Medicaid (2)
1,769,600 1,710,000 1,698,100 
Total Medicaid (4)
15,240,500 15,974,800 15,698,200 
Commercial Marketplace3,681,600 2,076,100 2,087,800 
Commercial Group424,200 441,100 439,800 
Total Commercial4,105,800 2,517,200 2,527,600 
Medicare (3) (4)
1,310,600 1,511,100 1,517,900 
Medicare PDP4,539,800 4,226,000 4,186,200 
Total at-risk membership25,196,700 24,229,100 23,929,900 
TRICARE eligibles2,773,200 2,832,300 2,832,300 
Total
27,969,900 27,061,400 26,762,200 
(1)
Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health Insurance Program (CHIP), Foster Care, and Behavioral Health.
(2)
Membership includes Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and Supports (LTSS), and Medicare-Medicaid Plans (MMP) Duals.
(3)
Membership includes Medicare Advantage and Medicare Supplement.
(4)
Membership includes 1,311,500, 1,291,300, and 1,285,600 Dual Eligible Special Needs Plans (D-SNP) beneficiaries for the periods ending September 30, 2023, December 31, 2022, and September 30, 2022, respectively.
28

RESULTS OF OPERATIONS

The following discussion and analysis is based on our Consolidated Statements of Operations, which reflect our results of operations for the three and nine months ended September 30, 2023 and 2022, prepared in accordance with generally accepted accounting principles in the United States (GAAP). 

Summarized comparative financial data for the three and nine months ended September 30, 2023 and 2022 is as follows ($ in millions, except per share data in dollars):
Three Months Ended September 30,
Nine Months Ended September 30,
 20232022% Change20232022% Change
Premium$33,866 $31,848 6 %$101,404 $95,247 6 %
Service1,101 1,878 (41)%3,353 6,679 (50)%
Premium and service revenues34,967 33,726 4 %104,757 101,926 3 %
Premium tax3,075 2,139 44 %9,782 7,060 39 %
Total revenues38,042 35,865 6 %114,539 108,986 5 %
Medical costs29,479 28,111 5 %88,260 83,261 6 %
Cost of services856 1,571 (46)%2,603 5,658 (54)%
Selling, general and administrative expenses3,048 2,846 7 %9,075 8,391 8 %
Depreciation expense148 150 (1)%436 470 (7)%
Amortization of acquired intangible assets180 211 (15)%542 609 (11)%
Premium tax expense3,156 2,211 43 %10,021 7,258 38 %
Impairment440 289 52 %478 1,739 (73)%
Earnings from operations735 476 54 %3,124 1,600 95 %
Investment and other income214 692 (69)%992 786 26 %
Debt extinguishment— 10 n.m.— 26 n.m.
Interest expense(181)(169)(7)%(542)(491)(10)%
Earnings before income tax768 1,009 (24)%3,574 1,921 86 %
Income tax expense293 269 9 %914 500 83 %
Net earnings475 740 (36)%2,660 1,421 87 %
(Earnings) attributable to noncontrolling interests(6)(2)n.m.(3)(6)50 %
Net earnings attributable to Centene Corporation$469 $738 (36)%$2,657 $1,415 88 %
Diluted earnings per common share attributable to Centene Corporation$0.87 $1.27 (31)%$4.85 $2.41 101 %
n.m.: not meaningful


29
Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022

Total Revenues

The following table sets forth supplemental revenue information for the three months ended September 30, ($ in millions):
20232022% Change
Medicaid$24,694 $23,293 6 %
Commercial6,453 4,292 50 %
Medicare (1)
5,430 5,639 (4)%
Other1,465 2,641 (45)%
Total revenues$38,042 $35,865 6 %
(1)
Medicare includes Medicare Advantage, Medicare Supplement, D-SNPs, and Medicare Prescription Drug Plan (PDP).

Total revenues increased 6% in the three months ended September 30, 2023, over the corresponding period in 2022, driven by membership growth in the Marketplace business due to strong product positioning as well as overall market growth. The revenue growth was partially offset by recent divestitures.

Operating Expenses

Medical Costs/HBR

The HBR for the three months ended September 30, 2023, was 87.0%, compared to 88.3% in the same period in 2022. The decrease is primarily attributed to growth in the Marketplace business, which runs at a lower HBR and strong performance from pricing discipline and execution.

Cost of Services

Cost of services decreased by $715 million in the three months ended September 30, 2023, compared to the corresponding period in 2022. The cost of service ratio for the three months ended September 30, 2023, was 77.7%, compared to 83.7% in the same period in 2022. The decreases were driven by recent divestitures.

Selling, General & Administrative Expenses

The SG&A expense ratio was 8.7% for the third quarter of 2023, compared to 8.4% in the third quarter of 2022. The adjusted SG&A expense ratio was 8.6% for the third quarter of 2023, compared to 8.3% in the third quarter of 2022. The increases were driven by growth in the Marketplace business, which operates at a meaningfully higher SG&A ratio as compared to Medicaid.

Impairment

During the third quarter of 2023, we recorded total impairment charges of $440 million, including a $251 million charge related to assets associated with the pending divestiture of Circle Health, a $142 million charge related to assets associated with our Operose Health business based on market indicators of fair value, and additional impairments of $47 million related to our ongoing real estate optimization initiatives.

During the third quarter of 2022, we recorded total impairment charges of $289 million, including a $165 million charge related to assets associated with the divestiture of our Spanish and Central European businesses and $124 million related to the reduction of our real estate footprint consisting of leased and owned real estate assets and related fixed assets.
30

Other Income (Expense)

The following table summarizes the components of other income (expense) for the three months ended September 30, ($ in millions): 
 20232022
Investment and other income$214 $692 
Debt extinguishment— 10 
Interest expense(181)(169)
Other income (expense), net$33 $533 

Investment and other income. Investment and other income decreased by $478 million in the three months ended September 30, 2023, compared to the corresponding period in 2022. The three months ended September 30, 2023 included a $75 million realized loss on the sale of investments from rebalancing a portion of our portfolio with a focus on higher interest rate investments. The three months ended September 30, 2022 included a $490 million gain on the sale of PANTHERx.

Debt extinguishment. During the third quarter of 2022, we repurchased $83 million of our 4.25% Senior Notes due 2027 and $176 million of our 4.625% Senior Notes due 2029 through our debt repurchase program, resulting in a gain on extinguishment of $10 million.

Interest expense. Interest expense increased by $12 million in the three months ended September 30, 2023, compared to the corresponding period in 2022. The increase was driven by higher interest rates on variable rate debt.

Income Tax Expense

For the three months ended September 30, 2023, we recorded income tax expense of $293 million on pre-tax earnings of $768 million, or an effective tax rate of 38.2%. The effective tax rate for the third quarter of 2023 reflects the tax effects of impairments as well as the pending divestiture of Circle Health. For the third quarter of 2023, our effective tax rate on adjusted earnings was 24.2%.

For the three months ended September 30, 2022, we recorded an income tax expense of $269 million on pre-tax earnings of $1.0 billion, or an effective tax rate of 26.6%. For the third quarter of 2022, our effective tax rate on adjusted earnings was 26.3%.
31

Segment Results

The following table summarizes our consolidated operating results by segment for the three months ended September 30, ($ in millions):
 20232022% Change
Total Revenues   
Medicaid$24,694 $23,293 6 %
Medicare5,430 5,639 (4)%
Commercial6,453 4,292 50 %
Other1,465 2,641 (45)%
Consolidated total$38,042 $35,865 6 %
Gross Margin (1)
  
Medicaid$2,012 $2,079 (3)%
Medicare968 909 6 %
Commercial1,364 679 101 %
Other288 377 (24)%
Consolidated total$4,632 $4,044 15 %
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Medicaid

Total revenues increased 6% in the three months ended September 30, 2023, compared to the corresponding period in 2022. Gross margin decreased $67 million in the three months ended September 30, 2023, compared to the corresponding period in 2022, driven by an increase in total revenue, offset by a retroactive rate decrease from one state.

Medicare

Total revenues decreased 4% in the three months ended September 30, 2023, compared to the corresponding period in 2022 driven by lower membership. Gross margin increased $59 million in the three months ended September 30, 2023, compared to the corresponding period in 2022, driven by product offerings designed to improve HBR.

Commercial

Total revenues increased 50% in the three months ended September 30, 2023, compared to the corresponding period in 2022. Gross margin increased $685 million in the three months ended September 30, 2023, compared to the corresponding period in 2022. Increases were primarily driven by 76% membership growth in the Marketplace business, resulting from strong product positioning and overall market growth.

Other

Total revenues decreased 45% in the three months ended September 30, 2023, compared to the corresponding period in 2022. Gross margin decreased $89 million in the three months ended September 30, 2023, compared to the corresponding period in 2022. Decreases were primarily due to recent divestitures.
32

Nine Months Ended September 30, 2023 Compared to Nine Months Ended September 30, 2022

Total Revenues

The following table sets forth supplemental revenue information for the nine months ended September 30, ($ in millions):
20232022% Change
Medicaid$75,523 $69,822 8 %
Commercial17,439 12,979 34 %
Medicare (1)
16,971 17,035 n.m.
Other4,606 9,150 (50)%
Total revenues$114,539 $108,986 5 %
(1)
Medicare includes Medicare Advantage, Medicare Supplement, D-SNPs, and Medicare PDP.
n.m.: not meaningful

Total revenues increased 5% in the nine months ended September 30, 2023, over the corresponding period in 2022 driven by 76% membership growth in the Marketplace business due to strong product positioning as well as overall market growth. The revenue growth was partially offset by recent divestitures.

Operating Expenses

Medical Costs/HBR

The HBR for the nine months ended September 30, 2023 was 87.0%, compared to 87.4% in the same period in 2022. The decrease is primarily attributed to growth in the Marketplace business, which runs at a lower HBR and strong performance from pricing discipline and execution.

Cost of Services

Cost of services decreased by $3.1 billion in the nine months ended September 30, 2023, compared to the corresponding period in 2022. The cost of service ratio for the nine months ended September 30, 2023 was 77.6%, compared to 84.7% in the same period in 2022. The decreases were driven by recent divestitures.

Selling, General & Administrative Expenses

The SG&A expense ratio for the nine months ended September 30, 2023 was 8.7%, compared to 8.2% for the corresponding period in 2022. The adjusted SG&A expense ratio for the nine months ended September 30, 2023 was 8.6%, compared to 8.1% for the nine months ended September 30, 2022. The increases were driven by growth in the Marketplace business, which operates at a meaningfully higher SG&A ratio as compared to Medicaid.

Impairment

During the nine months ended September 30, 2023 we recorded total impairment charges of $478 million, including a $251 million charge related to assets associated with the pending divestiture of Circle Health, a $142 million charge related to assets associated with our Operose Health business based on market indicators of fair value, and additional impairments of $85 million related to our ongoing real estate optimization initiatives.

During the nine months ended September 30, 2022, we recorded total impairment charges of $1.7 billion, primarily driven by $1.6 billion related to the reduction of our real estate footprint consisting of leased and owned real estate assets and related fixed assets. The nine months ended September 30, 2022 also included a $165 million charge related to assets associated with the divestiture of our Spanish and Central European businesses.

33
Other Income (Expense)

The following table summarizes the components of other income (expense) for the nine months ended September 30, ($ in millions): 
 20232022
Investment and other income$992 $786 
Debt extinguishment— 26 
Interest expense(542)(491)
Other income (expense), net$450 $321 

Investment and other income. Investment and other income increased by $206 million in the nine months ended September 30, 2023, compared to the corresponding period in 2022, driven by higher interest rates on larger investment balances, a $91 million gain on the sale of Apixio, a $79 million gain on the sale of Magellan Specialty Health, and a $15 million gain on the sale of Centurion, partially offset by a $75 million realized loss on the sale of investments from rebalancing a portion of our portfolio with a focus on higher interest rate investments, an additional loss on the sale of our Spanish and Central European businesses of $13 million, and a $10 million reduction to the previously recorded gain on the sale of Magellan Rx. The nine months ended September 30, 2022 included a $490 million gain on the sale of PANTHERx.

Debt extinguishment. During the third quarter of 2022, we repurchased $83 million of our 4.25% Senior Notes due 2027 and $176 million of our 4.625% Senior Notes due 2029 through our debt repurchase program, resulting in a gain on extinguishment of $10 million. In May 2022, we recognized a $13 million gain on the extinguishment of debt related to the refinancing of debt for our Circle Health subsidiary. The 2022 debt extinguishment also includes an immaterial gain related to the redemption of Magellan's outstanding Senior Notes in January 2022.

Interest expense. Interest expense increased by $51 million in the nine months ended September 30, 2023, compared to the corresponding period in 2022. The increase was driven by higher interest rates on variable rate debt.

Income Tax Expense

For the nine months ended September 30, 2023, we recorded income tax expense of $914 million on pre-tax earnings of $3.6 billion, or an effective tax rate of 25.6%. The effective tax rate for 2023 reflects the tax effects of the distribution of long-term stock awards to the estate of the Company's former CEO, divestiture gains, impairments as well as the pending divestiture of Circle Health. For the nine months ended September 30, 2023, our effective tax rate on adjusted earnings was 24.5%.

For the nine months ended September 30, 2022, we recorded income tax expense of $500 million on pre-tax earnings of $1.9 billion, or an effective tax rate of 26.0%. For the nine months ended September 30, 2022, our effective tax rate on adjusted earnings was 26.2%.

34
Segment Results

The following table summarizes our consolidated operating results by segment for the nine months ended September 30, ($ in millions):
 20232022% Change
Total Revenues   
Medicaid$75,523 $69,822 8 %
Medicare16,971 17,035 n.m.
Commercial17,439 12,979 34 %
Other4,606 9,150 (50)%
Consolidated total$114,539 $108,986 5 %
Gross Margin (1)
  
Medicaid$6,663 $6,654 n.m.
Medicare2,617 2,433 8 %
Commercial3,701 2,563 44 %
Other913 1,357 (33)%
Consolidated total$13,894 $13,007 7 %
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
n.m.: not meaningful

Medicaid

Total revenues increased 8% in the nine months ended September 30, 2023, compared to the corresponding period in 2022. Gross margin increased $9 million in the nine months ended September 30, 2023, compared to the corresponding period in 2022 primarily driven by net rate increases, partially offset by higher utilization.

Medicare

Total revenues were flat in the nine months ended September 30, 2023, compared to the corresponding period in 2022. Gross margin increased $184 million in the nine months ended September 30, 2023, compared to the corresponding period in 2022 driven primarily by product offerings designed to improve HBR.

Commercial

Total revenues increased 34% in the nine months ended September 30, 2023, compared to the corresponding period in 2022. Gross margin increased $1.1 billion in the nine months ended September 30, 2023, compared to the corresponding period in 2022. Increases were primarily driven by 76% membership growth in the Marketplace business, resulting from strong product positioning and overall market growth.

Other

Total revenues decreased 50% in the nine months ended September 30, 2023, compared to the corresponding period in 2022. Gross margin decreased $444 million in the nine months ended September 30, 2023, compared to the corresponding period in 2022. Decreases were primarily due to recent divestitures.
35

LIQUIDITY AND CAPITAL RESOURCES

Shown below is a condensed schedule of cash flows used in the discussion of liquidity and capital resources ($ in millions).
 Nine Months Ended September 30,
 20232022
Net cash provided by operating activities$7,836 $7,837 
Net cash (used in) investing activities(242)(3,142)
Net cash (used in) financing activities(1,457)(2,465)
Effect of exchange rate changes on cash and cash equivalents19 (37)
Net increase in cash, cash equivalents, and restricted cash and cash equivalents$6,156 $2,193 

Cash Flows Provided by Operating Activities

Normal operations are funded primarily through operating cash flows and borrowings under our revolving credit facility. Operating activities provided cash of $7.8 billion in the nine months ended September 30, 2023, compared to $7.8 billion in the comparable period in 2022. Cash flows provided by operations in 2023 were driven by net earnings and increases in unearned revenue and accounts payable driven by the early receipt of payments from CMS.

Cash flows provided by operations in 2022 were primarily driven by net earnings before the non-cash real estate impairment charge, an increase in medical claims liabilities, and increases in unearned revenue and accounts payable due to the early receipt of payments from CMS.

Cash Flows Used in Investing Activities

Investing activities used cash of $242 million in the nine months ended September 30, 2023, and $3.1 billion in the comparable period in 2022. Cash flows used in investing activities in 2023 primarily consisted of net additions to the investment portfolio of our regulated subsidiaries (including transfers from cash and cash equivalents to long-term investments) and capital expenditures, partially offset by divestiture proceeds.

In 2022, cash flows used in investing activities primarily related to net additions to the investment portfolio of our regulated subsidiaries (including transfers from cash and cash equivalents to long-term investments) and our acquisition of Magellan, partially offset by our PANTHERx divestiture proceeds.

We spent $576 million and $771 million in the nine months ended September 30, 2023 and 2022, respectively, on capital expenditures the majority of which was driven by system enhancements and computer hardware.

As of September 30, 2023, our investment portfolio consisted primarily of fixed-income securities with an average duration of 3.5 years. We had unregulated cash and investments of $1.0 billion at September 30, 2023, compared to $1.4 billion at December 31, 2022.

Cash Flows Used in Financing Activities

Financing activities used cash of $1.5 billion in the nine months ended September 30, 2023, compared to using cash of $2.5 billion in the comparable period in 2022. Financing activities in 2023 were driven by stock repurchases of $1.6 billion.

Financing activities in 2022 were driven by stock repurchases of $1.6 billion through our stock repurchase program, the redemption of Magellan's outstanding debt of $535 million acquired in the transaction using Magellan's cash on hand, and senior note debt repurchases of $259 million.

36
Liquidity Metrics

We have a stock repurchase program authorizing us to repurchase common stock from time to time on the open market or through privately negotiated transactions. In 2022, the Company's Board of Directors authorized up to a cumulative total of $6.0 billion of repurchases under the program.

During the quarter, we repurchased 11.6 million shares of common stock for $773 million under the stock repurchase program. We have approximately $1.3 billion remaining under the program for repurchases as of September 30, 2023. No duration has been placed on the repurchase program. We reserve the right to discontinue the repurchase program at any time. Refer to Note 10. Stockholders' Equity for further information on stock repurchases.

As of September 30, 2023, we had an aggregate principal amount of $15.7 billion of senior notes issued and outstanding. The indentures governing our various maturities of senior notes contain restrictive covenants. As of September 30, 2023, we were in compliance with all covenants.

As part of our capital allocation strategy, we may decide to repurchase debt or raise capital through the issuance of debt in the form of senior notes. In 2022, the Company's Board of Directors also authorized a $1.0 billion senior note debt repurchase program. No repurchases were made during the quarter ended September 30, 2023. As of September 30, 2023, there was $700 million available under the senior note debt repurchase program.

The credit agreement underlying our Revolving Credit Facility and Term Loan Facility contains customary covenants as well as financial covenants including a minimum fixed charge coverage ratio and a maximum debt-to-EBITDA ratio. Our maximum debt-to-EBITDA ratio under the credit agreement may not exceed 4.0 to 1.0. As of September 30, 2023, we had $309 million of borrowings outstanding under our Revolving Credit Facility, $2.1 billion of borrowings under our Term Loan Facility, and we were in compliance with all covenants. As of September 30, 2023, there were no limitations on the availability of our Revolving Credit Facility as a result of the debt-to-EBITDA ratio.

We had outstanding letters of credit of $212 million as of September 30, 2023, which were not part of our revolving credit facility. The letters of credit bore weighted interest of 0.7% as of September 30, 2023. In addition, we had outstanding surety bonds of $892 million as of September 30, 2023.

At September 30, 2023, our debt to capital ratio, defined as total debt divided by the sum of total debt and total equity, was 41.5%, compared to 42.7% at December 31, 2022. The debt to capital ratio decrease was driven by net earnings partially offset by year-to-date stock repurchases. We utilize the debt to capital ratio as a measure, among others, of our leverage and financial flexibility.

At September 30, 2023, we had working capital, defined as current assets less current liabilities, of $4.6 billion, compared to $1.7 billion at December 31, 2022. We manage our short-term and long-term investments with the goal of ensuring that a sufficient portion is held in investments that are highly liquid and can be sold to fund short-term requirements as needed.

2023 Expectations

During the remainder of 2023, we expect to receive net dividends from our insurance subsidiaries of approximately $340 million and spend approximately $180 million in additional capital expenditures. In October 2023, we made additional purchases of $27 million through our stock repurchase program.

Based on our operating plan, we expect that our available cash, cash equivalents and investments, cash from our operations and cash available under our Revolving Credit Facility will be sufficient to finance our general operations and capital expenditures for at least 12 months from the date of this filing. While we are currently in a strong liquidity position and believe we have adequate access to capital, we may elect to increase borrowings on our Revolving Credit Facility. Our long-term liquidity position is stable, with our senior notes maturing between December 2027 and August 2031, and our Revolving Credit Facility maturing in August 2026. From time to time we may elect to raise additional funds for working capital and other purposes, either through issuance of debt or equity, the sale of investment securities or otherwise, as appropriate. In addition, we may strategically pursue refinancing or redemption opportunities to extend maturities and/or improve terms of our indebtedness if we believe such opportunities are favorable to us.

37
We intend to continue to evaluate strategic actions in connection with our Value Creation Plan, targeting initiatives to improve productivity, efficiencies and reduced organizational costs, as well as capital deployment activities, including stock repurchases, portfolio optimization and the evaluation of refinancing opportunities. In addition to creating shareholder value, this plan encompasses a larger organizational mission to enhance our member and provider experience, improve outcomes for our members, and initiate new ways of doing business that make Centene a great partner in all aspects of our operations.
38
REGULATORY CAPITAL AND DIVIDEND RESTRICTIONS
 
Our operations are conducted through our subsidiaries. As managed care organizations, most of our subsidiaries are subject to state regulations and other requirements that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment and amount of dividends and other distributions that may be paid to us. Generally, the amount of dividend distributions that may be paid by a regulated subsidiary without prior approval by state regulatory authorities is limited based on the entity's level of statutory net income and statutory capital and surplus.

Our regulated subsidiaries are required to maintain minimum capital requirements prescribed by various regulatory authorities in each of the states in which we operate. During the nine months ended September 30, 2023, we received dividends of $1.8 billion from and made $261 million of capital contributions to our regulated subsidiaries. For our subsidiaries that file with the National Association of Insurance Commissioners (NAIC), the aggregate risk-based capital (RBC) level as of December 31, 2022, which was the most recent date for which reporting was required, was in excess of 350% of the Authorized Control Level. We intend to continue to maintain an aggregate RBC level in excess of 350% of the Authorized Control Level during 2023.

Under the California Knox-Keene Health Care Service Plan Act of 1975, as amended (Knox-Keene), certain of our California subsidiaries must comply with tangible net equity (TNE) requirements. Under these Knox-Keene TNE requirements, actual net worth less certain unsecured receivables and intangible assets must be more than the greater of (i) a fixed minimum amount, (ii) a minimum amount based on premiums or (iii) a minimum amount based on healthcare expenditures, excluding capitated amounts.

Under the New York State Department of Health Codes, Rules and Regulations Title 10, Part 98, our New York subsidiary must comply with contingent reserve requirements. Under these requirements, net worth based upon admitted assets must equal or exceed a minimum amount based on annual net premium income.

The NAIC has adopted rules which set minimum RBC requirements for insurance companies, managed care organizations and other entities bearing risk for healthcare coverage. As of September 30, 2023, each of our health plans was in compliance with the RBC requirements enacted in those states.

As a result of the above requirements and other regulatory requirements, certain of our subsidiaries are subject to restrictions on their ability to make dividend payments, loans or other transfers of cash to their parent companies. Such restrictions, unless amended or waived or unless regulatory approval is granted, limit the use of any cash generated by these subsidiaries to pay our obligations. The maximum amount of dividends that can be paid by our insurance company subsidiaries without prior approval of the applicable state insurance departments is subject to restrictions relating to statutory surplus, statutory income and unassigned surplus.

CRITICAL ACCOUNTING ESTIMATES

Please see "Critical Accounting Estimates in Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our 2022 Annual Report on Form 10-K for a description of our Critical Accounting Estimates.
39

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

INVESTMENTS AND DEBT

As of September 30, 2023, we had short-term investments of $2.2 billion and long-term investments of $16.6 billion, including restricted deposits of $1.3 billion. The short-term investments generally consist of highly liquid securities with maturities between three and 12 months. The long-term investments consist of municipal, corporate and U.S. Treasury securities, government-sponsored obligations, life insurance contracts, asset-backed securities, and equity securities, and have maturities greater than one year. Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. Due to the nature of the states' requirements, these investments are classified as long-term regardless of the contractual maturity date. Substantially all of our investments are subject to interest rate risk and will decrease in value if market rates increase. Assuming a hypothetical and immediate 1% increase in market interest rates at September 30, 2023, the fair value of our fixed income investments would decrease by approximately $601 million.

We have a foreign currency swap for a notional amount of $931 million with a creditworthy financial institution to manage foreign exchange risk related to the pending Circle Health divestiture. As a result, the fair value of the swap varies with foreign exchange rate fluctuations. Assuming a 1% increase in the Great British Pound to US Dollar foreign exchange rate at September 30, 2023, the fair value of our swap would decrease by approximately $9 million. An increase in the US Dollar to Great British Pound foreign exchange rate decreases the fair value of the swap and conversely, a decrease in the foreign currency exchange rate increases the value. We do not hold or issue any derivative instruments for trading or speculative purposes.

For a discussion of the interest rate risk that our investments are subject to, refer to our 10-K for the fiscal year ended December 31, 2022, Part 1, Item 1A, "Risk Factors – Our investment portfolio may suffer losses which could materially and adversely affect our results of operations or liquidity."

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures - We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (Exchange Act) that are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms; and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

In connection with the filing of this Form 10-Q, management evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2023. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2023.

Changes in Internal Control Over Financial Reporting - No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended September 30, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

40
PART II
OTHER INFORMATION


Item 1. Legal Proceedings.

A description of the legal proceedings to which the Company and its subsidiaries are a party is contained in Note 13. Contingencies to the consolidated financial statements included in Part I of this Quarterly Report on Form 10-Q, and is incorporated herein by reference.

Item 1A. Risk Factors.

There have been no material changes to the risk factors disclosed in our 2022 Annual Report on Form 10-K.



41

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

In November 2005, the Company's Board of Directors announced a stock repurchase program, which was most recently increased in December 2022. The Company is authorized to repurchase up to $6.0 billion, inclusive of past authorizations.

The stock repurchase program is effected primarily through regular open-market purchases (which may include repurchase plans designed to comply with Rule 10b5-1 and accelerated share repurchases), the amounts and timing of which are subject to the Company's discretion as part of its capital allocation strategy, and may be based upon general market conditions and the prevailing price and trading volumes of its common stock. No duration has been placed on the repurchase program. The Company reserves the right to discontinue the repurchase program at any time.

Issuer Purchases of Equity Securities
Third Quarter 2023
(Shares in thousands)
Period
 
Total Number of Shares Purchased (1)
Average Price Paid per Share (2)
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs ($ in millions) (3)
July 1, 2023 - July 31, 2023
4,549 $66.02 4,545 $1,729 
August 1, 2023 - August 31, 2023
2,986 67.05 2,984 1,529 
September 1, 2023 - September 30, 2023
4,085 66.88 4,080 1,256 
Total11,620 $66.59 11,609 $1,256 
(1)
Includes 11 thousand shares relinquished to the Company by certain employees for payment of taxes.
(2)
Average price paid per share excludes accrued share repurchase excise tax of $7 million.
(3)
A remaining amount of approximately $1.3 billion is available under the stock repurchase program as of September 30, 2023.
42

Item 6. Exhibits.
EXHIBIT NUMBER 
DESCRIPTION
31.1
31.2
32.1
32.2
101The following materials from the Centene Corporation Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations; (iii) the Consolidated Statements of Comprehensive Earnings (Loss); (iv) the Consolidated Statements of Stockholders' Equity; (v) the Consolidated Statements of Cash Flows and (vi) related notes.
104Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.
43
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized as of October 24, 2023.

 CENTENE CORPORATION
      
 By: /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)
 By: /s/ ANDREW L. ASHER
 Executive Vice President, Chief Financial Officer
(principal financial officer)
 By: /s/ KATIE N. CASSO
 Senior Vice President, Corporate Controller and Chief Accounting Officer
(principal accounting officer)

44
 EX-31.1 2 a2023093010-qexhibit311.htm EX-31.1 Document

EXHIBIT 31.1

 
CERTIFICATION
 
I, Sarah M. London, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Centene Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Dated:October 24, 2023 /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)

 EX-31.2 3 a2023093010-qexhibit312.htm EX-31.2 Document

EXHIBIT 31.2

 
CERTIFICATION
 
I, Andrew L. Asher, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Centene Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:October 24, 2023  /s/ ANDREW L. ASHER
 Executive Vice President, Chief Financial Officer
(principal financial officer)

 EX-32.1 4 a2023093010-qexhibit321.htm EX-32.1 Document

EXHIBIT 32.1

 
CERTIFICATION PURSUANT TO 18 U.S.C.  SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Centene Corporation (the Company) for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Sarah M. London, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
 
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:October 24, 2023 /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)

 EX-32.2 5 a2023093010-qexhibit322.htm EX-32.2 Document

EXHIBIT 32.2

 
CERTIFICATION PURSUANT TO 18 U.S.C.  SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Centene Corporation (the Company) for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Andrew L. Asher, Executive Vice President and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
 
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:October 24, 2023  /s/ ANDREW L. ASHER
 Executive Vice President, Chief Financial Officer
(principal financial officer)

 EX-101.SCH 6 cnc-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Organization and Operations link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Acquisitions and Divestitures link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Short-term and Long-term Investments, Restricted Deposits link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Medical Claims Liability link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Affordable Care Act link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Organization and Operations (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Medical Claims Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Affordable Care Act (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Acquisitions and Divestitures - Divestiture (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Goodwill and Intangible Assets - Summary of Changes in Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Medical Claims Liability - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Affordable Care Act - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Leases - Operating Lease Payments Over Next Five Years Excluding Circle Health (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Leases - Operating Lease Payments Over Next Five Years Excluding Circle Health (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Stockholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cnc-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 cnc-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 cnc-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Premium tax expense Premium Tax Expense Premium tax expense, similar assessments and provider pass through payments. Term Loan Facility Term Loan Credit Agreement [Member] Term Loan Credit Agreement [Member] (Earnings) attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Debt Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Share buybacks (in shares) Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Revolving Credit Agreement Revolving Credit Facility [Member] Effect of exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Deferred tax liability Deferred Income Tax Liabilities, Net Segment Reporting [Abstract] Segment Reporting [Abstract] Asset-backed securities Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value Corporate securities Corporate Debt Securities [Member] Purchases of investments Payments to Acquire Investments Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Pending claims Loss Contingency, Pending Claims, Number Accrued interest income Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss Commitments and contingencies Commitments and Contingencies Remaining asset impairment charges Other Asset Impairment Charges Premium Health Care, Premium [Member] Stockholders' Equity Equity [Text Block] Proceeds from common stock issuances Proceeds from Issuance of Common Stock Schedule of Goodwill [Table] Schedule of Goodwill [Table] Medical claims liability Balance, January 1 Balance, June 30 Liability for Claims and Claims Adjustment Expense Unearned revenue Increase (Decrease) in Contract with Customer, Liability Risk adjustment payable Affordable Care Act Reinsurance Payable Affordable Care Act Reinsurance, Payable Liabilities, Current [Abstract] Liabilities, Current [Abstract] Debt Securities Debt Securities, Available-for-Sale, Amortized Cost [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2023 and December 31, 2022 Preferred Stock, Value, Issued Eliminations Intersegment Eliminations [Member] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Proceeds from sale of business Proceeds from Divestiture of Businesses Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Diluted earnings per common share (in dollars per share) Earnings Per Share, Diluted Restricted deposits Other Restricted Assets, Noncurrent Goodwill [Roll Forward] Goodwill [Roll Forward] Level III Fair Value, Inputs, Level 3 [Member] Treasury stock (in shares) Treasury stock (in shares) Treasury stock (in shares) Treasury Stock, Common, Shares Premium tax Premium Tax Revenue Premium tax revenue, similar assessments and provider pass through payments. Reserve estimate Estimated Litigation Liability Fair Value Fair Value Debt Securities, Available-for-Sale, Excluding Accrued Interest Five years through ten years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Redeemable noncontrolling interests Redeemable Noncontrolling Interest, Equity, Carrying Amount Trading Symbol Trading Symbol Risk adjustment and reinsurance pre-tax benefit Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit) Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit) Total investments Investments, Fair Value Disclosure Centurion Centurion [Member] Centurion Other comprehensive earning (loss), tax Other Comprehensive Income (Loss), Tax Net earnings attributable to Centene Corporation Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] One year through five years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Leases Lessee, Operating Leases [Text Block] Risk adjustment receivable Affordable Care Act, Risk Adjustment Receivable Affordable Care Act, Risk Adjustment Receivable Total debt Debt and Lease Obligation LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Share buybacks Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes Short-term and Long-term Investments, Restricted Deposits Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Calculation of Basic and Diluted Net Earnings Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of services Cost of Goods and Services Sold Short-duration insurance contracts, Incurred but not reported and expected development on reported claims Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net 2026 Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Three Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Three Litigation Status [Domain] Litigation Status [Domain] Level I Fair Value, Inputs, Level 1 [Member] Goodwill Goodwill, Balance beginning Goodwill, Balance ending Goodwill Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Certificates of deposit Certificates of Deposit [Member] Current year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Entity Small Business Entity Small Business Prior years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years Local Phone Number Local Phone Number Change in unrealized gain (loss) on investments, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Long-term (recorded within other long-term liabilities) Operating Lease, Liability, Noncurrent Incurred related to: Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract] Gain on disposal, net of tax Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Net Of Tax Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Net Of Tax Contractual maturities of short-term and long-term investments and restricted deposits Investments Classified by Contractual Maturity Date [Table Text Block] $3,500 million 4.625% Senior Notes due December 15, 2029 $3,500 Million 4.625% Senior Notes due December 2029 [Member] $3,500 Million 4.625% Senior Notes due December 2029 Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Depreciation expense Depreciation Weighted-average discount rate for operating leases excluding disposal group Operating Lease, Weighted Average Discount Rate, Excluding Disposal Group, Percent Operating Lease, Weighted Average Discount Rate, Excluding Disposal Group, Percent $2,200 million 3.00% Senior Notes due October 15, 2030 $2,200 Million 3.00% Senior Notes Due October 2030 [Member] $2,200 Million 3.00% Senior Notes Due October 2030 Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Fair Value Debt Securities, Held-to-Maturity, Unrealized Loss Position, Fair Value [Abstract] Income tax withholding Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Maturity of Operating Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Greater than ten years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 Total revenues Revenues Revenues Commercial mortgage-backed securities Commercial mortgage-backed securities Commercial mortgage-backed securities Commercial Mortgage-Backed Securities [Member] Product and Service [Domain] Product and Service [Domain] Balance, January 1, net Balance, June 30, net Liability for Unpaid Claims and Claims Adjustment Expense, Net ROU Assets and Liabilities Lease, Cost [Table Text Block] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Litigation Status [Axis] Litigation Status [Axis] Medical costs Policyholder Benefits and Claims Incurred, Net, Health Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Reclassification to redeemable Noncontrolling Interest, Increase from Sale of Parent Equity Interest Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Payments for debt extinguishment Payment for Debt Extinguishment or Debt Prepayment Cost Interest expense Interest Expense Less: imputed interest Lessee, Operating Lease, Liability, Excluding Disposal Group, Undiscounted Excess Amount Lessee, Operating Lease, Liability, Excluding Disposal Group, Undiscounted Excess Amount Total paid Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] (Gain) loss on debt extinguishment Gain (Loss) on Extinguishment of Debt Goodwill [Line Items] Goodwill [Line Items] Fair value of unvested equity awards in connection with acquisition Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Investments: Debt Securities, Available-for-Sale [Abstract] Apixio Apixio [Member] Apixio Affordable Care Act [Abstract] Affordable Care Act [Abstract] Affordable Care Act [Abstract] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Short-term (recorded within accounts payable and accrued expenses) Operating Lease, Liability, Current Premium and service revenues Total Premium and Service [Member] Total Premium and Service Amortization of acquired intangible assets Amortization of Intangible Assets Entity Shell Company Entity Shell Company Long-term investments Long-Term Investments Total lease payments Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group Accounting Guidance Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Employee Stock Compensation Plan Employee Stock Compensation Plan [Member] Employee Stock Compensation Plan Notional amount Derivative Asset, Notional Amount Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period Cash, cash equivalents, and restricted cash and cash equivalents, end of period Total cash, cash equivalents, and restricted cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Asset Class [Axis] Asset Class [Axis] Insurance [Abstract] Insurance [Abstract] Premium and trade receivables Increase (Decrease) in Premiums Receivable Fair Value, 12 Months or More Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Input Definitions [Table Text Block] Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions Common stock, shares issued (in shares) Common Stock, Shares, Issued Total, Amortized Cost Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost Gross margin Gross Profit Sales and maturities of investments Proceeds from Sale, Maturity and Collection of Investments Unearned revenue Contract with Customer, Liability, Current Treasury stock, at cost (80,360 and 57,093 shares, respectively) Treasury Stock, Common, Value Security Exchange Name Security Exchange Name Total assets at fair value Assets, Fair Value Disclosure Finance leases and other Finance Lease Liability And Other Finance Lease Liability And Other Selling, general and administrative expenses Selling, General and Administrative Expense Goodwill, impairment, net of tax Goodwill, Impairment Loss, Net of Tax Accumulated other comprehensive (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Total operating expenses Costs and Expenses Other financing activities, net Proceeds from (Payments for) Other Financing Activities Comprehensive earnings (loss) attributable to Centene Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document Type Document Type Acquisition and purchase accounting adjustments Goodwill, Acquired During Period Currency Swap Currency Swap [Member] Entity Address, Address Line One Entity Address, Address Line One Common stock repurchases Common stock repurchases Common stock repurchases Treasury Stock, Value, Acquired, Cost Method Aggregate carrying amount of life insurance contracts and equity investments, fair value Life Insurance Contracts And Equity Investments, Fair Value Life Insurance Contracts And Equity Investments, Fair Value Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Other adjustments, net Other Noncash Income (Expense) Accelerated Share Repurchase Agreement Accelerated Share Repurchase Agreement [Member] Accelerated Share Repurchase Agreement Fair value, swap agreement Derivative, Fair Value, Net Subsequent Event Subsequent Event [Member] Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Statement [Abstract] Income Statement [Abstract] Total external revenues Revenue from Contract with Customer, Including Assessed Tax Title of 12(b) Security Title of 12(b) Security Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure External Credit Rating by Grouping [Axis] External Credit Rating by Grouping [Axis] Operating Segments Operating Segments [Member] Net earnings per common share attributable to Centene Corporation: Net Income (Loss) Attributable to Parent [Abstract] Net Income (Loss) Attributable to Parent [Abstract] Common stock issued for employee benefit plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Other current assets Other Assets, Current Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Purchase of noncontrolling interest Payments to Noncontrolling Interests Schedule of change in medical claims liability Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] Change in unrealized gain (loss) on investments, tax effect OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Entity Tax Identification Number Entity Tax Identification Number Translation impact Goodwill, Foreign Currency Translation Gain (Loss) Private equity investments Equity Method Investments Schedule Of Investments And Restricted Deposits By Type [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Entity Interactive Data Current Entity Interactive Data Current Schedule Of Investments And Restricted Deposits By Type [Table] Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Common stock repurchases Payments for Repurchase of Common Stock Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Acquisitions and Divestitures Mergers, Acquisitions and Dispositions Disclosures [Text Block] 2027 Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Four Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Four Segments [Domain] Segments [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Medical Claims Liability Insurance Disclosure [Text Block] Debt, face amount Debt Instrument, Face Amount Impairment charge, net of tax Asset Impairment Charges, Net Of Tax Asset Impairment Charges, Net Of Tax Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Assets, Current [Abstract] Assets, Current [Abstract] Leases [Abstract] Leases [Abstract] Prior years Prior Year Claims and Claims Adjustment Expense Assets held for sale Disposal Group, Including Discontinued Operation, Assets Entity Address, State or Province Entity Address, State or Province Reallocation Goodwill, Transfers Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Residential mortgage-backed securities Residential Mortgage-Backed Securities [Member] Cash and cash equivalents reclassified from (to) held for sale Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations Common stock, shares outstanding (in shares) Balance (in shares) Balance (in shares) Common Stock, Shares, Outstanding Disposal Group Name [Domain] Disposal Group Name [Domain] Premium and trade receivables Premiums and Other Receivables, Net Net earnings per common share attributable to Centene Corporation: Earnings Per Share, Basic [Abstract] ROU impairment Operating Lease, Impairment Loss Excluding Circle Health Excluding Circle Health [Member] Excluding Circle Health Investments Investments [Member] Restricted certificates of deposit Restricted Certificates Of Deposit [Member] Restricted certificates of deposit [member] Other operating activities, net Other Operating Activities, Cash Flow Statement Asset Class [Domain] Asset Class [Domain] Common stock, par value (in dollars per share) Par value (in dollars per share) Common Stock, Par or Stated Value Per Share Risk adjustment, increase to net receivables Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease) Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease) 2024 Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year One Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year One Class of Stock [Domain] Class of Stock [Domain] Net cash (used in) investing activities Net Cash Provided by (Used in) Investing Activities Equity securities Equity Securities, FV-NI, Current Earnings attributable to Centene Corporation Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Debt Instrument [Axis] Debt Instrument [Axis] Positions from which gross unrealized losses were generated Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities Total lease liabilities Operating Lease, Liability Credit Facility [Axis] Credit Facility [Axis] Change in unrealized gain (loss) on investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Total liabilities Liabilities Service Service [Member] Consideration received on divestiture Disposal Group, Including Discontinued Operation, Consideration Accumulated Other Comprehensive Earnings (Loss) AOCI Attributable to Parent [Member] 2025 Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Two Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Two $2,000 million 3.375% Senior Notes due February 15, 2030 $2,200 Million 3.75% Senior Notes Due February 2030 [Member] $2,200 Million 3.75% Senior Notes Due February 2030 Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Plan Name [Axis] Plan Name [Axis] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Affordable Care Act Affordable Care Act Disclosure [Text Block] Affordable Care Act Disclosure [Text Block] Common stock, $0.001 par value; authorized 800,000 shares; 614,956 issued and 534,596 outstanding at September 30, 2023, and 607,847 issued and 550,754 outstanding at December 31, 2022 Common Stock, Value, Issued Fair Value, Less Than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months One year through five years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Life insurance contracts Life Insurance, Corporate or Bank Owned, Amount Medicare Medicare Segment [Member] Medicare Segment Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Total senior notes Senior Notes, Total Senior Notes, Total Senior Notes Senior Notes [Member] Segment Reporting Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Rated Securities Rated Securities [Member] Rated Securities [Member] Impairment Impairment charge Asset Impairment Charges Equity securities Equity Securities [Member] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Entity Filer Category Entity Filer Category Class of Treasury Stock Class of Treasury Stock [Table Text Block] Statement [Table] Statement [Table] Minimum medical loss ratio Affordable Care Act Minimum Medical Loss Ratio Affordable Care Act, Minimum Medical Loss Ratio Current Fiscal Year End Date Current Fiscal Year End Date Disposal Group, Held-for-sale, Not Discontinued Operations Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations Concentration Risk, Percentage Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized U.S. Treasury securities and obligations of U.S. government corporations and agencies US Treasury and Government [Member] Schedule of Goodwill Schedule of Goodwill [Table Text Block] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Asset-backed securities Asset-Backed Securities [Member] Total, Fair Value Investments, Debt Securities, Equity Securities And Other, Fair Value Investments, Debt Securities, Equity Securities And Other, Fair Value Total lease liabilities Operating Lease, Excluding Disposal Group, Liability Operating Lease, Excluding Disposal Group, Liability Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Class of Stock [Axis] Class of Stock [Axis] Interest rate Debt Instrument, Interest Rate, Stated Percentage Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Lease Contractual Term [Domain] Lease Contractual Term [Domain] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Thereafter Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, After Year Five Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, After Year Five Commercial Commercial Segment [Member] Commercial Segment (Gain) loss on divestitures Gain on divestiture Gain (Loss) on Disposition of Business Business Combination and Asset Acquisition [Abstract] Total Centene stockholders' equity Equity, Attributable to Parent Consolidation Items [Axis] Consolidation Items [Axis] Goodwill impairment Impairments Impairments Goodwill, Impairment Loss Restricted cash and cash equivalents, included in restricted deposits Restricted Cash and Cash Equivalents Foreign currency translation adjustments, net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax $1,300 million 2.625% Senior Notes due August 1, 2031 $1,300 Million 2.625% Senior Notes due August 2031 [Member] $1,300 Million 2.625% Senior Notes due August 2031 Concentration Risk Type [Axis] Concentration Risk Type [Axis] Earnings before income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Level II Fair Value, Inputs, Level 2 [Member] Current year Current Year Claims and Claims Adjustment Expense Entity Emerging Growth Company Entity Emerging Growth Company Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Disposal Group Classification [Domain] Disposal Group Classification [Domain] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Period Focus Document Fiscal Period Focus Stock compensation expense Share-Based Payment Arrangement, Noncash Expense Common Stock Common Stock [Member] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Earnings Per Share Earnings Per Share [Text Block] Product and Service [Axis] Product and Service [Axis] Fair Value Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Total stockholders' equity Balance Balance Equity, Including Portion Attributable to Noncontrolling Interest Property, software and equipment, net Property, Plant and Equipment, Net Share Repurchase Program [Domain] Share Repurchase Program [Domain] Percentage of notional amount under ASR Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program Other comprehensive earnings (loss) Other comprehensive earnings (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Disposal Group Classification [Axis] Disposal Group Classification [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Assets [Abstract] Assets Assets [Abstract] Total incurred Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Greater than ten years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Proceeds from long-term debt Proceeds from Issuance of Long-Term Debt Liabilities Liabilities [Abstract] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other current assets Other Current Assets [Member] Net earnings Net earnings Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Income taxes paid Income Taxes Paid, Net Net cash (used in) financing activities Net Cash Provided by (Used in) Financing Activities Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Contingencies Commitments and Contingencies Disclosure [Text Block] Retained Earnings Retained Earnings [Member] Current portion of long-term debt Less: current portion Long-Term Debt, Current Maturities Total liabilities, redeemable noncontrolling interests and stockholders' equity Liabilities and Equity External Credit Rating by Grouping [Domain] External Credit Rating by Grouping [Domain] Other income (expense): Nonoperating Income (Expense) [Abstract] Other long-term assets Other Assets, Noncurrent ROU assets (recorded within other long-term assets) Operating Lease, Right-of-Use Asset Net unrealized gain on cash flow hedge, net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Basic earnings per common share (in dollars per share) Earnings Per Share, Basic Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Class of Treasury Stock [Table] Class of Treasury Stock [Table] Schedule of net receivables (payables) related to the Affordable Care Act Programs Schedule Of Receivables (Payables) Related To The Affordable Care Act Programs [Table Text Block] Schedule of Receivables (Payables) Related to the Affordable Care Act Programs Magellan Specialty Health Magellan Specialty Health [Member] Magellan Specialty Health Short-term and long-term investments and restricted deposits by investment type Short Term And Long Term Investments And Restricted Deposits By Investment Type [Table Text Block] Short-term and long-term investments and restricted deposits by investment type Accelerated share repurchases agreement, amount (up to) Accelerated Share Repurchases Agreement, Amount Accelerated Share Repurchases Agreement, Amount Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Entity Address, City or Town Entity Address, City or Town Contingent consideration on disposal (up to) Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High Segment Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Asset-backed securities Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost $2,500 million 4.25% Senior Notes due December 15, 2027 Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member] Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member] Pending Litigation Pending Litigation [Member] Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Document Transition Report Document Transition Report $2,200 million 2.50% Senior Notes due March 1, 2031 $2,200 Million 2.50% Senior Notes due March 2031 [Member] $2,200 Million 2.50% Senior Notes due March 2031 Stock repurchase program, remaining available Stock Repurchase Program, Remaining Authorized Repurchase Amount Purchase of redeemable and non-redeemable noncontrolling interest Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Circle Health Circle Health [Member] Circle Health Common stock, shares authorized (in shares) Common Stock, Shares Authorized Medical claims liabilities Increase (Decrease) in Health Care Insurance Liabilities Paid related to: Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Restricted cash equivalents Restricted Cash Equivalents [Member] Restricted Cash Equivalents [Member] Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] Less: Reinsurance recoverable Plus: Reinsurance recoverable Reinsurance Recoverable for Unpaid Claims and Claims Adjustments Adjustments to reconcile net earnings to net cash provided by operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Gain on disposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal One year or less Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Comprehensive (earnings) attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Five years through ten years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Net earnings (loss) Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Foreign currency swap agreement Derivative Asset Deferred income taxes Deferred Income Tax Expense (Benefit) Subsequent Event Type [Axis] Subsequent Event Type [Axis] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Remaining lease payments in 2023 excluding disposal group Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Remainder of Fiscal Year Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Remainder of Fiscal Year Acquisitions and divestitures Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions Municipal securities Municipal Bonds [Member] Divestiture proceeds, net of divested cash Proceeds from Divestiture of Businesses, Net of Cash Divested Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Common stock issued for employee benefit plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Other Other/Eliminations Other Segments [Member] Entity Registrant Name Entity Registrant Name Common stock equivalents (as determined by applying the treasury stock method) (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Other assets Increase (Decrease) in Other Operating Assets Return of premium payable Return of Premium Payable Return of Premium Payable Lease Contractual Term [Axis] Lease Contractual Term [Axis] Nonredeemable noncontrolling interest Equity, Attributable to Noncontrolling Interest Document Period End Date Document Period End Date Disposal Group Name [Axis] Disposal Group Name [Axis] Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Payments and repurchases of long-term debt Repayments of Long-Term Debt Treasury Stock Treasury Stock, Common [Member] Entity Central Index Key Entity Central Index Key Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Organization and Operations Basis of Presentation and Significant Accounting Policies [Text Block] Income tax expense Income Tax Expense (Benefit) Fair Value Measurements Fair Value Disclosures [Text Block] Spanish and Central European Businesses Spanish and Central European Businesses [Member] Spanish and Central European Businesses 12 Months or More Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Equity [Abstract] Equity [Abstract] Schedule Of Investments And Restricted Deposits By Type [Line Items] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Reclassification adjustment, net of tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Premium and service revenues Revenue from Contract with Customer, Excluding Assessed Tax Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Less Than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Income tax withholding (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Stock repurchases, excise tax accrual Accrual For Stock Repurchases, Excise Tax Accrual For Stock Repurchases, Excise Tax Weighted-average discount rate for operating leases Operating Lease, Weighted Average Discount Rate, Percent Senior notes Senior Notes Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Comprehensive earnings (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Assets Assets, Fair Value Disclosure [Abstract] One year or less Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Credit Facility [Domain] Credit Facility [Domain] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Short-term time deposits Short-term time deposits Bank Time Deposits [Member] Common stock repurchases (in shares) Common stock repurchases (in shares) Treasury Stock, Shares, Acquired Long-term debt  Long-term debt Long-Term Debt, Excluding Current Maturities Stock repurchase program, increase to authorized amount Stock Repurchase Program, Increase, Authorized Amount Stock Repurchase Program, Increase, Authorized Amount External Credit Rating, Investment Grade External Credit Rating, Investment Grade [Member] Diluted (in shares) Weighted average number of common shares and potential dilutive common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years) Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs Amounts Recorded As An Adjustment to Premium Revenues Related to Minimum HBR and Return of Premium Programs Amounts Recorded As An Adjustment To Premium Revenues Related To Minimum HBR and Return Of Premium Programs Restricted Deposits Restricted deposits Deposits [Member] Divestitures Goodwill, Written off Related to Sale of Business Unit Expenses: Operating Expenses [Abstract] Investment Securities Investment Securities [Member] Investment Securities Capital expenditures Payments to Acquire Property, Plant, and Equipment Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid-in Capital Additional Paid-in Capital [Member] Total assets Assets Share Repurchase Program [Axis] Share Repurchase Program [Axis] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover [Abstract] Cover [Abstract] Investment and other income Investment Income, Nonoperating Stock compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Other long-term liabilities Other Liabilities, Noncurrent Short-term investments Short-Term Investments Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Segment Information Segment Reporting Disclosure [Text Block] Net increase in cash, cash equivalents, and restricted cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Equity Component [Domain] Equity Component [Domain] Cost sharing reduction payable Affordable Care Act Cost Sharing Reductions, Payable Affordable Care Act Cost Sharing Reductions, Payable Weighted average number of common shares outstanding: Shares used in computing per share amounts: Earnings Per Share, Basic, Other Disclosure [Abstract] Debt Instrument [Line Items] Debt Instrument [Line Items] Basic (in shares) Weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Debt issuance costs Unamortized Debt Issuance Expense Debt extinguishment Gain (Loss) on Extinguishment of Debt , Including Cash Portion Gain (Loss) on Extinguishment of Debt , Including Cash Portion Earnings from operations Operating Income (Loss) $2,300 million 2.45% Senior Notes due July 15, 2028 $2,300 Million 2.45% Senior Nots due July 2028 [Member] $2,300 Million 2.45% Senior Nots due July 2028 Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Revenues: Revenues [Abstract] Cash and cash equivalents Cash and Cash Equivalents [Member] Total investment positions Debt Securities, Available -for-Sale, Number of Positions Debt Securities, Available -for-Sale, Number of Positions Changes in assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract] 2028 Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Five Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Five Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Medicaid Medicaid Segment [Member] Medicaid Segment Schedule of Debt Schedule of Debt [Table Text Block] Credit facility Long-Term Line of Credit Stockholders' equity: Stockholders' equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract] Noncontrolling Interest Noncontrolling Interest [Member] EX-101.PRE 10 cnc-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover - shares
shares in Thousands
 9 Months Ended
Sep. 30, 2023
Oct. 20, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 001-31826  
Entity Registrant Name CENTENE CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 42-1406317  
Entity Address, Address Line One 7700 Forsyth Boulevard  
Entity Address, City or Town St. Louis,  
Entity Address, State or Province MO  
Entity Address, Postal Zip Code 63105  
City Area Code 314  
Local Phone Number 725-4477  
Title of 12(b) Security Common Stock $0.001 Par Value  
Trading Symbol CNC  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   534,201
Entity Central Index Key 0001071739  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Assets, Current [Abstract]    
Cash and cash equivalents $ 18,190 $ 12,074
Premium and trade receivables 15,503 13,272
Short-term investments 2,241 2,321
Other current assets 5,471 2,461
Total current assets 41,405 30,128
Long-term investments 15,234 14,684
Restricted deposits 1,343 1,217
Property, software and equipment, net 2,004 2,432
Goodwill 17,558 18,812
Intangible assets, net 6,277 6,911
Other long-term assets 560 2,686
Total assets 84,381 76,870
Liabilities, Current [Abstract]    
Medical claims liability 17,141 16,745
Accounts payable and accrued expenses 15,081 9,525
Return of premium payable 2,160 1,634
Unearned revenue 2,356 478
Current portion of long-term debt 113 82
Total current liabilities 36,851 28,464
Long-term debt 17,888 17,938
Deferred tax liability 577 615
Other long-term liabilities 3,649 5,616
Total liabilities 58,965 52,633
Commitments and contingencies
Redeemable noncontrolling interests 21 56
Stockholders' equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2023 and December 31, 2022 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 614,956 issued and 534,596 outstanding at September 30, 2023, and 607,847 issued and 550,754 outstanding at December 31, 2022 1 1
Additional paid-in capital 20,243 20,060
Accumulated other comprehensive (loss) (1,122) (1,132)
Retained earnings 11,998 9,341
Treasury stock, at cost (80,360 and 57,093 shares, respectively) (5,825) (4,213)
Total Centene stockholders' equity 25,295 24,057
Nonredeemable noncontrolling interest 100 124
Total stockholders' equity 25,395 24,181
Total liabilities, redeemable noncontrolling interests and stockholders' equity $ 84,381 $ 76,870
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Stockholders' equity    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 800,000,000 800,000,000
Common stock, shares issued (in shares) 614,956,000 607,847,000
Common stock, shares outstanding (in shares) 534,596,000 550,754,000
Treasury stock (in shares) 80,360,000 57,093,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:        
Premium and service revenues $ 34,967 $ 33,726 $ 104,757 $ 101,926
Premium tax 3,075 2,139 9,782 7,060
Total revenues 38,042 35,865 114,539 108,986
Expenses:        
Medical costs 29,479 28,111 88,260 83,261
Cost of services 856 1,571 2,603 5,658
Selling, general and administrative expenses 3,048 2,846 9,075 8,391
Depreciation expense 148 150 436 470
Amortization of acquired intangible assets 180 211 542 609
Premium tax expense 3,156 2,211 10,021 7,258
Impairment 440 289 478 1,739
Total operating expenses 37,307 35,389 111,415 107,386
Earnings from operations 735 476 3,124 1,600
Other income (expense):        
Investment and other income 214 692 992 786
Debt extinguishment 0 10 0 26
Interest expense (181) (169) (542) (491)
Earnings before income tax 768 1,009 3,574 1,921
Income tax expense 293 269 914 500
Net earnings 475 740 2,660 1,421
(Earnings) attributable to noncontrolling interests (6) (2) (3) (6)
Net earnings attributable to Centene Corporation $ 469 $ 738 $ 2,657 $ 1,415
Net earnings per common share attributable to Centene Corporation:        
Basic earnings per common share (in dollars per share) $ 0.87 $ 1.29 $ 4.86 $ 2.44
Diluted earnings per common share (in dollars per share) $ 0.87 $ 1.27 $ 4.85 $ 2.41
Weighted average number of common shares outstanding:        
Basic (in shares) 539,535 573,961 546,374 580,277
Diluted (in shares) 541,270 580,607 548,412 587,084
Premium        
Revenues:        
Premium and service revenues $ 33,866 $ 31,848 $ 101,404 $ 95,247
Service        
Revenues:        
Premium and service revenues $ 1,101 $ 1,878 $ 3,353 $ 6,679
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net earnings $ 475 $ 740 $ 2,660 $ 1,421
Change in unrealized gain (loss) on investments (235) (503) (124) (1,664)
Change in unrealized gain (loss) on investments, tax effect 56 120 29 397
Change in unrealized gain (loss) on investments, net of tax (179) (383) (95) (1,267)
Reclassification adjustment, net of tax 57 3 61 12
Foreign currency translation adjustments, net of tax (22) (101) 24 (216)
Net unrealized gain on cash flow hedge, net of tax 20 0 20 0
Other comprehensive earnings (loss) (124) (481) 10 (1,471)
Comprehensive earnings (loss) 351 259 2,670 (50)
Comprehensive (earnings) attributable to noncontrolling interests (6) (2) (3) (6)
Comprehensive earnings (loss) attributable to Centene Corporation $ 345 $ 257 $ 2,667 $ (56)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Earnings (Loss)
Retained Earnings
Treasury Stock
Noncontrolling Interest
Balance (in shares) at Dec. 31, 2021   602,704          
Treasury stock (in shares) at Dec. 31, 2021           20,225  
Balance at Dec. 31, 2021 $ 26,940 $ 1 $ 19,672 $ 77 $ 8,139 $ (1,094) $ 145
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 848       849   (1)
Other comprehensive earnings (loss), net of tax (562)     (562)      
Common stock issued for employee benefit plans (in shares)   3,221          
Common stock issued for employee benefit plans 28   28        
Fair value of unvested equity awards in connection with acquisition 60   60        
Common stock repurchases (in shares)           846  
Common stock repurchases (71)         $ (71)  
Stock compensation expense 70   70        
Balance (in shares) at Mar. 31, 2022   605,925          
Treasury stock (in shares) at Mar. 31, 2022           21,071  
Balance at Mar. 31, 2022 27,313 $ 1 19,830 (485) 8,988 $ (1,165) 144
Balance (in shares) at Dec. 31, 2021   602,704          
Treasury stock (in shares) at Dec. 31, 2021           20,225  
Balance at Dec. 31, 2021 26,940 $ 1 19,672 77 8,139 $ (1,094) 145
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive earnings (loss), net of tax (1,471)            
Balance (in shares) at Sep. 30, 2022   606,931          
Treasury stock (in shares) at Sep. 30, 2022           36,840  
Balance at Sep. 30, 2022 25,534 $ 1 19,774 (1,394) 9,554 $ (2,557) 156
Balance (in shares) at Mar. 31, 2022   605,925          
Treasury stock (in shares) at Mar. 31, 2022           21,071  
Balance at Mar. 31, 2022 27,313 $ 1 19,830 (485) 8,988 $ (1,165) 144
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) (175)       (172)   (3)
Other comprehensive earnings (loss), net of tax (428)     (428)      
Common stock issued for employee benefit plans (in shares)   519          
Common stock issued for employee benefit plans 10   10        
Common stock repurchases (in shares)           4,249  
Common stock repurchases (349)         $ (349)  
Stock compensation expense 59   59        
Balance (in shares) at Jun. 30, 2022   606,444          
Treasury stock (in shares) at Jun. 30, 2022           25,320  
Balance at Jun. 30, 2022 26,430 $ 1 19,899 (913) 8,816 $ (1,514) 141
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 736       738   (2)
Other comprehensive earnings (loss), net of tax (481)     (481)      
Common stock issued for employee benefit plans (in shares)   487          
Common stock issued for employee benefit plans 24   24        
Common stock repurchases (in shares)           11,520  
Common stock repurchases (1,243)   (200)     $ (1,043)  
Stock compensation expense 51   51        
Reclassification to redeemable 17           17
Balance (in shares) at Sep. 30, 2022   606,931          
Treasury stock (in shares) at Sep. 30, 2022           36,840  
Balance at Sep. 30, 2022 $ 25,534 $ 1 19,774 (1,394) 9,554 $ (2,557) 156
Balance (in shares) at Dec. 31, 2022 550,754 607,847          
Treasury stock (in shares) at Dec. 31, 2022 57,093         57,093  
Balance at Dec. 31, 2022 $ 24,181 $ 1 20,060 (1,132) 9,341 $ (4,213) 124
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 1,130       1,130    
Other comprehensive earnings (loss), net of tax 217     217      
Common stock issued for employee benefit plans (in shares)   6,508          
Common stock issued for employee benefit plans 12   12        
Common stock repurchases (in shares)           5,548  
Common stock repurchases (423)         $ (423)  
Stock compensation expense 61   61        
Purchase of redeemable and non-redeemable noncontrolling interest (12)   (12)        
Balance (in shares) at Mar. 31, 2023   614,355          
Treasury stock (in shares) at Mar. 31, 2023           62,641  
Balance at Mar. 31, 2023 $ 25,166 $ 1 20,121 (915) 10,471 $ (4,636) 124
Balance (in shares) at Dec. 31, 2022 550,754 607,847          
Treasury stock (in shares) at Dec. 31, 2022 57,093         57,093  
Balance at Dec. 31, 2022 $ 24,181 $ 1 20,060 (1,132) 9,341 $ (4,213) 124
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive earnings (loss), net of tax $ 10            
Balance (in shares) at Sep. 30, 2023 534,596 614,956          
Treasury stock (in shares) at Sep. 30, 2023 80,360         80,360  
Balance at Sep. 30, 2023 $ 25,395 $ 1 20,243 (1,122) 11,998 $ (5,825) 100
Balance (in shares) at Mar. 31, 2023   614,355          
Treasury stock (in shares) at Mar. 31, 2023           62,641  
Balance at Mar. 31, 2023 25,166 $ 1 20,121 (915) 10,471 $ (4,636) 124
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 1,055       1,058   (3)
Other comprehensive earnings (loss), net of tax (83)     (83)      
Common stock issued for employee benefit plans (in shares)   388          
Common stock issued for employee benefit plans 9   9        
Common stock repurchases (in shares)           6,099  
Common stock repurchases (408)         $ (408)  
Stock compensation expense 56   56        
Purchase of redeemable and non-redeemable noncontrolling interest (27)   (3)       (24)
Balance (in shares) at Jun. 30, 2023   614,743          
Treasury stock (in shares) at Jun. 30, 2023           68,740  
Balance at Jun. 30, 2023 25,768 $ 1 20,183 (998) 11,529 $ (5,044) 97
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 472       469   3
Other comprehensive earnings (loss), net of tax (124)     (124)      
Common stock issued for employee benefit plans (in shares)   213          
Common stock issued for employee benefit plans 11   11        
Common stock repurchases (in shares)           11,620  
Common stock repurchases (781)         $ (781)  
Stock compensation expense 50   50        
Purchase of redeemable and non-redeemable noncontrolling interest $ (1)   (1)        
Balance (in shares) at Sep. 30, 2023 534,596 614,956          
Treasury stock (in shares) at Sep. 30, 2023 80,360         80,360  
Balance at Sep. 30, 2023 $ 25,395 $ 1 $ 20,243 $ (1,122) $ 11,998 $ (5,825) $ 100
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Par value (in dollars per share) $ 0.001           $ 0.001  
Other comprehensive earning (loss), tax $ (34) $ (34) $ 61 $ (120) $ (106) $ (171)    
Common Stock                
Par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 0.001 $ 0.001
Treasury Stock                
Par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:          
Net earnings $ 475 $ 740 $ 2,660 $ 1,421  
Adjustments to reconcile net earnings to net cash provided by operating activities          
Depreciation and amortization     978 1,079  
Stock compensation expense     167 180  
Impairment 440 289 478 1,739  
(Gain) loss on debt extinguishment     0 (26)  
Deferred income taxes     14 (682)  
(Gain) loss on divestitures     (172) (503)  
Other adjustments, net     158 164  
Changes in assets and liabilities          
Premium and trade receivables     (2,329) (1,274)  
Other assets     (103) 152  
Medical claims liabilities     401 1,976  
Unearned revenue     1,878 1,964  
Accounts payable and accrued expenses     3,127 686  
Other long-term liabilities     583 863  
Other operating activities, net     (4) 98  
Net cash provided by operating activities     7,836 7,837  
Cash flows from investing activities:          
Capital expenditures     (576) (771)  
Purchases of investments     (4,729) (5,118)  
Sales and maturities of investments     4,373 2,842  
Acquisitions, net of cash acquired     0 (1,457)  
Divestiture proceeds, net of divested cash     690 1,362  
Net cash (used in) investing activities     (242) (3,142)  
Cash flows from financing activities:          
Proceeds from long-term debt     2,170 357  
Payments and repurchases of long-term debt     (1,970) (1,202)  
Common stock repurchases     (1,602) (1,663)  
Proceeds from common stock issuances     32 62  
Payments for debt extinguishment     0 (14)  
Purchase of noncontrolling interest     (87) 0  
Other financing activities, net     0 (5)  
Net cash (used in) financing activities     (1,457) (2,465)  
Effect of exchange rate changes on cash, cash equivalents, and restricted cash     19 (37)  
Net increase in cash, cash equivalents, and restricted cash and cash equivalents     6,156 2,193  
Cash and cash equivalents reclassified from (to) held for sale (36) (192) (36) (192)  
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period     12,330 13,214 $ 13,214
Cash, cash equivalents, and restricted cash and cash equivalents, end of period 18,450 15,215 18,450 15,215 12,330
Supplemental disclosures of cash flow information:          
Interest paid     496 462  
Income taxes paid     759 448  
The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:          
Cash and cash equivalents 18,190 14,987 18,190 14,987 12,074
Restricted cash and cash equivalents, included in restricted deposits 260 228 260 228  
Total cash, cash equivalents, and restricted cash and cash equivalents $ 18,450 $ 15,215 $ 18,450 $ 15,215 $ 12,330
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Operations
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Operations Organization and Operations
Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2022. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2022 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2022 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2023 presentation, including reclassifications related to the Company's new segment reporting structure as outlined below. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

Segment Reporting

In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment, and (4) an Other segment.

The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind, or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans (D-SNPs), and Medicare Prescription Drug Plans (PDPs), also known as Medicare Part D. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.

Accounting Guidance Not Yet Adopted

The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions and Divestitures
 9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Acquisitions and Divestitures Acquisitions and Divestitures
On January 5, 2023, the Company completed the divestiture of HealthSmart, its third-party health plan administration business.

On January 10, 2023, the Company signed and closed on a definitive agreement to divest Centurion, its prison healthcare business. During 2022, the Company recorded impairment charges related to goodwill and other current assets associated with the divestiture. During the second quarter of 2023, the Company recognized a $15 million gain on the divestiture of the Centurion business reflecting additional proceeds for contingent consideration, partially offset by net working capital adjustments. The gain is included in investment and other income in the Consolidated Statements of Operations.

On January 20, 2023, the Company completed the divestiture of Magellan Specialty Health for approximately $646 million in cash and stock, including an estimated working capital adjustment, and recognized a pre-tax gain of $79 million. The stock consideration was subsequently sold in April 2023 for cash proceeds of $245 million. The Company could also receive up to an additional $150 million in cash and stock in 2024 based on certain 2023 performance metrics. The Company will recognize the appropriate amount of contingent consideration related to the additional $150 million when realized or realizable.

On June 13, 2023, the Company completed the divestiture of its majority stake in Apixio. The Company recognized a pre-tax gain of $91 million, or $63 million after-tax, which is included in investment and other income in the Consolidated Statements of Operations.

During the second quarter of 2023, the Company recognized an additional $13 million expense related to the divestiture of its Spanish and Central European businesses, in addition to the previously recorded impairment charge of $163 million, or $140 million after-tax. The expense is included in investment and other income in the Consolidated Statements of Operations.

Circle Health Group Divestiture

On August 28, 2023, the Company signed a definitive agreement to sell Circle Health Group (Circle Health), one of the U.K.'s largest independent hospital operators, which is included in the Other segment. As of September 30, 2023, the assets and liabilities of Circle Health were considered held for sale resulting in $3,744 million of assets held for sale in other current assets and $2,947 million of liabilities held for sale in accounts payable and accrued expenses in the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as other long-term assets, goodwill and property, software and equipment. The majority of the liabilities were previously reported as debt and other long-term liabilities.

During the third quarter of 2023, the Company recorded an impairment charge related to goodwill associated with the pending divestiture of $251 million, or $269 million after-tax.

In order to manage the foreign exchange risk on the sale price associated with the pending divestiture of Circle Health, in August 2023 the Company entered into a foreign currency swap agreement for a notional amount of $931 million, to sell £740 million. The swap agreement was formally designated and qualified as a cash flow hedge. The swap expires on March 28, 2024. The gain or loss due to changes in the fair value of the foreign currency swap is recorded in other comprehensive income until the Circle Health divestiture closes, at which time the gain or loss will be recorded in earnings to the same line in the Consolidated Statement of Operations as the gain or loss on sale. The fair value of the swap agreement as of September 30, 2023 was $27 million, which was recorded in other current assets in the Consolidated Balance Sheet.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Short-term and Long-term Investments, Restricted Deposits
 9 Months Ended
Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
Short-term and Long-term Investments, Restricted Deposits Short-term and Long-term Investments, Restricted Deposits
Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 September 30, 2023December 31, 2022
 Amortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair ValueAmortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair Value
Debt securities:
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$421 $— $(13)$408 $695 $— $(16)$679 
Corporate securities9,922 2 (750)9,174 10,127 12 (778)9,361 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
260 — — 260 256 — — 256 
Short-term time deposits
470 — — 470 204 — — 204 
Municipal securities3,931 1 (294)3,638 4,055 6 (280)3,781 
Asset-backed securities1,633 2 (52)1,583 1,396 — (70)1,326 
Residential mortgage-backed securities1,475 — (172)1,303 1,165 2 (121)1,046 
Commercial mortgage-backed securities
1,100 — (112)988 961 — (99)862 
Equity securities2 — — 2 5 — — 5 
Private equity investments
810 — — 810 529 — — 529 
Life insurance contracts
178 — — 178 169 — — 169 
Total$20,206 $5 $(1,393)$18,818 $19,566 $20 $(1,364)$18,222 

The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments, and life insurance contracts. Private equity investments include direct investments in private equity securities as well as private equity funds. The Company's investment policies are designed to provide liquidity, preserve capital, and maximize total return on invested assets with a focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of September 30, 2023, 99% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At September 30, 2023, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $144 million and $132 million at September 30, 2023 and December 31, 2022, respectively, and is included in other current assets in the Consolidated Balance Sheets.

The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AA+ and a weighted average duration of 4 years at September 30, 2023.
The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 September 30, 2023December 31, 2022
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair Value
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$(1)$161 $(12)$247 $(5)$342 $(11)$184 
Corporate securities(76)2,470 (674)6,393 (340)5,368 (438)3,400 
Municipal securities(44)1,308 (250)2,211 (142)2,437 (138)995 
Asset-backed securities(7)486 (45)946 (29)786 (41)486 
Residential mortgage-backed securities(23)517 (149)786 (55)629 (66)352 
Commercial mortgage-backed securities(11)228 (101)748 (49)513 (50)330 
Total$(162)$5,170 $(1,231)$11,331 $(620)$10,075 $(744)$5,747 

As of September 30, 2023, the gross unrealized losses were generated from 6,355 positions out of a total of 6,604 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.

For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.

In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates, and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit-related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.

The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 September 30, 2023December 31, 2022
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized CostFair ValueAmortized CostFair ValueAmortized CostFair ValueAmortized CostFair Value
One year or less$2,121 $2,091 $537 $534 $2,207 $2,179 $534 $532 
One year through five years7,421 6,906 531 496 7,651 7,147 524 490 
Five years through ten years3,931 3,501 312 282 4,066 3,613 224 195 
Greater than ten years123 113 32 31 135 129 — — 
Asset-backed securities4,208 3,874 — — 3,522 3,234 — — 
Total$17,804 $16,485 $1,412 $1,343 $17,581 $16,302 $1,282 $1,217 
 
Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments, and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem substantially all of the securities included in the greater than ten years category listed above at amortized cost.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at September 30, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$18,190 $— $— $18,190 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$81 $— $— $81 
Corporate securities— 9,142 — 9,142 
Municipal securities— 2,918 — 2,918 
Short-term time deposits— 470 — 470 
Asset-backed securities— 1,583 — 1,583 
Residential mortgage-backed securities— 1,303 — 1,303 
Commercial mortgage-backed securities— 988 — 988 
Equity securities— 2 — 2 
Total investments$81 $16,406 $— $16,487 
Restricted deposits:    
Cash and cash equivalents$260 $— $— $260 
U.S. Treasury securities and obligations of U.S. government corporations and agencies327 — — 327 
Corporate securities— 32 — 32 
Certificates of deposit— 4 — 4 
Municipal securities— 720 — 720 
Total restricted deposits$587 $756 $— $1,343 
Other current assets:
Foreign currency swap agreement$— $27 $— $27 
Total assets at fair value$18,858 $17,189 $— $36,047 
The following table summarizes fair value measurements by level at December 31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$12,074 $— $— $12,074 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$366 $5 $— $371 
Corporate securities— 9,328 — 9,328 
Municipal securities— 3,165 — 3,165 
Short-term time deposits— 204 — 204 
Asset backed securities— 1,326 — 1,326 
Residential mortgage-backed securities— 1,046 — 1,046 
Commercial mortgage-backed securities— 862 — 862 
Equity securities3 2 — 5 
Total investments$369 $15,938 $— $16,307 
Restricted deposits:    
Cash and cash equivalents$256 $— $— $256 
U.S. Treasury securities and obligations of U.S. government corporations and agencies308 — — 308 
Corporate securities— 33 — 33 
Certificates of deposit— 4 — 4 
Municipal securities— 616 — 616 
Total restricted deposits$564 $653 $— $1,217 
Total assets at fair value$13,007 $16,591 $— $29,598 
 
The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $988 million and $698 million as of September 30, 2023 and December 31, 2022, respectively.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Intangible Assets
 9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
As discussed in Note 1. Organization and Operations, in the first quarter of 2023, the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.

The following table summarizes the changes in goodwill by operating segment ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, December 31, 2021$10,194 $1,592 $5,424 $2,561 $19,771 
Acquisition and purchase accounting adjustments— — — 1,077 1,077 
Divestitures— — — (1,533)(1,533)
Reallocation4 — — (4)— 
Impairments— — — (370)(370)
Translation impact— — — (133)(133)
Balance, December 31, 2022$10,198 $1,592 $5,424 $1,598 $18,812 
Divestitures— — — (933)(933)
Impairments— — — (348)(348)
Translation impact— — — 27 27 
Balance, September 30, 2023$10,198 $1,592 $5,424 $344 $17,558 

The decrease in the Other segment goodwill in 2023 was primarily driven by the pending divestiture of Circle Health, which resulted in held for sale accounting and an impairment of $251 million as discussed in Note 2. Acquisitions and Divestitures, and an impairment of the Company's Operose Health business based on market indicators of fair value.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Medical Claims Liability
 9 Months Ended
Sep. 30, 2023
Insurance [Abstract]  
Medical Claims Liability Medical Claims Liability
As discussed in Note 1. Organization and Operations, in the first quarter of 2023, the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.

The following table summarizes the change in medical claims liability for the nine months ended September 30, 2023 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2023$11,253 $3,431 $1,921 $140 $16,745 
Less: Reinsurance recoverable7 — 19 — 26 
Balance, January 1, 2023, net11,246 3,431 1,902 140 16,719 
Incurred related to:
Current year60,379 14,680 13,994 1,095 90,148 
Prior years(1,303)(326)(256)(3)(1,888)
Total incurred59,076 14,354 13,738 1,092 88,260 
Paid related to:
Current year50,774 12,069 11,575 984 75,402 
Prior years8,517 2,452 1,376 136 12,481 
Total paid59,291 14,521 12,951 1,120 87,883 
Balance, September 30, 2023, net
11,031 3,264 2,689 112 17,096 
Plus: Reinsurance recoverable4 — 41 — 45 
Balance, September 30, 2023
$11,035 $3,264 $2,730 $112 $17,141 
The following table summarizes the change in medical claims liability for the nine months ended September 30, 2022 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2022$9,845 $2,286 $2,014 $98 $14,243 
Less: Reinsurance recoverable23 — — — 23 
Balance, January 1, 2022, net9,822 2,286 2,014 98 14,220 
Acquisitions and divestitures— — — 249 249 
Incurred related to:
Current year57,074 14,624 10,609 2,150 84,457 
Prior years(966)(22)(193)(15)(1,196)
Total incurred56,108 14,602 10,416 2,135 83,261 
Paid related to:
Current year47,481 11,603 9,046 2,175 70,305 
Prior years7,343 1,963 1,580 82 10,968 
Total paid54,824 13,566 10,626 2,257 81,273 
Balance, September 30, 2022, net
11,106 3,322 1,804 225 16,457 
Plus: Reinsurance recoverable8 — — — 8 
Balance, September 30, 2022
$11,114 $3,322 $1,804 $225 $16,465 

Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of development within "Incurred related to: Prior years," the Company recorded $341 million and $121 million as a reduction to premium revenue in the nine months ended September 30, 2023 and 2022, respectively, for minimum health benefits ratio (HBR) and other return of premium programs.

Incurred but not reported (IBNR) plus expected development on reported claims as of September 30, 2023 was $11,661 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Affordable Care Act
 9 Months Ended
Sep. 30, 2023
Affordable Care Act [Abstract]  
Affordable Care Act Affordable Care Act
The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions.

The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
September 30, 2023December 31, 2022
Risk adjustment receivable$1,130 $838 
Risk adjustment payable(2,312)(780)
Minimum medical loss ratio(90)(103)
Cost sharing reduction payable(104)(99)

In June 2023, the Centers for Medicare and Medicaid Services (CMS) announced the final risk adjustment transfers for the 2022 benefit year. As a result of and subsequent to the announcement, the Company increased its risk adjustment net receivables by $244 million from December 31, 2022. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was approximately $198 million in the nine months ended September 30, 2023.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Debt
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Debt Debt
 
Debt consists of the following ($ in millions):
 September 30, 2023December 31, 2022
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,395 $2,393 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,303 2,303 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,277 3,277 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,675 15,673 
Term Loan Facility2,142 2,183 
Revolving Credit Agreement309 58 
Finance leases and other3 253 
Debt issuance costs(128)(147)
Total debt18,001 18,020 
Less: current portion(113)(82)
 Long-term debt$17,888 $17,938 

In May 2023, the Company entered into a first amendment to the Company's Fourth Amended and Restated Credit Agreement. The amendment removed and replaced the interest rate benchmark based on the London Interbank Offered Rate (LIBOR) and related LIBOR-based mechanics applicable to U.S. dollar borrowings under the Amended and Restated Credit Agreement with an interest rate benchmark based on the Secured Overnight Financing Rate (SOFR) (including a customary credit spread adjustment) and related SOFR-based mechanics. Additionally, the amendment removed certain provisions which required the Company to make certain mandatory prepayments of the Term Loan Facility.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Leases
 9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Leases Leases
The following table sets forth the right-of-use (ROU) assets and lease liabilities ($ in millions):
 September 30, 2023December 31, 2022
Assets
ROU assets (recorded within other long-term assets)$430 $2,554 
Liabilities
Short-term (recorded within accounts payable and accrued expenses)$170 $180 
Long-term (recorded within other long-term liabilities)936 3,133 
Total lease liabilities$1,106 $3,313 

The decrease in ROU assets and lease liabilities in 2023 was primarily driven by divestiture related activity as discussed in Note 2. Acquisitions and Divestitures. Specifically, as of September 30, 2023, Circle Health was considered held for sale and accordingly the associated ROU assets and lease liabilities were reclassified to other current assets and accounts payable and accrued expenses, respectively, in the Consolidated Balance Sheet.
Additionally, in conjunction with ongoing real estate optimization initiatives, the Company recognized $35 million and $37 million of ROU asset impairments for the three and nine months ended September 30, 2023, respectively. The remainder of the $85 million real estate optimization impairment charge for the nine months ended September 30, 2023 was related to property, software and equipment.

As of September 30, 2023, the weighted average remaining lease term for the Company was 20.3 years. The average remaining lease term of the Circle Health portfolio is 26.5 years. Excluding Circle Health, the Company's portfolio average remaining lease term is 8.3 years. The lease liabilities as of September 30, 2023, reflect a weighted average discount rate of 5.8%, or 3.2% excluding Circle Health.

Excluding Circle Health, the Company had $51 million remaining in lease payments for 2023 as of September 30, 2023. Lease payments over the next five years and thereafter are as follows ($ in millions):
 Lease Payments
2024$201 
2025176 
2026151 
2027133 
2028113 
Thereafter441 
Total lease payments1,215 
Less: imputed interest(160)
Total lease liabilities$1,055 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Stockholders' Equity Stockholders' Equity
The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. In 2022, the Company's Board of Directors authorized increases under the program including $3,000 million in June 2022 and an additional $2,000 million in December 2022. With these increases, the Company is authorized to repurchase up to $6,000 million, inclusive of past authorizations. As of September 30, 2023, the Company had a remaining amount of $1,256 million available under the stock repurchase program. In October 2023, the Company repurchased an additional 397 thousand shares for $27 million.

The following represents the Company's share repurchase activity ($ in millions, shares in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2023
2022 (2)
2023
2022 (2)
SharesCostSharesCostSharesCostSharesCost
Share buybacks11,609 $773 11,486 $1,040 22,489 $1,550 15,674 $1,384 
Income tax withholding11 1 34 3 778 52 941 79 
Total share repurchases (1)
11,620 $774 11,520 $1,043 23,267 $1,602 16,615 $1,463 
(1)
Excludes share repurchase excise tax of $10 million accrued as of September 30, 2023.
(2)
Includes 8.6 million shares delivered as part of an accelerated share repurchase (ASR) agreement, representing 80% of the $1,000 million notional amount. Remaining shares were delivered in the fourth quarter of 2022 upon the settlement of the ASR.
Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share
 9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Earnings attributable to Centene Corporation$469 $738 $2,657 $1,415 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding539,535 573,961 546,374 580,277 
Common stock equivalents (as determined by applying the treasury stock method) (1)
1,735 6,646 2,038 6,807 
Weighted average number of common shares and potential dilutive common shares outstanding541,270 580,607 548,412 587,084 
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$0.87 $1.29 $4.86 $2.44 
Diluted earnings per common share$0.87 $1.27 $4.85 $2.41 
(1)
The reduction in common stock equivalents is primarily driven by the distribution of long-term stock awards to the estate of the Company's former CEO during the first quarter of 2023, which were fully dilutive prior to their distribution.

The calculation of diluted earnings per common share for the three months ended September 30, 2023 and 2022 excludes 1,313 thousand shares and 152 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.

The calculation of diluted earnings per common share for the nine months ended September 30, 2023 and 2022 excludes 1,383 thousand shares and 193 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Information
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information
In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. Prior year information has been adjusted to reflect the change in segment reporting.

The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.

Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.
Segment information for the three months ended September 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,619 $5,430 $6,451 $366 $33,866 
Service— — 2 1,099 1,101 
Premium and service revenues21,619 5,430 6,453 1,465 34,967 
Premium tax3,075 — — — 3,075 
Total external revenues24,694 5,430 6,453 1,465 38,042 
Internal revenues— — — 3,978 3,978 
Eliminations— — — (3,978)(3,978)
Total revenues$24,694 $5,430 $6,453 $1,465 $38,042 
Medical costs$19,607 $4,462 $5,089 $321 $29,479 
Cost of services$— $— $— $856 $856 
Gross margin (1)
$2,012 $968 $1,364 $288 $4,632 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the three months ended September 30, 2022, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,154 $5,639 $4,291 $764 $31,848 
Service— — 1 1,877 1,878 
Premium and service revenues21,154 5,639 4,292 2,641 33,726 
Premium tax2,139 — — — 2,139 
Total external revenues23,293 5,639 4,292 2,641 35,865 
Internal revenues— — — 6,420 6,420 
Eliminations— — — (6,420)(6,420)
Total revenues$23,293 $5,639 $4,292 $2,641 $35,865 
Medical costs$19,075 $4,730 $3,613 $693 $28,111 
Cost of services$— $— $— $1,571 $1,571 
Gross margin (1)
$2,079 $909 $679 $377 $4,044 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
Segment information for the nine months ended September 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$65,741 $16,971 $17,437 $1,255 $101,404 
Service— — 2 3,351 3,353 
Premium and service revenues65,741 16,971 17,439 4,606 104,757 
Premium tax9,782 — — — 9,782 
Total external revenues75,523 16,971 17,439 4,606 114,539 
Internal revenues— — — 11,634 11,634 
Eliminations— — — (11,634)(11,634)
Total revenues$75,523 $16,971 $17,439 $4,606 $114,539 
Medical costs$59,076 $14,354 $13,738 $1,092 $88,260 
Cost of services$2 $— $— $2,601 $2,603 
Gross margin (1)
$6,663 $2,617 $3,701 $913 $13,894 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the nine months ended September 30, 2022, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$62,763 $17,035 $12,977 $2,472 $95,247 
Service(1)— 2 6,678 6,679 
Premium and service revenues62,762 17,035 12,979 9,150 101,926 
Premium tax7,060 — — — 7,060 
Total external revenues69,822 17,035 12,979 9,150 108,986 
Internal revenues— — — 18,856 18,856 
Eliminations— — — (18,856)(18,856)
Total revenues$69,822 $17,035 $12,979 $9,150 $108,986 
Medical costs$56,108 $14,602 $10,416 $2,135 $83,261 
Cost of services$— $— $— $5,658 $5,658 
Gross margin (1)
$6,654 $2,433 $2,563 $1,357 $13,007 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
Overview

The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:

•periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to CMS related to risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;
•litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property and employment-related claims; and

•disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.

Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought.

The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.

As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits management (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the discussion below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.

Accellion

Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing, and at a mediation in September 2021, the Company reached a settlement with plaintiffs in three of the pending class actions which, if approved by court, should resolve most or all of the pending litigation related to this matter. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company's financial condition, results of operations and cash flows.

Pharmacy Benefits Management Matters

On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan. The Company has reached a no-fault settlement with the Ohio Attorney General regarding this matter and the complaint was dismissed.
The Company has reached no-fault settlement agreements with the Attorneys General in other states to resolve claims and/or allegations made by those states related to services previously provided by Envolve. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250 million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews or investigations relating to the Company's historical PBM business across products may be brought by other states, the federal government, or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial condition, results of operations and cash flows.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Operations (Policies)
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2022. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2022 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2022 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2023 presentation, including reclassifications related to the Company's new segment reporting structure as outlined below. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.
Segment Reporting
Segment Reporting

In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment, and (4) an Other segment.

The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind, or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans (D-SNPs), and Medicare Prescription Drug Plans (PDPs), also known as Medicare Part D. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.
Accounting Guidance Not Yet Adopted
Accounting Guidance Not Yet Adopted

The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Short-term and Long-term Investments, Restricted Deposits (Tables)
 9 Months Ended
Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
Short-term and long-term investments and restricted deposits by investment type
Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 September 30, 2023December 31, 2022
 Amortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair ValueAmortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair Value
Debt securities:
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$421 $— $(13)$408 $695 $— $(16)$679 
Corporate securities9,922 2 (750)9,174 10,127 12 (778)9,361 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
260 — — 260 256 — — 256 
Short-term time deposits
470 — — 470 204 — — 204 
Municipal securities3,931 1 (294)3,638 4,055 6 (280)3,781 
Asset-backed securities1,633 2 (52)1,583 1,396 — (70)1,326 
Residential mortgage-backed securities1,475 — (172)1,303 1,165 2 (121)1,046 
Commercial mortgage-backed securities
1,100 — (112)988 961 — (99)862 
Equity securities2 — — 2 5 — — 5 
Private equity investments
810 — — 810 529 — — 529 
Life insurance contracts
178 — — 178 169 — — 169 
Total$20,206 $5 $(1,393)$18,818 $19,566 $20 $(1,364)$18,222 
Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time
The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 September 30, 2023December 31, 2022
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair Value
U.S. Treasury securities and obligations of
U.S. government corporations and agencies
$(1)$161 $(12)$247 $(5)$342 $(11)$184 
Corporate securities(76)2,470 (674)6,393 (340)5,368 (438)3,400 
Municipal securities(44)1,308 (250)2,211 (142)2,437 (138)995 
Asset-backed securities(7)486 (45)946 (29)786 (41)486 
Residential mortgage-backed securities(23)517 (149)786 (55)629 (66)352 
Commercial mortgage-backed securities(11)228 (101)748 (49)513 (50)330 
Total$(162)$5,170 $(1,231)$11,331 $(620)$10,075 $(744)$5,747 
Contractual maturities of short-term and long-term investments and restricted deposits
The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 September 30, 2023December 31, 2022
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized CostFair ValueAmortized CostFair ValueAmortized CostFair ValueAmortized CostFair Value
One year or less$2,121 $2,091 $537 $534 $2,207 $2,179 $534 $532 
One year through five years7,421 6,906 531 496 7,651 7,147 524 490 
Five years through ten years3,931 3,501 312 282 4,066 3,613 224 195 
Greater than ten years123 113 32 31 135 129 — — 
Asset-backed securities4,208 3,874 — — 3,522 3,234 — — 
Total$17,804 $16,485 $1,412 $1,343 $17,581 $16,302 $1,282 $1,217 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions
Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.
Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes fair value measurements by level at September 30, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$18,190 $— $— $18,190 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$81 $— $— $81 
Corporate securities— 9,142 — 9,142 
Municipal securities— 2,918 — 2,918 
Short-term time deposits— 470 — 470 
Asset-backed securities— 1,583 — 1,583 
Residential mortgage-backed securities— 1,303 — 1,303 
Commercial mortgage-backed securities— 988 — 988 
Equity securities— 2 — 2 
Total investments$81 $16,406 $— $16,487 
Restricted deposits:    
Cash and cash equivalents$260 $— $— $260 
U.S. Treasury securities and obligations of U.S. government corporations and agencies327 — — 327 
Corporate securities— 32 — 32 
Certificates of deposit— 4 — 4 
Municipal securities— 720 — 720 
Total restricted deposits$587 $756 $— $1,343 
Other current assets:
Foreign currency swap agreement$— $27 $— $27 
Total assets at fair value$18,858 $17,189 $— $36,047 
The following table summarizes fair value measurements by level at December 31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$12,074 $— $— $12,074 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$366 $5 $— $371 
Corporate securities— 9,328 — 9,328 
Municipal securities— 3,165 — 3,165 
Short-term time deposits— 204 — 204 
Asset backed securities— 1,326 — 1,326 
Residential mortgage-backed securities— 1,046 — 1,046 
Commercial mortgage-backed securities— 862 — 862 
Equity securities3 2 — 5 
Total investments$369 $15,938 $— $16,307 
Restricted deposits:    
Cash and cash equivalents$256 $— $— $256 
U.S. Treasury securities and obligations of U.S. government corporations and agencies308 — — 308 
Corporate securities— 33 — 33 
Certificates of deposit— 4 — 4 
Municipal securities— 616 — 616 
Total restricted deposits$564 $653 $— $1,217 
Total assets at fair value$13,007 $16,591 $— $29,598 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table summarizes the changes in goodwill by operating segment ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, December 31, 2021$10,194 $1,592 $5,424 $2,561 $19,771 
Acquisition and purchase accounting adjustments— — — 1,077 1,077 
Divestitures— — — (1,533)(1,533)
Reallocation4 — — (4)— 
Impairments— — — (370)(370)
Translation impact— — — (133)(133)
Balance, December 31, 2022$10,198 $1,592 $5,424 $1,598 $18,812 
Divestitures— — — (933)(933)
Impairments— — — (348)(348)
Translation impact— — — 27 27 
Balance, September 30, 2023$10,198 $1,592 $5,424 $344 $17,558 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Medical Claims Liability (Tables)
 9 Months Ended
Sep. 30, 2023
Insurance [Abstract]  
Schedule of change in medical claims liability
The following table summarizes the change in medical claims liability for the nine months ended September 30, 2023 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2023$11,253 $3,431 $1,921 $140 $16,745 
Less: Reinsurance recoverable7 — 19 — 26 
Balance, January 1, 2023, net11,246 3,431 1,902 140 16,719 
Incurred related to:
Current year60,379 14,680 13,994 1,095 90,148 
Prior years(1,303)(326)(256)(3)(1,888)
Total incurred59,076 14,354 13,738 1,092 88,260 
Paid related to:
Current year50,774 12,069 11,575 984 75,402 
Prior years8,517 2,452 1,376 136 12,481 
Total paid59,291 14,521 12,951 1,120 87,883 
Balance, September 30, 2023, net
11,031 3,264 2,689 112 17,096 
Plus: Reinsurance recoverable4 — 41 — 45 
Balance, September 30, 2023
$11,035 $3,264 $2,730 $112 $17,141 
The following table summarizes the change in medical claims liability for the nine months ended September 30, 2022 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2022$9,845 $2,286 $2,014 $98 $14,243 
Less: Reinsurance recoverable23 — — — 23 
Balance, January 1, 2022, net9,822 2,286 2,014 98 14,220 
Acquisitions and divestitures— — — 249 249 
Incurred related to:
Current year57,074 14,624 10,609 2,150 84,457 
Prior years(966)(22)(193)(15)(1,196)
Total incurred56,108 14,602 10,416 2,135 83,261 
Paid related to:
Current year47,481 11,603 9,046 2,175 70,305 
Prior years7,343 1,963 1,580 82 10,968 
Total paid54,824 13,566 10,626 2,257 81,273 
Balance, September 30, 2022, net
11,106 3,322 1,804 225 16,457 
Plus: Reinsurance recoverable8 — — — 8 
Balance, September 30, 2022
$11,114 $3,322 $1,804 $225 $16,465 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Affordable Care Act (Tables)
 9 Months Ended
Sep. 30, 2023
Affordable Care Act [Abstract]  
Schedule of net receivables (payables) related to the Affordable Care Act Programs
The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
September 30, 2023December 31, 2022
Risk adjustment receivable$1,130 $838 
Risk adjustment payable(2,312)(780)
Minimum medical loss ratio(90)(103)
Cost sharing reduction payable(104)(99)
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Debt (Tables)
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Debt
Debt consists of the following ($ in millions):
 September 30, 2023December 31, 2022
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,395 $2,393 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,303 2,303 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,277 3,277 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,675 15,673 
Term Loan Facility2,142 2,183 
Revolving Credit Agreement309 58 
Finance leases and other3 253 
Debt issuance costs(128)(147)
Total debt18,001 18,020 
Less: current portion(113)(82)
 Long-term debt$17,888 $17,938 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Leases (Tables)
 9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
ROU Assets and Liabilities
The following table sets forth the right-of-use (ROU) assets and lease liabilities ($ in millions):
 September 30, 2023December 31, 2022
Assets
ROU assets (recorded within other long-term assets)$430 $2,554 
Liabilities
Short-term (recorded within accounts payable and accrued expenses)$170 $180 
Long-term (recorded within other long-term liabilities)936 3,133 
Total lease liabilities$1,106 $3,313 
Maturity of Operating Lease Liabilities Lease payments over the next five years and thereafter are as follows ($ in millions):
 Lease Payments
2024$201 
2025176 
2026151 
2027133 
2028113 
Thereafter441 
Total lease payments1,215 
Less: imputed interest(160)
Total lease liabilities$1,055 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Class of Treasury Stock
The following represents the Company's share repurchase activity ($ in millions, shares in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2023
2022 (2)
2023
2022 (2)
SharesCostSharesCostSharesCostSharesCost
Share buybacks11,609 $773 11,486 $1,040 22,489 $1,550 15,674 $1,384 
Income tax withholding11 1 34 3 778 52 941 79 
Total share repurchases (1)
11,620 $774 11,520 $1,043 23,267 $1,602 16,615 $1,463 
(1)
Excludes share repurchase excise tax of $10 million accrued as of September 30, 2023.
(2)
Includes 8.6 million shares delivered as part of an accelerated share repurchase (ASR) agreement, representing 80% of the $1,000 million notional amount. Remaining shares were delivered in the fourth quarter of 2022 upon the settlement of the ASR.
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Calculation of Basic and Diluted Net Earnings Per Common Share
The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Earnings attributable to Centene Corporation$469 $738 $2,657 $1,415 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding539,535 573,961 546,374 580,277 
Common stock equivalents (as determined by applying the treasury stock method) (1)
1,735 6,646 2,038 6,807 
Weighted average number of common shares and potential dilutive common shares outstanding541,270 580,607 548,412 587,084 
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$0.87 $1.29 $4.86 $2.44 
Diluted earnings per common share$0.87 $1.27 $4.85 $2.41 
(1)
The reduction in common stock equivalents is primarily driven by the distribution of long-term stock awards to the estate of the Company's former CEO during the first quarter of 2023, which were fully dilutive prior to their distribution.
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment Information
Segment information for the three months ended September 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,619 $5,430 $6,451 $366 $33,866 
Service— — 2 1,099 1,101 
Premium and service revenues21,619 5,430 6,453 1,465 34,967 
Premium tax3,075 — — — 3,075 
Total external revenues24,694 5,430 6,453 1,465 38,042 
Internal revenues— — — 3,978 3,978 
Eliminations— — — (3,978)(3,978)
Total revenues$24,694 $5,430 $6,453 $1,465 $38,042 
Medical costs$19,607 $4,462 $5,089 $321 $29,479 
Cost of services$— $— $— $856 $856 
Gross margin (1)
$2,012 $968 $1,364 $288 $4,632 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the three months ended September 30, 2022, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,154 $5,639 $4,291 $764 $31,848 
Service— — 1 1,877 1,878 
Premium and service revenues21,154 5,639 4,292 2,641 33,726 
Premium tax2,139 — — — 2,139 
Total external revenues23,293 5,639 4,292 2,641 35,865 
Internal revenues— — — 6,420 6,420 
Eliminations— — — (6,420)(6,420)
Total revenues$23,293 $5,639 $4,292 $2,641 $35,865 
Medical costs$19,075 $4,730 $3,613 $693 $28,111 
Cost of services$— $— $— $1,571 $1,571 
Gross margin (1)
$2,079 $909 $679 $377 $4,044 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
Segment information for the nine months ended September 30, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$65,741 $16,971 $17,437 $1,255 $101,404 
Service— — 2 3,351 3,353 
Premium and service revenues65,741 16,971 17,439 4,606 104,757 
Premium tax9,782 — — — 9,782 
Total external revenues75,523 16,971 17,439 4,606 114,539 
Internal revenues— — — 11,634 11,634 
Eliminations— — — (11,634)(11,634)
Total revenues$75,523 $16,971 $17,439 $4,606 $114,539 
Medical costs$59,076 $14,354 $13,738 $1,092 $88,260 
Cost of services$2 $— $— $2,601 $2,603 
Gross margin (1)
$6,663 $2,617 $3,701 $913 $13,894 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the nine months ended September 30, 2022, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$62,763 $17,035 $12,977 $2,472 $95,247 
Service(1)— 2 6,678 6,679 
Premium and service revenues62,762 17,035 12,979 9,150 101,926 
Premium tax7,060 — — — 7,060 
Total external revenues69,822 17,035 12,979 9,150 108,986 
Internal revenues— — — 18,856 18,856 
Eliminations— — — (18,856)(18,856)
Total revenues$69,822 $17,035 $12,979 $9,150 $108,986 
Medical costs$56,108 $14,602 $10,416 $2,135 $83,261 
Cost of services$— $— $— $5,658 $5,658 
Gross margin (1)
$6,654 $2,433 $2,563 $1,357 $13,007 
(1)
Gross margin represents premium and service revenues less medical costs and cost of services.
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions and Divestitures - Divestiture (Details)
£ in Millions, $ in Millions
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 13, 2023
USD ($)
Jan. 20, 2023
USD ($)
Apr. 30, 2023
USD ($)
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Aug. 31, 2023
USD ($)
Aug. 31, 2023
GBP (£)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Gain on divestiture             $ 172 $ 503      
Impairment charge       $ (440)   $ (289) (478) $ (1,739)      
Goodwill impairment             348   $ 370    
Currency Swap                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Notional amount                   $ 931 £ 740
Fair value, swap agreement       27     27        
Centurion | Disposal Group, Disposed of by Sale, Not Discontinued Operations                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Gain on divestiture         $ 15            
Magellan Specialty Health | Disposal Group, Disposed of by Sale, Not Discontinued Operations                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Gain on divestiture   $ 79                  
Consideration received on divestiture   646                  
Proceeds from sale of business     $ 245                
Contingent consideration on disposal (up to)   $ 150                  
Apixio | Disposal Group, Disposed of by Sale, Not Discontinued Operations                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Gain on disposal $ 91                    
Gain on disposal, net of tax $ 63                    
Spanish and Central European Businesses | Disposal Group, Disposed of by Sale, Not Discontinued Operations                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Gain on divestiture         $ 13            
Impairment charge                 (163)    
Impairment charge, net of tax                 $ (140)    
Circle Health | Disposal Group, Held-for-sale, Not Discontinued Operations                      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                      
Assets held for sale       3,744     3,744        
Liabilities held for sale       2,947     $ 2,947        
Goodwill impairment       251              
Goodwill, impairment, net of tax       $ 269              
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Debt Securities    
Gross Unrealized Gains $ 5 $ 20
Gross Unrealized Losses (1,393) (1,364)
Equity securities 2 5
Private equity investments 810 529
Life insurance contracts 178 169
Total, Amortized Cost 20,206 19,566
Total, Fair Value 18,818 18,222
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Debt Securities    
Amortized Cost 421 695
Gross Unrealized Gains 0 0
Gross Unrealized Losses (13) (16)
Fair Value 408 679
Corporate securities    
Debt Securities    
Amortized Cost 9,922 10,127
Gross Unrealized Gains 2 12
Gross Unrealized Losses (750) (778)
Fair Value 9,174 9,361
Restricted certificates of deposit    
Debt Securities    
Amortized Cost 4 4
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 4 4
Restricted cash equivalents    
Debt Securities    
Amortized Cost 260 256
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 260 256
Short-term time deposits    
Debt Securities    
Amortized Cost 470 204
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 470 204
Municipal securities    
Debt Securities    
Amortized Cost 3,931 4,055
Gross Unrealized Gains 1 6
Gross Unrealized Losses (294) (280)
Fair Value 3,638 3,781
Asset-backed securities    
Debt Securities    
Amortized Cost 1,633 1,396
Gross Unrealized Gains 2 0
Gross Unrealized Losses (52) (70)
Fair Value 1,583 1,326
Residential mortgage-backed securities    
Debt Securities    
Amortized Cost 1,475 1,165
Gross Unrealized Gains 0 2
Gross Unrealized Losses (172) (121)
Fair Value 1,303 1,046
Commercial mortgage-backed securities    
Debt Securities    
Amortized Cost 1,100 961
Gross Unrealized Gains 0 0
Gross Unrealized Losses (112) (99)
Fair Value $ 988 $ 862
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2023
USD ($)
position
Dec. 31, 2022
USD ($)
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Accrued interest income | $ $ 144 $ 132
Positions from which gross unrealized losses were generated 6,355  
Total investment positions 6,604  
Commercial mortgage-backed securities    
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years) 4 years  
Rated Securities | External Credit Rating, Investment Grade | Investment Securities    
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations 99.00%  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Unrealized Losses    
Less Than 12 Months $ (162) $ (620)
12 Months or More (1,231) (744)
Fair Value    
Fair Value, Less Than 12 Months 5,170 10,075
Fair Value, 12 Months or More 11,331 5,747
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Unrealized Losses    
Less Than 12 Months (1) (5)
12 Months or More (12) (11)
Fair Value    
Fair Value, Less Than 12 Months 161 342
Fair Value, 12 Months or More 247 184
Corporate securities    
Unrealized Losses    
Less Than 12 Months (76) (340)
12 Months or More (674) (438)
Fair Value    
Fair Value, Less Than 12 Months 2,470 5,368
Fair Value, 12 Months or More 6,393 3,400
Municipal securities    
Unrealized Losses    
Less Than 12 Months (44) (142)
12 Months or More (250) (138)
Fair Value    
Fair Value, Less Than 12 Months 1,308 2,437
Fair Value, 12 Months or More 2,211 995
Asset-backed securities    
Unrealized Losses    
Less Than 12 Months (7) (29)
12 Months or More (45) (41)
Fair Value    
Fair Value, Less Than 12 Months 486 786
Fair Value, 12 Months or More 946 486
Residential mortgage-backed securities    
Unrealized Losses    
Less Than 12 Months (23) (55)
12 Months or More (149) (66)
Fair Value    
Fair Value, Less Than 12 Months 517 629
Fair Value, 12 Months or More 786 352
Commercial mortgage-backed securities    
Unrealized Losses    
Less Than 12 Months (11) (49)
12 Months or More (101) (50)
Fair Value    
Fair Value, Less Than 12 Months 228 513
Fair Value, 12 Months or More $ 748 $ 330
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Investments    
Amortized Cost    
One year or less $ 2,121 $ 2,207
One year through five years 7,421 7,651
Five years through ten years 3,931 4,066
Greater than ten years 123 135
Asset-backed securities 4,208 3,522
Amortized Cost 17,804 17,581
Fair Value    
One year or less 2,091 2,179
One year through five years 6,906 7,147
Five years through ten years 3,501 3,613
Greater than ten years 113 129
Asset-backed securities 3,874 3,234
Fair Value 16,485 16,302
Restricted Deposits    
Amortized Cost    
One year or less 537 534
One year through five years 531 524
Five years through ten years 312 224
Greater than ten years 32 0
Asset-backed securities 0 0
Amortized Cost 1,412 1,282
Fair Value    
One year or less 534 532
One year through five years 496 490
Five years through ten years 282 195
Greater than ten years 31 0
Asset-backed securities 0 0
Fair Value $ 1,343 $ 1,217
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 18,190 $ 12,074
Investments:    
Equity securities 2 5
Total assets at fair value 36,047 29,598
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 408 679
Corporate securities    
Investments:    
Fair Value 9,174 9,361
Municipal securities    
Investments:    
Fair Value 3,638 3,781
Short-term time deposits    
Investments:    
Fair Value 470 204
Asset-backed securities    
Investments:    
Fair Value 1,583 1,326
Residential mortgage-backed securities    
Investments:    
Fair Value 1,303 1,046
Commercial mortgage-backed securities    
Investments:    
Fair Value 988 862
Investments    
Investments:    
Fair Value 16,485 16,302
Total investments 16,487 16,307
Investments | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 81 371
Investments | Corporate securities    
Investments:    
Fair Value 9,142 9,328
Investments | Municipal securities    
Investments:    
Fair Value 2,918 3,165
Investments | Short-term time deposits    
Investments:    
Fair Value 470 204
Investments | Asset-backed securities    
Investments:    
Fair Value 1,583 1,326
Investments | Residential mortgage-backed securities    
Investments:    
Fair Value 1,303 1,046
Investments | Commercial mortgage-backed securities    
Investments:    
Fair Value 988 862
Investments | Equity securities    
Investments:    
Equity securities 2 5
Restricted deposits    
Investments:    
Fair Value 1,343 1,217
Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 327 308
Restricted deposits | Corporate securities    
Investments:    
Fair Value 32 33
Restricted deposits | Municipal securities    
Investments:    
Fair Value 720 616
Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 260 256
Restricted deposits | Certificates of deposit    
Investments:    
Fair Value 4 4
Other current assets | Currency Swap    
Investments:    
Foreign currency swap agreement 27  
Level I    
Assets    
Cash and cash equivalents 18,190 12,074
Investments:    
Total assets at fair value 18,858 13,007
Level I | Investments    
Investments:    
Total investments 81 369
Level I | Investments | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 81 366
Level I | Investments | Corporate securities    
Investments:    
Fair Value 0 0
Level I | Investments | Municipal securities    
Investments:    
Fair Value 0 0
Level I | Investments | Short-term time deposits    
Investments:    
Fair Value 0 0
Level I | Investments | Asset-backed securities    
Investments:    
Fair Value 0 0
Level I | Investments | Residential mortgage-backed securities    
Investments:    
Fair Value 0 0
Level I | Investments | Commercial mortgage-backed securities    
Investments:    
Fair Value 0 0
Level I | Investments | Equity securities    
Investments:    
Equity securities 0 3
Level I | Restricted deposits    
Investments:    
Fair Value 587 564
Level I | Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 327 308
Level I | Restricted deposits | Corporate securities    
Investments:    
Fair Value 0 0
Level I | Restricted deposits | Municipal securities    
Investments:    
Fair Value 0 0
Level I | Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 260 256
Level I | Restricted deposits | Certificates of deposit    
Investments:    
Fair Value 0 0
Level I | Other current assets | Currency Swap    
Investments:    
Foreign currency swap agreement 0  
Level II    
Assets    
Cash and cash equivalents 0 0
Investments:    
Total assets at fair value 17,189 16,591
Level II | Investments    
Investments:    
Total investments 16,406 15,938
Level II | Investments | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 5
Level II | Investments | Corporate securities    
Investments:    
Fair Value 9,142 9,328
Level II | Investments | Municipal securities    
Investments:    
Fair Value 2,918 3,165
Level II | Investments | Short-term time deposits    
Investments:    
Fair Value 470 204
Level II | Investments | Asset-backed securities    
Investments:    
Fair Value 1,583 1,326
Level II | Investments | Residential mortgage-backed securities    
Investments:    
Fair Value 1,303 1,046
Level II | Investments | Commercial mortgage-backed securities    
Investments:    
Fair Value 988 862
Level II | Investments | Equity securities    
Investments:    
Equity securities 2 2
Level II | Restricted deposits    
Investments:    
Fair Value 756 653
Level II | Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 0
Level II | Restricted deposits | Corporate securities    
Investments:    
Fair Value 32 33
Level II | Restricted deposits | Municipal securities    
Investments:    
Fair Value 720 616
Level II | Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 0 0
Level II | Restricted deposits | Certificates of deposit    
Investments:    
Fair Value 4 4
Level II | Other current assets | Currency Swap    
Investments:    
Foreign currency swap agreement 27  
Level III    
Assets    
Cash and cash equivalents 0 0
Investments:    
Total assets at fair value 0 0
Level III | Investments    
Investments:    
Total investments 0 0
Level III | Investments | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 0
Level III | Investments | Corporate securities    
Investments:    
Fair Value 0 0
Level III | Investments | Municipal securities    
Investments:    
Fair Value 0 0
Level III | Investments | Short-term time deposits    
Investments:    
Fair Value 0 0
Level III | Investments | Asset-backed securities    
Investments:    
Fair Value 0 0
Level III | Investments | Residential mortgage-backed securities    
Investments:    
Fair Value 0 0
Level III | Investments | Commercial mortgage-backed securities    
Investments:    
Fair Value 0 0
Level III | Investments | Equity securities    
Investments:    
Equity securities 0 0
Level III | Restricted deposits    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Corporate securities    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Municipal securities    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Certificates of deposit    
Investments:    
Fair Value 0 $ 0
Level III | Other current assets | Currency Swap    
Investments:    
Foreign currency swap agreement $ 0  
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Fair Value Disclosures [Abstract]    
Aggregate carrying amount of life insurance contracts and equity investments, fair value $ 988 $ 698
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Intangible Assets - Summary of Changes in Goodwill (Details) - USD ($)
$ in Millions
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill, Balance beginning $ 18,812 $ 19,771
Acquisition and purchase accounting adjustments   1,077
Divestitures (933) (1,533)
Reallocation   0
Impairments (348) (370)
Translation impact 27 (133)
Goodwill, Balance ending 17,558 18,812
Medicaid    
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill, Balance beginning 10,198 10,194
Acquisition and purchase accounting adjustments   0
Divestitures 0 0
Reallocation   4
Impairments 0 0
Translation impact 0 0
Goodwill, Balance ending 10,198 10,198
Medicare    
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill, Balance beginning 1,592 1,592
Acquisition and purchase accounting adjustments   0
Divestitures 0 0
Reallocation   0
Impairments 0 0
Translation impact 0 0
Goodwill, Balance ending 1,592 1,592
Commercial    
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill, Balance beginning 5,424 5,424
Acquisition and purchase accounting adjustments   0
Divestitures 0 0
Reallocation   0
Impairments 0 0
Translation impact 0 0
Goodwill, Balance ending 5,424 5,424
Other    
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill, Balance beginning 1,598 2,561
Acquisition and purchase accounting adjustments   1,077
Divestitures (933) (1,533)
Reallocation   (4)
Impairments (348) (370)
Translation impact 27 (133)
Goodwill, Balance ending $ 344 $ 1,598
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Dec. 31, 2022
Goodwill [Line Items]      
Impairments   $ 348 $ 370
Circle Health | Disposal Group, Held-for-sale, Not Discontinued Operations      
Goodwill [Line Items]      
Impairments $ 251    
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 $ 16,745 $ 14,243
Less: Reinsurance recoverable 26 23
Balance, January 1, net 16,719 14,220
Acquisitions and divestitures   249
Incurred related to:    
Current year 90,148 84,457
Prior years (1,888) (1,196)
Total incurred 88,260 83,261
Paid related to:    
Current year 75,402 70,305
Prior years 12,481 10,968
Total paid 87,883 81,273
Balance, June 30, net 17,096 16,457
Plus: Reinsurance recoverable 45 8
Balance, June 30 17,141 16,465
Medicaid    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 11,253 9,845
Less: Reinsurance recoverable 7 23
Balance, January 1, net 11,246 9,822
Acquisitions and divestitures   0
Incurred related to:    
Current year 60,379 57,074
Prior years (1,303) (966)
Total incurred 59,076 56,108
Paid related to:    
Current year 50,774 47,481
Prior years 8,517 7,343
Total paid 59,291 54,824
Balance, June 30, net 11,031 11,106
Plus: Reinsurance recoverable 4 8
Balance, June 30 11,035 11,114
Medicare    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 3,431 2,286
Less: Reinsurance recoverable 0 0
Balance, January 1, net 3,431 2,286
Acquisitions and divestitures   0
Incurred related to:    
Current year 14,680 14,624
Prior years (326) (22)
Total incurred 14,354 14,602
Paid related to:    
Current year 12,069 11,603
Prior years 2,452 1,963
Total paid 14,521 13,566
Balance, June 30, net 3,264 3,322
Plus: Reinsurance recoverable 0 0
Balance, June 30 3,264 3,322
Commercial    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 1,921 2,014
Less: Reinsurance recoverable 19 0
Balance, January 1, net 1,902 2,014
Acquisitions and divestitures   0
Incurred related to:    
Current year 13,994 10,609
Prior years (256) (193)
Total incurred 13,738 10,416
Paid related to:    
Current year 11,575 9,046
Prior years 1,376 1,580
Total paid 12,951 10,626
Balance, June 30, net 2,689 1,804
Plus: Reinsurance recoverable 41 0
Balance, June 30 2,730 1,804
Other    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1 140 98
Less: Reinsurance recoverable 0 0
Balance, January 1, net 140 98
Acquisitions and divestitures   249
Incurred related to:    
Current year 1,095 2,150
Prior years (3) (15)
Total incurred 1,092 2,135
Paid related to:    
Current year 984 2,175
Prior years 136 82
Total paid 1,120 2,257
Balance, June 30, net 112 225
Plus: Reinsurance recoverable 0 0
Balance, June 30 $ 112 $ 225
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Medical Claims Liability - Narrative (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Insurance [Abstract]    
Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs $ 341 $ 121
Short-duration insurance contracts, Incurred but not reported and expected development on reported claims $ 11,661  
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Affordable Care Act [Abstract]    
Risk adjustment receivable $ 1,130 $ 838
Risk adjustment payable (2,312) (780)
Minimum medical loss ratio (90) (103)
Cost sharing reduction payable $ (104) $ (99)
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Affordable Care Act - Additional information (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2023
USD ($)
Affordable Care Act [Abstract]  
Risk adjustment, increase to net receivables $ 244
Risk adjustment and reinsurance pre-tax benefit $ 198
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Debt - Schedule of Debt (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Total senior notes $ 15,675,000,000 $ 15,673,000,000
Finance leases and other 3,000,000 253,000,000
Debt issuance costs (128,000,000) (147,000,000)
Total debt 18,001,000,000 18,020,000,000
Less: current portion (113,000,000) (82,000,000)
 Long-term debt 17,888,000,000 17,938,000,000
Revolving Credit Agreement    
Debt Instrument [Line Items]    
Credit facility 309,000,000 58,000,000
Term Loan Facility    
Debt Instrument [Line Items]    
Credit facility 2,142,000,000 2,183,000,000
$2,500 million 4.25% Senior Notes due December 15, 2027 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,500,000,000  
Interest rate 4.25%  
Senior notes $ 2,395,000,000 2,393,000,000
$2,300 million 2.45% Senior Notes due July 15, 2028 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,300,000,000  
Interest rate 2.45%  
Senior notes $ 2,303,000,000 2,303,000,000
$3,500 million 4.625% Senior Notes due December 15, 2029 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 3,500,000,000  
Interest rate 4.625%  
Senior notes $ 3,277,000,000 3,277,000,000
$2,000 million 3.375% Senior Notes due February 15, 2030 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,000,000,000  
Interest rate 3.375%  
Senior notes $ 2,000,000,000 2,000,000,000
$2,200 million 3.00% Senior Notes due October 15, 2030 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,200,000,000  
Interest rate 3.00%  
Senior notes $ 2,200,000,000 2,200,000,000
$2,200 million 2.50% Senior Notes due March 1, 2031 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,200,000,000  
Interest rate 2.50%  
Senior notes $ 2,200,000,000 2,200,000,000
$1,300 million 2.625% Senior Notes due August 1, 2031 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 1,300,000,000  
Interest rate 2.625%  
Senior notes $ 1,300,000,000 $ 1,300,000,000
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Assets    
ROU assets (recorded within other long-term assets) $ 430 $ 2,554
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other long-term assets Other long-term assets
Liabilities    
Short-term (recorded within accounts payable and accrued expenses) $ 170 $ 180
Long-term (recorded within other long-term liabilities) 936 3,133
Total lease liabilities $ 1,106 $ 3,313
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accounts payable and accrued expenses Accounts payable and accrued expenses
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Other long-term liabilities Other long-term liabilities
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Leases - Narrative (Details)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2023
USD ($)
Lessee, Lease, Description [Line Items]    
ROU impairment $ 35 $ 37
Remaining asset impairment charges   $ 85
Weighted average remaining lease term 20 years 3 months 18 days 20 years 3 months 18 days
Weighted-average discount rate for operating leases 5.80% 5.80%
Weighted-average discount rate for operating leases excluding disposal group 3.20% 3.20%
Remaining lease payments in 2023 excluding disposal group $ 51 $ 51
Circle Health    
Lessee, Lease, Description [Line Items]    
Weighted average remaining lease term 26 years 6 months 26 years 6 months
Excluding Circle Health    
Lessee, Lease, Description [Line Items]    
Weighted average remaining lease term 8 years 3 months 18 days 8 years 3 months 18 days
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Leases - Operating Lease Payments Over Next Five Years Excluding Circle Health (Details)
$ in Millions
Sep. 30, 2023
USD ($)
Leases [Abstract]  
2024 $ 201
2025 176
2026 151
2027 133
2028 113
Thereafter 441
Total lease payments 1,215
Less: imputed interest (160)
Total lease liabilities $ 1,055
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity - Narrative (Details) - USD ($)
shares in Thousands, $ in Millions
 1 Months Ended 3 Months Ended
Oct. 24, 2023
Dec. 31, 2022
Jun. 30, 2022
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Equity, Class of Treasury Stock [Line Items]                  
Stock repurchase program, increase to authorized amount   $ 2,000 $ 3,000            
Stock repurchase program, authorized amount       $ 6,000          
Stock repurchase program, remaining available       1,256          
Common stock repurchases       $ 781 $ 408 $ 423 $ 1,243 $ 349 $ 71
Subsequent Event                  
Equity, Class of Treasury Stock [Line Items]                  
Common stock repurchases (in shares) 397                
Common stock repurchases $ 27                
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity - Share Repurchase Activity (Details) - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Subsidiary, Sale of Stock [Line Items]                
Common stock repurchases $ 781 $ 408 $ 423 $ 1,243 $ 349 $ 71    
Stock repurchases, excise tax accrual $ 10           $ 10  
Employee Stock Compensation Plan                
Subsidiary, Sale of Stock [Line Items]                
Income tax withholding (in shares) 11     34     778 941
Income tax withholding $ 1     $ 3     $ 52 $ 79
Common Stock                
Subsidiary, Sale of Stock [Line Items]                
Share buybacks (in shares) 11,609     11,486     22,489 15,674
Common stock repurchases (in shares) 11,620     11,520     23,267 16,615
Share buybacks $ 773     $ 1,040     $ 1,550 $ 1,384
Common stock repurchases $ 774     $ 1,043     $ 1,602 $ 1,463
Common Stock | Accelerated Share Repurchase Agreement                
Subsidiary, Sale of Stock [Line Items]                
Common stock repurchases (in shares)       8,600       8,600
Percentage of notional amount under ASR       80.00%       80.00%
Accelerated share repurchases agreement, amount (up to)       $ 1,000       $ 1,000
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Net Income (Loss) Attributable to Parent [Abstract]        
Earnings attributable to Centene Corporation $ 469 $ 738 $ 2,657 $ 1,415
Shares used in computing per share amounts:        
Weighted average number of common shares outstanding (in shares) 539,535 573,961 546,374 580,277
Common stock equivalents (as determined by applying the treasury stock method) (in shares) 1,735 6,646 2,038 6,807
Weighted average number of common shares and potential dilutive common shares outstanding (in shares) 541,270 580,607 548,412 587,084
Net earnings per common share attributable to Centene Corporation:        
Basic earnings per common share (in dollars per share) $ 0.87 $ 1.29 $ 4.86 $ 2.44
Diluted earnings per common share (in dollars per share) $ 0.87 $ 1.27 $ 4.85 $ 2.41
Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares) 1,313 152 1,383 193
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Premium and service revenues $ 34,967 $ 33,726 $ 104,757 $ 101,926
Premium tax 3,075 2,139 9,782 7,060
Total external revenues 38,042 35,865 114,539 108,986
Revenues 38,042 35,865 114,539 108,986
Medical costs 29,479 28,111 88,260 83,261
Cost of services 856 1,571 2,603 5,658
Gross margin 4,632 4,044 13,894 13,007
Operating Segments        
Segment Reporting Information [Line Items]        
Revenues 3,978 6,420 11,634 18,856
Eliminations        
Segment Reporting Information [Line Items]        
Revenues (3,978) (6,420) (11,634) (18,856)
Premium        
Segment Reporting Information [Line Items]        
Premium and service revenues 33,866 31,848 101,404 95,247
Service        
Segment Reporting Information [Line Items]        
Premium and service revenues 1,101 1,878 3,353 6,679
Premium and service revenues        
Segment Reporting Information [Line Items]        
Premium and service revenues 34,967 33,726 104,757 101,926
Medicaid        
Segment Reporting Information [Line Items]        
Revenues 24,694 23,293 75,523 69,822
Medical costs 19,607 19,075 59,076 56,108
Cost of services 0 0 2 0
Gross margin 2,012 2,079 6,663 6,654
Medicaid | Operating Segments        
Segment Reporting Information [Line Items]        
Premium tax 3,075 2,139 9,782 7,060
Total external revenues 24,694 23,293 75,523 69,822
Revenues 0 0 0 0
Medicaid | Eliminations        
Segment Reporting Information [Line Items]        
Revenues 0 0 0 0
Medicaid | Premium | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 21,619 21,154 65,741 62,763
Medicaid | Service | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 0 0 0 (1)
Medicaid | Premium and service revenues | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 21,619 21,154 65,741 62,762
Medicare        
Segment Reporting Information [Line Items]        
Revenues 5,430 5,639 16,971 17,035
Medical costs 4,462 4,730 14,354 14,602
Cost of services 0 0 0 0
Gross margin 968 909 2,617 2,433
Medicare | Operating Segments        
Segment Reporting Information [Line Items]        
Premium tax 0 0 0 0
Total external revenues 5,430 5,639 16,971 17,035
Revenues 0 0 0 0
Medicare | Eliminations        
Segment Reporting Information [Line Items]        
Revenues 0 0 0 0
Medicare | Premium | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 5,430 5,639 16,971 17,035
Medicare | Service | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 0 0 0 0
Medicare | Premium and service revenues | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 5,430 5,639 16,971 17,035
Commercial        
Segment Reporting Information [Line Items]        
Revenues 6,453 4,292 17,439 12,979
Medical costs 5,089 3,613 13,738 10,416
Cost of services 0 0 0 0
Gross margin 1,364 679 3,701 2,563
Commercial | Operating Segments        
Segment Reporting Information [Line Items]        
Premium tax 0 0 0 0
Total external revenues 6,453 4,292 17,439 12,979
Revenues 0 0 0 0
Commercial | Eliminations        
Segment Reporting Information [Line Items]        
Revenues 0 0 0 0
Commercial | Premium        
Segment Reporting Information [Line Items]        
Premium and service revenues 6,451 4,291 17,437 12,977
Commercial | Service | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 2 1 2 2
Commercial | Premium and service revenues | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 6,453 4,292 17,439 12,979
Other/Eliminations        
Segment Reporting Information [Line Items]        
Revenues 1,465 2,641 4,606 9,150
Medical costs 321 693 1,092 2,135
Cost of services 856 1,571 2,601 5,658
Gross margin 288 377 913 1,357
Other/Eliminations | Operating Segments        
Segment Reporting Information [Line Items]        
Premium tax 0 0 0 0
Total external revenues 1,465 2,641 4,606 9,150
Revenues 3,978 6,420 11,634 18,856
Other/Eliminations | Eliminations        
Segment Reporting Information [Line Items]        
Revenues (3,978) (6,420) (11,634) (18,856)
Other/Eliminations | Premium | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 366 764 1,255 2,472
Other/Eliminations | Service | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues 1,099 1,877 3,351 6,678
Other/Eliminations | Premium and service revenues | Operating Segments        
Segment Reporting Information [Line Items]        
Premium and service revenues $ 1,465 $ 2,641 $ 4,606 $ 9,150
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.3
Contingencies (Details) - Pending Litigation
$ in Millions
Sep. 30, 2021
claim
Jun. 30, 2021
USD ($)
Loss Contingencies [Line Items]    
Pending claims | claim 3  
Reserve estimate | $   $ 1,250
XML 65 cnc-20230930_htm.xml IDEA: XBRL DOCUMENT 0001071739 2023-01-01 2023-09-30 0001071739 2023-10-20 0001071739 2023-09-30 0001071739 2022-12-31 0001071739 us-gaap:HealthCarePremiumMember 2023-07-01 2023-09-30 0001071739 us-gaap:HealthCarePremiumMember 2022-07-01 2022-09-30 0001071739 us-gaap:HealthCarePremiumMember 2023-01-01 2023-09-30 0001071739 us-gaap:HealthCarePremiumMember 2022-01-01 2022-09-30 0001071739 us-gaap:ServiceMember 2023-07-01 2023-09-30 0001071739 us-gaap:ServiceMember 2022-07-01 2022-09-30 0001071739 us-gaap:ServiceMember 2023-01-01 2023-09-30 0001071739 us-gaap:ServiceMember 2022-01-01 2022-09-30 0001071739 2023-07-01 2023-09-30 0001071739 2022-07-01 2022-09-30 0001071739 2022-01-01 2022-09-30 0001071739 us-gaap:CommonStockMember 2023-09-30 0001071739 us-gaap:CommonStockMember 2022-12-31 0001071739 us-gaap:CommonStockMember 2023-03-31 0001071739 us-gaap:CommonStockMember 2023-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2023-09-30 0001071739 us-gaap:TreasuryStockCommonMember 2022-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2023-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2023-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001071739 us-gaap:RetainedEarningsMember 2022-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-12-31 0001071739 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001071739 2023-01-01 2023-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001071739 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001071739 us-gaap:RetainedEarningsMember 2023-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2023-03-31 0001071739 2023-03-31 0001071739 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001071739 2023-04-01 2023-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001071739 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001071739 us-gaap:RetainedEarningsMember 2023-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2023-06-30 0001071739 2023-06-30 0001071739 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001071739 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001071739 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001071739 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001071739 us-gaap:RetainedEarningsMember 2023-09-30 0001071739 us-gaap:NoncontrollingInterestMember 2023-09-30 0001071739 us-gaap:CommonStockMember 2022-09-30 0001071739 us-gaap:CommonStockMember 2022-03-31 0001071739 us-gaap:CommonStockMember 2022-06-30 0001071739 us-gaap:CommonStockMember 2021-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2021-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-09-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001071739 us-gaap:RetainedEarningsMember 2021-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2021-12-31 0001071739 2021-12-31 0001071739 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001071739 2022-01-01 2022-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001071739 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001071739 us-gaap:RetainedEarningsMember 2022-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-03-31 0001071739 2022-03-31 0001071739 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001071739 2022-04-01 2022-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001071739 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2022-04-01 2022-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001071739 us-gaap:RetainedEarningsMember 2022-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2022-06-30 0001071739 2022-06-30 0001071739 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001071739 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001071739 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001071739 us-gaap:TreasuryStockCommonMember 2022-07-01 2022-09-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001071739 us-gaap:RetainedEarningsMember 2022-09-30 0001071739 us-gaap:NoncontrollingInterestMember 2022-09-30 0001071739 2022-09-30 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:CenturionMember 2023-04-01 2023-06-30 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:MagellanSpecialtyHealthMember 2023-01-20 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:MagellanSpecialtyHealthMember 2023-01-20 2023-01-20 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:MagellanSpecialtyHealthMember 2023-04-01 2023-04-30 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:ApixioMember 2023-06-13 2023-06-13 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:SpanishAndCentralEuropeanBusinessesMember 2023-04-01 2023-06-30 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:SpanishAndCentralEuropeanBusinessesMember 2022-01-01 2022-12-31 0001071739 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember cnc:CircleHealthMember 2023-09-30 0001071739 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember cnc:CircleHealthMember 2023-07-01 2023-09-30 0001071739 us-gaap:CurrencySwapMember 2023-08-31 0001071739 us-gaap:CurrencySwapMember 2023-09-30 0001071739 us-gaap:USTreasuryAndGovernmentMember 2023-09-30 0001071739 us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0001071739 us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 cnc:RestrictedCertificatesOfDepositMember 2023-09-30 0001071739 cnc:RestrictedCertificatesOfDepositMember 2022-12-31 0001071739 cnc:RestrictedCashEquivalentsMember 2023-09-30 0001071739 cnc:RestrictedCashEquivalentsMember 2022-12-31 0001071739 us-gaap:BankTimeDepositsMember 2023-09-30 0001071739 us-gaap:BankTimeDepositsMember 2022-12-31 0001071739 us-gaap:MunicipalBondsMember 2023-09-30 0001071739 us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:AssetBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2022-12-31 0001071739 cnc:RatedSecuritiesMember cnc:InvestmentSecuritiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2023-01-01 2023-09-30 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2023-01-01 2023-09-30 0001071739 us-gaap:InvestmentsMember 2023-09-30 0001071739 us-gaap:DepositsMember 2023-09-30 0001071739 us-gaap:InvestmentsMember 2022-12-31 0001071739 us-gaap:DepositsMember 2022-12-31 0001071739 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001071739 us-gaap:FairValueInputsLevel2Member 2023-09-30 0001071739 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:MunicipalBondsMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:BankTimeDepositsMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:BankTimeDepositsMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:BankTimeDepositsMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:AssetBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:CommercialMortgageBackedSecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:EquitySecuritiesMember 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:CashAndCashEquivalentsMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:USTreasuryAndGovernmentMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:CorporateDebtSecuritiesMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:CertificatesOfDepositMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:MunicipalBondsMember 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001071739 us-gaap:CurrencySwapMember us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001071739 us-gaap:CurrencySwapMember us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001071739 us-gaap:CurrencySwapMember us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001071739 us-gaap:CurrencySwapMember us-gaap:OtherCurrentAssetsMember 2023-09-30 0001071739 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001071739 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001071739 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:BankTimeDepositsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:BankTimeDepositsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:BankTimeDepositsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:CommercialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:EquitySecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:CashAndCashEquivalentsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:CertificatesOfDepositMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001071739 cnc:MedicaidSegmentMember 2021-12-31 0001071739 cnc:MedicareSegmentMember 2021-12-31 0001071739 cnc:CommercialSegmentMember 2021-12-31 0001071739 us-gaap:AllOtherSegmentsMember 2021-12-31 0001071739 cnc:MedicaidSegmentMember 2022-01-01 2022-12-31 0001071739 cnc:MedicareSegmentMember 2022-01-01 2022-12-31 0001071739 cnc:CommercialSegmentMember 2022-01-01 2022-12-31 0001071739 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-12-31 0001071739 2022-01-01 2022-12-31 0001071739 cnc:MedicaidSegmentMember 2022-12-31 0001071739 cnc:MedicareSegmentMember 2022-12-31 0001071739 cnc:CommercialSegmentMember 2022-12-31 0001071739 us-gaap:AllOtherSegmentsMember 2022-12-31 0001071739 cnc:MedicaidSegmentMember 2023-01-01 2023-09-30 0001071739 cnc:MedicareSegmentMember 2023-01-01 2023-09-30 0001071739 cnc:CommercialSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:AllOtherSegmentsMember 2023-01-01 2023-09-30 0001071739 cnc:MedicaidSegmentMember 2023-09-30 0001071739 cnc:MedicareSegmentMember 2023-09-30 0001071739 cnc:CommercialSegmentMember 2023-09-30 0001071739 us-gaap:AllOtherSegmentsMember 2023-09-30 0001071739 cnc:MedicaidSegmentMember 2022-01-01 2022-09-30 0001071739 cnc:MedicareSegmentMember 2022-01-01 2022-09-30 0001071739 cnc:CommercialSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-09-30 0001071739 cnc:MedicaidSegmentMember 2022-09-30 0001071739 cnc:MedicareSegmentMember 2022-09-30 0001071739 cnc:CommercialSegmentMember 2022-09-30 0001071739 us-gaap:AllOtherSegmentsMember 2022-09-30 0001071739 cnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember us-gaap:SeniorNotesMember 2023-09-30 0001071739 cnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A2300Million245SeniorNotsDueJuly2028Member us-gaap:SeniorNotesMember 2023-09-30 0001071739 cnc:A2300Million245SeniorNotsDueJuly2028Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A3500Million4625SeniorNotesDueDecember2029Member us-gaap:SeniorNotesMember 2023-09-30 0001071739 cnc:A3500Million4625SeniorNotesDueDecember2029Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A2200Million375SeniorNotesDueFebruary2030Member us-gaap:SeniorNotesMember 2023-09-30 0001071739 cnc:A2200Million375SeniorNotesDueFebruary2030Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A2200Million300SeniorNotesDueOctober2030Member us-gaap:SeniorNotesMember 2023-09-30 0001071739 cnc:A2200Million300SeniorNotesDueOctober2030Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A2200Million250SeniorNotesDueMarch2031Member us-gaap:SeniorNotesMember 2023-09-30 0001071739 cnc:A2200Million250SeniorNotesDueMarch2031Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A1300Million2625SeniorNotesDueAugust2031Member us-gaap:SeniorNotesMember 2023-09-30 0001071739 cnc:A1300Million2625SeniorNotesDueAugust2031Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:TermLoanCreditAgreementMember 2023-09-30 0001071739 cnc:TermLoanCreditAgreementMember 2022-12-31 0001071739 us-gaap:RevolvingCreditFacilityMember 2023-09-30 0001071739 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001071739 cnc:CircleHealthMember 2023-09-30 0001071739 cnc:ExcludingCircleHealthMember 2023-09-30 0001071739 2022-06-01 2022-06-30 0001071739 2022-12-01 2022-12-31 0001071739 us-gaap:SubsequentEventMember 2023-10-01 2023-10-24 0001071739 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001071739 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001071739 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001071739 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001071739 cnc:EmployeeStockCompensationPlanMember 2023-07-01 2023-09-30 0001071739 cnc:EmployeeStockCompensationPlanMember 2022-07-01 2022-09-30 0001071739 cnc:EmployeeStockCompensationPlanMember 2023-01-01 2023-09-30 0001071739 cnc:EmployeeStockCompensationPlanMember 2022-01-01 2022-09-30 0001071739 cnc:AcceleratedShareRepurchaseAgreementMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001071739 cnc:AcceleratedShareRepurchaseAgreementMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicaidSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicareSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:HealthCarePremiumMember cnc:CommercialSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember us-gaap:AllOtherSegmentsMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicaidSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicareSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:CommercialSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember us-gaap:AllOtherSegmentsMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicaidSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicareSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:CommercialSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember us-gaap:AllOtherSegmentsMember 2023-07-01 2023-09-30 0001071739 cnc:TotalPremiumAndServiceMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicaidSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicareSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:CommercialSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember 2023-07-01 2023-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicaidSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicareSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:CommercialSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2023-07-01 2023-09-30 0001071739 us-gaap:IntersegmentEliminationMember 2023-07-01 2023-09-30 0001071739 cnc:MedicaidSegmentMember 2023-07-01 2023-09-30 0001071739 cnc:MedicareSegmentMember 2023-07-01 2023-09-30 0001071739 cnc:CommercialSegmentMember 2023-07-01 2023-09-30 0001071739 us-gaap:AllOtherSegmentsMember 2023-07-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicaidSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicareSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:HealthCarePremiumMember cnc:CommercialSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember us-gaap:AllOtherSegmentsMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicaidSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicareSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:CommercialSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember us-gaap:AllOtherSegmentsMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicaidSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicareSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:CommercialSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember us-gaap:AllOtherSegmentsMember 2022-07-01 2022-09-30 0001071739 cnc:TotalPremiumAndServiceMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicaidSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicareSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:CommercialSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicaidSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicareSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:CommercialSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2022-07-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember 2022-07-01 2022-09-30 0001071739 cnc:MedicaidSegmentMember 2022-07-01 2022-09-30 0001071739 cnc:MedicareSegmentMember 2022-07-01 2022-09-30 0001071739 cnc:CommercialSegmentMember 2022-07-01 2022-09-30 0001071739 us-gaap:AllOtherSegmentsMember 2022-07-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicaidSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicareSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:HealthCarePremiumMember cnc:CommercialSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicaidSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicareSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:CommercialSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicaidSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicareSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:CommercialSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-09-30 0001071739 cnc:TotalPremiumAndServiceMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicaidSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicareSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:CommercialSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember 2023-01-01 2023-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicaidSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicareSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:CommercialSegmentMember 2023-01-01 2023-09-30 0001071739 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-09-30 0001071739 us-gaap:IntersegmentEliminationMember 2023-01-01 2023-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicaidSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicareSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:HealthCarePremiumMember cnc:CommercialSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicaidSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicareSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:CommercialSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicaidSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicareSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:CommercialSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-09-30 0001071739 cnc:TotalPremiumAndServiceMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicaidSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicareSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember cnc:CommercialSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-09-30 0001071739 us-gaap:OperatingSegmentsMember 2022-01-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicaidSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicareSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember cnc:CommercialSegmentMember 2022-01-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-09-30 0001071739 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-09-30 0001071739 us-gaap:PendingLitigationMember 2021-09-30 0001071739 us-gaap:PendingLitigationMember 2021-06-30 shares iso4217:USD iso4217:USD shares iso4217:GBP pure cnc:position cnc:claim 0001071739 --12-31 2023 Q3 false http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent 10-Q true 2023-09-30 false 001-31826 CENTENE CORPORATION DE 42-1406317 7700 Forsyth Boulevard St. Louis, MO 63105 314 725-4477 Common Stock $0.001 Par Value CNC NYSE Yes Yes Large Accelerated Filer false false false 534201000 18190000000 12074000000 15503000000 13272000000 2241000000 2321000000 5471000000 2461000000 41405000000 30128000000 15234000000 14684000000 1343000000 1217000000 2004000000 2432000000 17558000000 18812000000 6277000000 6911000000 560000000 2686000000 84381000000 76870000000 17141000000 16745000000 15081000000 9525000000 2160000000 1634000000 2356000000 478000000 113000000 82000000 36851000000 28464000000 17888000000 17938000000 577000000 615000000 3649000000 5616000000 58965000000 52633000000 21000000 56000000 0.001 0.001 10000000 10000000 0 0 0 0 0 0 0.001 0.001 800000000 800000000 614956000 534596000 607847000 550754000 1000000 1000000 20243000000 20060000000 -1122000000 -1132000000 11998000000 9341000000 80360000 57093000 5825000000 4213000000 25295000000 24057000000 100000000 124000000 25395000000 24181000000 84381000000 76870000000 33866000000 31848000000 101404000000 95247000000 1101000000 1878000000 3353000000 6679000000 34967000000 33726000000 104757000000 101926000000 3075000000 2139000000 9782000000 7060000000 38042000000 35865000000 114539000000 108986000000 29479000000 28111000000 88260000000 83261000000 856000000 1571000000 2603000000 5658000000 3048000000 2846000000 9075000000 8391000000 148000000 150000000 436000000 470000000 180000000 211000000 542000000 609000000 3156000000 2211000000 10021000000 7258000000 440000000 289000000 478000000 1739000000 37307000000 35389000000 111415000000 107386000000 735000000 476000000 3124000000 1600000000 214000000 692000000 992000000 786000000 0 10000000 0 26000000 181000000 169000000 542000000 491000000 768000000 1009000000 3574000000 1921000000 293000000 269000000 914000000 500000000 475000000 740000000 2660000000 1421000000 6000000 2000000 3000000 6000000 469000000 738000000 2657000000 1415000000 0.87 1.29 4.86 2.44 0.87 1.27 4.85 2.41 539535000 573961000 546374000 580277000 541270000 580607000 548412000 587084000 475000000 740000000 2660000000 1421000000 -235000000 -503000000 -124000000 -1664000000 -56000000 -120000000 -29000000 -397000000 -179000000 -383000000 -95000000 -1267000000 -57000000 -3000000 -61000000 -12000000 -22000000 -101000000 24000000 -216000000 20000000 0 20000000 0 -124000000 -481000000 10000000 -1471000000 351000000 259000000 2670000000 -50000000 6000000 2000000 3000000 6000000 345000000 257000000 2667000000 -56000000 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 607847000 1000000 20060000000 -1132000000 9341000000 57093000 -4213000000 124000000 24181000000 1130000000 1130000000 61000000 217000000 217000000 6508000 12000000 12000000 5548000 423000000 423000000 61000000 61000000 12000000 12000000 614355000 1000000 20121000000 -915000000 10471000000 62641000 -4636000000 124000000 25166000000 1058000000 -3000000 1055000000 -34000000 -83000000 -83000000 388000 9000000 9000000 6099000 408000000 408000000 56000000 56000000 3000000 24000000 27000000 614743000 1000000 20183000000 -998000000 11529000000 68740000 -5044000000 97000000 25768000000 469000000 3000000 472000000 -34000000 -124000000 -124000000 213000 11000000 11000000 11620000 781000000 781000000 50000000 50000000 1000000 1000000 614956000 1000000 20243000000 -1122000000 11998000000 80360000 -5825000000 100000000 25395000000 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 602704000 1000000 19672000000 77000000 8139000000 20225000 -1094000000 145000000 26940000000 849000000 -1000000 848000000 -171000000 -562000000 -562000000 3221000 28000000 28000000 60000000 60000000 846000 71000000 71000000 70000000 70000000 605925000 1000000 19830000000 -485000000 8988000000 21071000 -1165000000 144000000 27313000000 -172000000 -3000000 -175000000 -106000000 -428000000 -428000000 519000 10000000 10000000 4249000 349000000 349000000 59000000 59000000 606444000 1000000 19899000000 -913000000 8816000000 25320000 -1514000000 141000000 26430000000 738000000 -2000000 736000000 -120000000 -481000000 -481000000 487000 24000000 24000000 200000000 11520000 1043000000 1243000000 51000000 51000000 17000000 17000000 606931000 1000000 19774000000 -1394000000 9554000000 36840000 -2557000000 156000000 25534000000 2660000000 1421000000 978000000 1079000000 167000000 180000000 478000000 1739000000 0 26000000 14000000 -682000000 172000000 503000000 -158000000 -164000000 2329000000 1274000000 103000000 -152000000 401000000 1976000000 1878000000 1964000000 3127000000 686000000 583000000 863000000 -4000000 98000000 7836000000 7837000000 576000000 771000000 4729000000 5118000000 4373000000 2842000000 0 1457000000 690000000 1362000000 -242000000 -3142000000 2170000000 357000000 1970000000 1202000000 1602000000 1663000000 32000000 62000000 0 14000000 87000000 0 0 -5000000 -1457000000 -2465000000 19000000 -37000000 6156000000 2193000000 36000000 192000000 12330000000 13214000000 18450000000 15215000000 496000000 462000000 759000000 448000000 18190000000 14987000000 260000000 228000000 18450000000 15215000000 Organization and Operations <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2022. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2022 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain 2022 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2023 presentation, including reclassifications related to the Company's new segment reporting structure as outlined below. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment, and (4) an Other segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind, or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans (D-SNPs), and Medicare Prescription Drug Plans (PDPs), also known as Medicare Part D. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2022. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2022 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain 2022 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2023 presentation, including reclassifications related to the Company's new segment reporting structure as outlined below. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment, and (4) an Other segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind, or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans (D-SNPs), and Medicare Prescription Drug Plans (PDPs), also known as Medicare Part D. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.</span></div> Acquisitions and Divestitures<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2023, the Company completed the divestiture of HealthSmart, its third-party health plan administration business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 10, 2023, the Company signed and closed on a definitive agreement to divest Centurion, its prison healthcare business. During 2022, the Company recorded impairment charges related to goodwill and other current assets associated with the divestiture. During the second quarter of 2023, the Company recognized a $15 million gain on the divestiture of the Centurion business reflecting additional proceeds for contingent consideration, partially offset by net working capital adjustments. The gain is included in investment and other income in the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2023, the Company completed the divestiture of Magellan Specialty Health for approximately $646 million in cash and stock, including an estimated working capital adjustment, and recognized a pre-tax gain of $79 million. The stock consideration was subsequently sold in April 2023 for cash proceeds of $245 million. The Company could also receive up to an additional $150 million in cash and stock in 2024 based on certain 2023 performance metrics. The Company will recognize the appropriate amount of contingent consideration related to the additional $150 million when realized or realizable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 13, 2023, the Company completed the divestiture of its majority stake in Apixio. The Company recognized a pre-tax gain of $91 million, or $63 million after-tax, which is included in investment and other income in the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2023, the Company recognized an additional $13 million expense related to the divestiture of its Spanish and Central European businesses, in addition to the previously recorded impairment charge of $163 million, or $140 million after-tax. The expense is included in investment and other income in the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Circle Health Group Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2023, the Company signed a definitive agreement to sell Circle Health Group (Circle Health), one of the U.K.'s largest independent hospital operators, which is included in the Other segment. As of September 30, 2023, the assets and liabilities of Circle Health were considered held for sale resulting in $3,744 million of assets held for sale in other current assets and $2,947 million of liabilities held for sale in accounts payable and accrued expenses in the Consolidated Balance Sheet. The majority of the held for sale assets were previously reported as other long-term assets, goodwill and property, software and equipment. The majority of the liabilities were previously reported as debt and other long-term liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2023, the Company recorded an impairment charge related to goodwill associated with the pending divestiture of $251 million, or $269 million after-tax.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage the foreign exchange risk on the sale price associated with the pending divestiture of Circle Health, in August 2023 the Company entered into a foreign currency swap agreement for a notional amount of $931 million, to sell £740 million. The swap agreement was formally designated and qualified as a cash flow hedge. The swap expires on March 28, 2024. The gain or loss due to changes in the fair value of the foreign currency swap is recorded in other comprehensive income until the Circle Health divestiture closes, at which time the gain or loss will be recorded in earnings to the same line in the Consolidated Statement of Operations as the gain or loss on sale. The fair value of the swap agreement as of September 30, 2023 was $27 million, which was recorded in other current assets in the Consolidated Balance Sheet.</span></div> 15000000 646000000 79000000 245000000 150000000 150000000 91000000 63000000 13000000 163000000 140000000 3744000000 2947000000 251000000 269000000 931000000 740000000 27000000 Short-term and Long-term Investments, Restricted Deposits<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of </span></div><div style="padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government corporations and agencies</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,361 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,633 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,475 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">988 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,206 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,393)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,818 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,566 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,364)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,222 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments, and life insurance contracts. Private equity investments include direct investments in private equity securities as well as private equity funds. The Company's investment policies are designed to provide liquidity, preserve capital, and maximize total return on invested assets with a focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of September 30, 2023, 99% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At September 30, 2023, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $144 million and $132 million at September 30, 2023 and December 31, 2022, respectively, and is included in other current assets in the Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AA+ and a weighted average duration of 4 years at September 30, 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of </span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government corporations and agencies</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,470 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,393 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,170 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,231)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,331 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,075 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,747 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, the gross unrealized losses were generated from 6,355 positions out of a total of 6,604 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates, and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit-related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,091 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,421 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,501 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,066 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,874 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,804 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,485 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,302 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments, and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem substantially all of the securities included in the greater than ten years category listed above at amortized cost.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of </span></div><div style="padding-left:24.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government corporations and agencies</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,361 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,633 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,475 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">988 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,206 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,393)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,818 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,566 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,364)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,222 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 421000000 0 13000000 408000000 695000000 0 16000000 679000000 9922000000 2000000 750000000 9174000000 10127000000 12000000 778000000 9361000000 4000000 0 0 4000000 4000000 0 0 4000000 260000000 0 0 260000000 256000000 0 0 256000000 470000000 0 0 470000000 204000000 0 0 204000000 3931000000 1000000 294000000 3638000000 4055000000 6000000 280000000 3781000000 1633000000 2000000 52000000 1583000000 1396000000 0 70000000 1326000000 1475000000 0 172000000 1303000000 1165000000 2000000 121000000 1046000000 1100000000 0 112000000 988000000 961000000 0 99000000 862000000 2000000 2000000 5000000 5000000 810000000 810000000 529000000 529000000 178000000 178000000 169000000 169000000 20206000000 5000000 1393000000 18818000000 19566000000 20000000 1364000000 18222000000 0.99 144000000 132000000 P4Y <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of </span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government corporations and agencies</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,470 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,393 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,170 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,231)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,331 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,075 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,747 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1000000 161000000 12000000 247000000 5000000 342000000 11000000 184000000 76000000 2470000000 674000000 6393000000 340000000 5368000000 438000000 3400000000 44000000 1308000000 250000000 2211000000 142000000 2437000000 138000000 995000000 7000000 486000000 45000000 946000000 29000000 786000000 41000000 486000000 23000000 517000000 149000000 786000000 55000000 629000000 66000000 352000000 11000000 228000000 101000000 748000000 49000000 513000000 50000000 330000000 162000000 5170000000 1231000000 11331000000 620000000 10075000000 744000000 5747000000 6355 6604 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,091 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,421 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,501 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,066 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,874 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,804 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,485 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,302 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div> 2121000000 2091000000 537000000 534000000 2207000000 2179000000 534000000 532000000 7421000000 6906000000 531000000 496000000 7651000000 7147000000 524000000 490000000 3931000000 3501000000 312000000 282000000 4066000000 3613000000 224000000 195000000 123000000 113000000 32000000 31000000 135000000 129000000 0 0 4208000000 3874000000 0 0 3522000000 3234000000 0 0 17804000000 16485000000 1412000000 1343000000 17581000000 16302000000 1282000000 1217000000 Fair Value Measurements <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level Input:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at September 30, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,190 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,190 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,406 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency swap agreement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,858 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,189 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,047 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December 31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,938 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,007 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,591 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,598 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $988 million and $698 million as of September 30, 2023 and December 31, 2022, respectively.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level Input:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at September 30, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,190 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,190 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,406 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency swap agreement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,858 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,189 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,047 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December 31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,938 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,007 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,591 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,598 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 18190000000 0 0 18190000000 81000000 0 0 81000000 0 9142000000 0 9142000000 0 2918000000 0 2918000000 0 470000000 0 470000000 0 1583000000 0 1583000000 0 1303000000 0 1303000000 0 988000000 0 988000000 0 2000000 0 2000000 81000000 16406000000 0 16487000000 260000000 0 0 260000000 327000000 0 0 327000000 0 32000000 0 32000000 0 4000000 0 4000000 0 720000000 0 720000000 587000000 756000000 0 1343000000 0 27000000 0 27000000 18858000000 17189000000 0 36047000000 12074000000 0 0 12074000000 366000000 5000000 0 371000000 0 9328000000 0 9328000000 0 3165000000 0 3165000000 0 204000000 0 204000000 0 1326000000 0 1326000000 0 1046000000 0 1046000000 0 862000000 0 862000000 3000000 2000000 0 5000000 369000000 15938000000 0 16307000000 256000000 0 0 256000000 308000000 0 0 308000000 0 33000000 0 33000000 0 4000000 0 4000000 0 616000000 0 616000000 564000000 653000000 0 1217000000 13007000000 16591000000 0 29598000000 988000000 698000000 Goodwill and Intangible Assets<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Operations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the first quarter of 2023, the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in goodwill by operating segment ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,194 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,771 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,198 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,812 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,198 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,558 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in the Other segment goodwill in 2023 was primarily driven by the pending divestiture of Circle Health, which resulted in held for sale accounting and an impairment of $251 million as discussed in Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and an impairment of the Company's Operose Health business based on market indicators of fair value.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in goodwill by operating segment ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,194 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,771 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,198 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,812 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(933)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,198 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,558 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 10194000000 1592000000 5424000000 2561000000 19771000000 0 0 0 1077000000 1077000000 0 0 0 1533000000 1533000000 4000000 0 0 -4000000 0 0 0 0 370000000 370000000 0 0 0 -133000000 -133000000 10198000000 1592000000 5424000000 1598000000 18812000000 0 0 0 933000000 933000000 0 0 0 348000000 348000000 0 0 0 27000000 27000000 10198000000 1592000000 5424000000 344000000 17558000000 251000000 Medical Claims Liability<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Operations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the first quarter of 2023, the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the nine months ended September 30, 2023 ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,745 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2023, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,246 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,076 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,354 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,738 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,092 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,260 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,774 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,069 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,517 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,291 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,521 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,951 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,883 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2023, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,031 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,096 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,035 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,141 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the nine months ended September 30, 2022 ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,845 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2022, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,822 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,074 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(966)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,108 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,602 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,135 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,261 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,046 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,968 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,824 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,566 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,626 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,273 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2022, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,106 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,322 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,457 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,114 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,322 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,465 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of development within "Incurred related to: Prior years," the Company recorded $341 million and $121 million as a reduction to premium revenue in the nine months ended September 30, 2023 and 2022, respectively, for minimum health benefits ratio (HBR) and other return of premium programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incurred but not reported (IBNR) plus expected development on reported claims as of September 30, 2023 was $11,661 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the nine months ended September 30, 2023 ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,745 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2023, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,246 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,680 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,076 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,354 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,738 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,092 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,260 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,774 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,069 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,517 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,291 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,521 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,951 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,883 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2023, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,031 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,096 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,035 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,141 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the nine months ended September 30, 2022 ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,845 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2022, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,822 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,074 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,624 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(966)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,108 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,602 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,135 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,261 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,046 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,968 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,824 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,566 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,626 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,273 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2022, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,106 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,322 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,457 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,114 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,322 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,465 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 11253000000 3431000000 1921000000 140000000 16745000000 7000000 0 19000000 0 26000000 11246000000 3431000000 1902000000 140000000 16719000000 60379000000 14680000000 13994000000 1095000000 90148000000 -1303000000 -326000000 -256000000 -3000000 -1888000000 59076000000 14354000000 13738000000 1092000000 88260000000 50774000000 12069000000 11575000000 984000000 75402000000 8517000000 2452000000 1376000000 136000000 12481000000 59291000000 14521000000 12951000000 1120000000 87883000000 11031000000 3264000000 2689000000 112000000 17096000000 4000000 0 41000000 0 45000000 11035000000 3264000000 2730000000 112000000 17141000000 9845000000 2286000000 2014000000 98000000 14243000000 23000000 0 0 0 23000000 9822000000 2286000000 2014000000 98000000 14220000000 0 0 0 249000000 249000000 57074000000 14624000000 10609000000 2150000000 84457000000 -966000000 -22000000 -193000000 -15000000 -1196000000 56108000000 14602000000 10416000000 2135000000 83261000000 47481000000 11603000000 9046000000 2175000000 70305000000 7343000000 1963000000 1580000000 82000000 10968000000 54824000000 13566000000 10626000000 2257000000 81273000000 11106000000 3322000000 1804000000 225000000 16457000000 8000000 0 0 0 8000000 11114000000 3322000000 1804000000 225000000 16465000000 -341000000 -121000000 11661000000 Affordable Care Act <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.274%"><tr><td style="width:1.0%"></td><td style="width:58.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, the Centers for Medicare and Medicaid Services (CMS) announced the final risk adjustment transfers for the 2022 benefit year. As a result of and subsequent to the announcement, the Company increased its risk adjustment net receivables by $244 million from December 31, 2022. After consideration of minimum MLR and other related impacts, the net pre-tax benefit recognized was approximately $198 million in the nine months ended September 30, 2023.</span></div> <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.274%"><tr><td style="width:1.0%"></td><td style="width:58.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1130000000 838000000 2312000000 780000000 90000000 103000000 104000000 99000000 244000000 -198000000 Debt <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.274%"><tr><td style="width:1.0%"></td><td style="width:58.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,500 million 4.25% Senior Notes due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,300 million 2.45% Senior Notes due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,500 million 4.625% Senior Notes due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.375% Senior Notes due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 3.00% Senior Notes due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 2.50% Senior Notes due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,300 million 2.625% Senior Notes due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,675 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,673 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Facility</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,001 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,888 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,938 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, the Company entered into a first amendment to the Company's Fourth Amended and Restated Credit Agreement. The amendment removed and replaced the interest rate benchmark based on the London Interbank Offered Rate (LIBOR) and related LIBOR-based mechanics applicable to U.S. dollar borrowings under the Amended and Restated Credit Agreement with an interest rate benchmark based on the Secured Overnight Financing Rate (SOFR) (including a customary credit spread adjustment) and related SOFR-based mechanics. Additionally, the amendment removed certain provisions which required the Company to make certain mandatory prepayments of the Term Loan Facility.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.274%"><tr><td style="width:1.0%"></td><td style="width:58.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,500 million 4.25% Senior Notes due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,300 million 2.45% Senior Notes due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,500 million 4.625% Senior Notes due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.375% Senior Notes due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 3.00% Senior Notes due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 2.50% Senior Notes due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,300 million 2.625% Senior Notes due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,675 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,673 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Facility</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,001 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,888 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,938 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2500000000 0.0425 2395000000 2393000000 2300000000 0.0245 2303000000 2303000000 3500000000 0.04625 3277000000 3277000000 2000000000 0.03375 2000000000 2000000000 2200000000 0.0300 2200000000 2200000000 2200000000 0.0250 2200000000 2200000000 1300000000 0.02625 1300000000 1300000000 15675000000 15673000000 2142000000 2183000000 309000000 58000000 3000000 253000000 128000000 147000000 18001000000 18020000000 113000000 82000000 17888000000 17938000000 Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the right-of-use (ROU) assets and lease liabilities ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.128%"><tr><td style="width:1.0%"></td><td style="width:57.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets (recorded within other long-term assets)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1149">430</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1151">2,554</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term (recorded within accounts payable and accrued expenses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1154">170</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1156">180</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term (recorded within other long-term liabilities)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1158">936</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1159">3,133</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in ROU assets and lease liabilities in 2023 was primarily driven by divestiture related activity as discussed in Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Specifically, as of September 30, 2023, Circle Health was considered held for sale and accordingly the associated ROU assets and lease liabilities were reclassified to other current assets and accounts payable and accrued expenses, respectively, in the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in conjunction with ongoing real estate optimization initiatives, the Company recognized $35 million and $37 million of ROU asset impairments for the three and nine months ended September 30, 2023, respectively. The remainder of the $85 million real estate optimization impairment charge for the nine months ended September 30, 2023 was related to property, software and equipment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, the weighted average remaining lease term for the Company was 20.3 years. The average remaining lease term of the Circle Health portfolio is 26.5 years. Excluding Circle Health, the Company's portfolio average remaining lease term is 8.3 years. The lease liabilities as of September 30, 2023, reflect a weighted average discount rate of 5.8%, or 3.2% excluding Circle Health.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding Circle Health, the Company had $51 million remaining in lease payments for 2023 as of September 30, 2023. Lease payments over the next five years and thereafter are as follows ($ in millions):</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.713%"><tr><td style="width:1.0%"></td><td style="width:69.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.198%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the right-of-use (ROU) assets and lease liabilities ($ in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.128%"><tr><td style="width:1.0%"></td><td style="width:57.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets (recorded within other long-term assets)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1149">430</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1151">2,554</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term (recorded within accounts payable and accrued expenses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1154">170</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1156">180</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term (recorded within other long-term liabilities)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1158">936</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1159">3,133</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 430000000 2554000000 170000000 180000000 936000000 3133000000 1106000000 3313000000 35000000 37000000 85000000 P20Y3M18D P26Y6M P8Y3M18D 0.058 0.032 51000000 Lease payments over the next five years and thereafter are as follows ($ in millions):<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.713%"><tr><td style="width:1.0%"></td><td style="width:69.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.198%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Payments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,215 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 201000000 176000000 151000000 133000000 113000000 441000000 1215000000 160000000 1055000000 Stockholders' Equity <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. In 2022, the Company's Board of Directors authorized increases under the program including $3,000 million in June 2022 and an additional $2,000 million in December 2022. With these increases, the Company is authorized to repurchase up to $6,000 million, inclusive of past authorizations. As of September 30, 2023, the Company had a remaining amount of $1,256 million available under the stock repurchase program. In October 2023, the Company repurchased an additional 397 thousand shares for $27 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company's share repurchase activity ($ in millions, shares in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buybacks</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,609 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,486 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,489 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,674 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,620 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,520 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,043 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,267 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,615 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Excludes share repurchase excise tax of $10 million accrued as of September 30, 2023.</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Includes 8.6 million shares delivered as part of an accelerated share repurchase (ASR) agreement, representing 80% of the $1,000 million notional amount. Remaining shares were delivered in the fourth quarter of 2022 upon the settlement of the ASR.</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock.</span></div> 3000000000 2000000000 6000000000 1256000000 397000 27000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company's share repurchase activity ($ in millions, shares in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buybacks</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,609 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,486 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,489 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,674 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,384 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,620 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,520 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,043 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,267 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,615 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Excludes share repurchase excise tax of $10 million accrued as of September 30, 2023.</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Includes 8.6 million shares delivered as part of an accelerated share repurchase (ASR) agreement, representing 80% of the $1,000 million notional amount. Remaining shares were delivered in the fourth quarter of 2022 upon the settlement of the ASR.</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 11609000 773000000 11486000 1040000000 22489000 1550000000 15674000 1384000000 11000 1000000 34000 3000000 778000 52000000 941000 79000000 11620000 774000000 11520000 1043000000 23267000 1602000000 16615000 1463000000 10000000 8600000 8600000 0.80 0.80 1000000000 1000000000 Earnings Per Share <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,657 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,535 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,961 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,374 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,277 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,807 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541,270 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,607 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,412 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587,084 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.86 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The reduction in common stock equivalents is primarily driven by the distribution of long-term stock awards to the estate of the Company's former CEO during the first quarter of 2023, which were fully dilutive prior to their distribution.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted earnings per common share for the three months ended September 30, 2023 and 2022 excludes 1,313 thousand shares and 152 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted earnings per common share for the nine months ended September 30, 2023 and 2022 excludes 1,383 thousand shares and 193 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,657 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,535 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,961 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,374 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,277 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,807 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541,270 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580,607 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,412 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587,084 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.86 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The reduction in common stock equivalents is primarily driven by the distribution of long-term stock awards to the estate of the Company's former CEO during the first quarter of 2023, which were fully dilutive prior to their distribution.</span></div></td></tr></table></div> 469000000 738000000 2657000000 1415000000 539535000 573961000 546374000 580277000 1735000 6646000 2038000 6807000 541270000 580607000 548412000 587084000 0.87 1.29 4.86 2.44 0.87 1.27 4.85 2.41 1313000 152000 1383000 193000 Segment Information <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. Prior year information has been adjusted to reflect the change in segment reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended September 30, 2023, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,619 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,430 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,451 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,866 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,619 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,430 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,453 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,967 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,694 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,430 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,453 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,042 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,978)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,978)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,694 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,430 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,453 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,042 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,632 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended September 30, 2022, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,154 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,291 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,848 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,154 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,292 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,641 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,726 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,293 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,292 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,641 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,865 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,420)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,420)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,293 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,292 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,641 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,865 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,075 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,730 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,044 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the nine months ended September 30, 2023, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,741 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,971 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,437 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,404 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,351 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,353 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,741 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,971 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,439 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,606 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,757 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,523 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,971 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,439 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,606 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,539 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,634)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,634)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,523 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,439 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,606 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,539 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,354 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,601 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,663 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,617 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,701 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,894 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the nine months ended September 30, 2022, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,763 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,035 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,977 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,247 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,678 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,679 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,762 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,035 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,979 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,150 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,926 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,822 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,035 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,979 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,150 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,822 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,035 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,979 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,150 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,986 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,602 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,416 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,654 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,563 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,007 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></td></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended September 30, 2023, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,619 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,430 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,451 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,866 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,619 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,430 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,453 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,967 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,694 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,430 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,453 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,042 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,978)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,978)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,694 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,430 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,453 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,042 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,632 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended September 30, 2022, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,154 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,291 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,848 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,154 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,292 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,641 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,726 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,293 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,292 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,641 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,865 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,420)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,420)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,293 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,292 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,641 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,865 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,075 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,730 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,044 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the nine months ended September 30, 2023, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,741 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,971 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,437 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,404 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,351 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,353 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,741 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,971 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,439 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,606 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,757 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,523 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,971 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,439 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,606 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,539 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,634)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,634)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,523 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,439 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,606 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,539 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,354 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,601 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,663 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,617 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,701 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,894 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the nine months ended September 30, 2022, is as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,763 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,035 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,977 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,247 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,678 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,679 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,762 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,035 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,979 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,150 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,926 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,822 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,035 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,979 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,150 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,822 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,035 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,979 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,150 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,986 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,602 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,416 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,654 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,433 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,563 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,007 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;text-align:right;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></td></tr></table></div> 21619000000 5430000000 6451000000 366000000 33866000000 0 0 2000000 1099000000 1101000000 21619000000 5430000000 6453000000 1465000000 34967000000 3075000000 0 0 0 3075000000 24694000000 5430000000 6453000000 1465000000 38042000000 0 0 0 3978000000 3978000000 0 0 0 -3978000000 -3978000000 24694000000 5430000000 6453000000 1465000000 38042000000 19607000000 4462000000 5089000000 321000000 29479000000 0 0 0 856000000 856000000 2012000000 968000000 1364000000 288000000 4632000000 21154000000 5639000000 4291000000 764000000 31848000000 0 0 1000000 1877000000 1878000000 21154000000 5639000000 4292000000 2641000000 33726000000 2139000000 0 0 0 2139000000 23293000000 5639000000 4292000000 2641000000 35865000000 0 0 0 6420000000 6420000000 0 0 0 -6420000000 -6420000000 23293000000 5639000000 4292000000 2641000000 35865000000 19075000000 4730000000 3613000000 693000000 28111000000 0 0 0 1571000000 1571000000 2079000000 909000000 679000000 377000000 4044000000 65741000000 16971000000 17437000000 1255000000 101404000000 0 0 2000000 3351000000 3353000000 65741000000 16971000000 17439000000 4606000000 104757000000 9782000000 0 0 0 9782000000 75523000000 16971000000 17439000000 4606000000 114539000000 0 0 0 11634000000 11634000000 0 0 0 -11634000000 -11634000000 75523000000 16971000000 17439000000 4606000000 114539000000 59076000000 14354000000 13738000000 1092000000 88260000000 2000000 0 0 2601000000 2603000000 6663000000 2617000000 3701000000 913000000 13894000000 62763000000 17035000000 12977000000 2472000000 95247000000 -1000000 0 2000000 6678000000 6679000000 62762000000 17035000000 12979000000 9150000000 101926000000 7060000000 0 0 0 7060000000 69822000000 17035000000 12979000000 9150000000 108986000000 0 0 0 18856000000 18856000000 0 0 0 -18856000000 -18856000000 69822000000 17035000000 12979000000 9150000000 108986000000 56108000000 14602000000 10416000000 2135000000 83261000000 0 0 0 5658000000 5658000000 6654000000 2433000000 2563000000 1357000000 13007000000 Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to CMS related to risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property and employment-related claims; and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits management (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the discussion below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accellion</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing, and at a mediation in September 2021, the Company reached a settlement with plaintiffs in three of the pending class actions which, if approved by court, should resolve most or all of the pending litigation related to this matter. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company's financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Benefits Management Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan. The Company has reached a no-fault settlement with the Ohio Attorney General regarding this matter and the complaint was dismissed.</span></div>The Company has reached no-fault settlement agreements with the Attorneys General in other states to resolve claims and/or allegations made by those states related to services previously provided by Envolve. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250 million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews or investigations relating to the Company's historical PBM business across products may be brought by other states, the federal government, or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial condition, results of operations and cash flows. 3 1250000000 EXCEL 66 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 68 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 69 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 433 294 1 false 61 0 false 7 false false R1.htm 0000001 - Document - Cover Sheet http://www.centene.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 0000009 - Disclosure - Organization and Operations Sheet http://www.centene.com/role/OrganizationandOperations Organization and Operations Notes 9 false false R10.htm 0000010 - Disclosure - Acquisitions and Divestitures Sheet http://www.centene.com/role/AcquisitionsandDivestitures Acquisitions and Divestitures Notes 10 false false R11.htm 0000011 - Disclosure - Short-term and Long-term Investments, Restricted Deposits Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits Short-term and Long-term Investments, Restricted Deposits Notes 11 false false R12.htm 0000012 - Disclosure - Fair Value Measurements Sheet http://www.centene.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 0000013 - Disclosure - Goodwill and Intangible Assets Sheet http://www.centene.com/role/GoodwillandIntangibleAssets Goodwill and Intangible Assets Notes 13 false false R14.htm 0000014 - Disclosure - Medical Claims Liability Sheet http://www.centene.com/role/MedicalClaimsLiability Medical Claims Liability Notes 14 false false R15.htm 0000015 - Disclosure - Affordable Care Act Sheet http://www.centene.com/role/AffordableCareAct Affordable Care Act Notes 15 false false R16.htm 0000016 - Disclosure - Debt Sheet http://www.centene.com/role/Debt Debt Notes 16 false false R17.htm 0000017 - Disclosure - Leases Sheet http://www.centene.com/role/Leases Leases Notes 17 false false R18.htm 0000018 - Disclosure - Stockholders' Equity Sheet http://www.centene.com/role/StockholdersEquity Stockholders' Equity Notes 18 false false R19.htm 0000019 - Disclosure - Earnings Per Share Sheet http://www.centene.com/role/EarningsPerShare Earnings Per Share Notes 19 false false R20.htm 0000020 - Disclosure - Segment Information Sheet http://www.centene.com/role/SegmentInformation Segment Information Notes 20 false false R21.htm 0000021 - Disclosure - Contingencies Sheet http://www.centene.com/role/Contingencies Contingencies Notes 21 false false R22.htm 9954471 - Disclosure - Organization and Operations (Policies) Sheet http://www.centene.com/role/OrganizationandOperationsPolicies Organization and Operations (Policies) Policies 22 false false R23.htm 9954472 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables Short-term and Long-term Investments, Restricted Deposits (Tables) Tables http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits 23 false false R24.htm 9954473 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.centene.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.centene.com/role/FairValueMeasurements 24 false false R25.htm 9954474 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.centene.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.centene.com/role/GoodwillandIntangibleAssets 25 false false R26.htm 9954475 - Disclosure - Medical Claims Liability (Tables) Sheet http://www.centene.com/role/MedicalClaimsLiabilityTables Medical Claims Liability (Tables) Tables http://www.centene.com/role/MedicalClaimsLiability 26 false false R27.htm 9954476 - Disclosure - Affordable Care Act (Tables) Sheet http://www.centene.com/role/AffordableCareActTables Affordable Care Act (Tables) Tables http://www.centene.com/role/AffordableCareAct 27 false false R28.htm 9954477 - Disclosure - Debt (Tables) Sheet http://www.centene.com/role/DebtTables Debt (Tables) Tables http://www.centene.com/role/Debt 28 false false R29.htm 9954478 - Disclosure - Leases (Tables) Sheet http://www.centene.com/role/LeasesTables Leases (Tables) Tables http://www.centene.com/role/Leases 29 false false R30.htm 9954479 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.centene.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.centene.com/role/StockholdersEquity 30 false false R31.htm 9954480 - Disclosure - Earnings Per Share (Tables) Sheet http://www.centene.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.centene.com/role/EarningsPerShare 31 false false R32.htm 9954481 - Disclosure - Segment Information (Tables) Sheet http://www.centene.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.centene.com/role/SegmentInformation 32 false false R33.htm 9954482 - Disclosure - Acquisitions and Divestitures - Divestiture (Details) Sheet http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails Acquisitions and Divestitures - Divestiture (Details) Details 33 false false R34.htm 9954483 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) Details 34 false false R35.htm 9954484 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) Details http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables 35 false false R36.htm 9954485 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) Details 36 false false R37.htm 9954486 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) Details 37 false false R38.htm 9954487 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 38 false false R39.htm 9954488 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.centene.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 39 false false R40.htm 9954489 - Disclosure - Goodwill and Intangible Assets - Summary of Changes in Goodwill (Details) Sheet http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails Goodwill and Intangible Assets - Summary of Changes in Goodwill (Details) Details 40 false false R41.htm 9954490 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) Sheet http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails Goodwill and Intangible Assets - Narrative (Details) Details 41 false false R42.htm 9954491 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) Sheet http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) Details 42 false false R43.htm 9954492 - Disclosure - Medical Claims Liability - Narrative (Details) Sheet http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails Medical Claims Liability - Narrative (Details) Details 43 false false R44.htm 9954493 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) Sheet http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) Details 44 false false R45.htm 9954494 - Disclosure - Affordable Care Act - Additional information (Details) Sheet http://www.centene.com/role/AffordableCareActAdditionalinformationDetails Affordable Care Act - Additional information (Details) Details 45 false false R46.htm 9954495 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.centene.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 46 false false R47.htm 9954496 - Disclosure - Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details) Sheet http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details) Details 47 false false R48.htm 9954497 - Disclosure - Leases - Narrative (Details) Sheet http://www.centene.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 48 false false R49.htm 9954498 - Disclosure - Leases - Operating Lease Payments Over Next Five Years Excluding Circle Health (Details) Sheet http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails Leases - Operating Lease Payments Over Next Five Years Excluding Circle Health (Details) Details 49 false false R50.htm 9954499 - Disclosure - Stockholders' Equity - Narrative (Details) Sheet http://www.centene.com/role/StockholdersEquityNarrativeDetails Stockholders' Equity - Narrative (Details) Details 50 false false R51.htm 9954500 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details) Sheet http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails Stockholders' Equity - Share Repurchase Activity (Details) Details 51 false false R52.htm 9954501 - Disclosure - Earnings Per Share (Details) Sheet http://www.centene.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.centene.com/role/EarningsPerShareTables 52 false false R53.htm 9954502 - Disclosure - Segment Information (Details) Sheet http://www.centene.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.centene.com/role/SegmentInformationTables 53 false false R54.htm 9954503 - Disclosure - Contingencies (Details) Sheet http://www.centene.com/role/ContingenciesDetails Contingencies (Details) Details http://www.centene.com/role/Contingencies 54 false false All Reports Book All Reports cnc-20230930.htm cnc-20230930.xsd cnc-20230930_cal.xml cnc-20230930_def.xml cnc-20230930_lab.xml cnc-20230930_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 71 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cnc-20230930.htm": { "nsprefix": "cnc", "nsuri": "http://www.centene.com/20230930", "dts": { "inline": { "local": [ "cnc-20230930.htm" ] }, "schema": { "local": [ "cnc-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "cnc-20230930_cal.xml" ] }, "definitionLink": { "local": [ "cnc-20230930_def.xml" ] }, "labelLink": { "local": [ "cnc-20230930_lab.xml" ] }, "presentationLink": { "local": [ "cnc-20230930_pre.xml" ] } }, "keyStandard": 251, "keyCustom": 43, "axisStandard": 22, "axisCustom": 0, "memberStandard": 35, "memberCustom": 24, "hidden": { "total": 11, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 6 }, "contextCount": 433, "entityCount": 1, "segmentCount": 61, "elementCount": 469, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1352, "http://xbrl.sec.gov/dei/2023": 29 }, "report": { "R1": { "role": "http://www.centene.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "longName": "0000002 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:PremiumsAndOtherReceivablesNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R3": { "role": "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "longName": "0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R5": { "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R6": { "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-64", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-76", "name": "us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R7": { "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical", "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:OtherComprehensiveIncomeLossTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R8": { "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R9": { "role": "http://www.centene.com/role/OrganizationandOperations", "longName": "0000009 - Disclosure - Organization and Operations", "shortName": "Organization and Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.centene.com/role/AcquisitionsandDivestitures", "longName": "0000010 - Disclosure - Acquisitions and Divestitures", "shortName": "Acquisitions and Divestitures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits", "longName": "0000011 - Disclosure - Short-term and Long-term Investments, Restricted Deposits", "shortName": "Short-term and Long-term Investments, Restricted Deposits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.centene.com/role/FairValueMeasurements", "longName": "0000012 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.centene.com/role/GoodwillandIntangibleAssets", "longName": "0000013 - Disclosure - Goodwill and Intangible Assets", "shortName": "Goodwill and Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.centene.com/role/MedicalClaimsLiability", "longName": "0000014 - Disclosure - Medical Claims Liability", "shortName": "Medical Claims Liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InsuranceDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InsuranceDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.centene.com/role/AffordableCareAct", "longName": "0000015 - Disclosure - Affordable Care Act", "shortName": "Affordable Care Act", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "cnc:AffordableCareActDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:AffordableCareActDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.centene.com/role/Debt", "longName": "0000016 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.centene.com/role/Leases", "longName": "0000017 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.centene.com/role/StockholdersEquity", "longName": "0000018 - Disclosure - Stockholders' Equity", "shortName": "Stockholders' Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.centene.com/role/EarningsPerShare", "longName": "0000019 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.centene.com/role/SegmentInformation", "longName": "0000020 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.centene.com/role/Contingencies", "longName": "0000021 - Disclosure - Contingencies", "shortName": "Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.centene.com/role/OrganizationandOperationsPolicies", "longName": "9954471 - Disclosure - Organization and Operations (Policies)", "shortName": "Organization and Operations (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables", "longName": "9954472 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables)", "shortName": "Short-term and Long-term Investments, Restricted Deposits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.centene.com/role/FairValueMeasurementsTables", "longName": "9954473 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.centene.com/role/GoodwillandIntangibleAssetsTables", "longName": "9954474 - Disclosure - Goodwill and Intangible Assets (Tables)", "shortName": "Goodwill and Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.centene.com/role/MedicalClaimsLiabilityTables", "longName": "9954475 - Disclosure - Medical Claims Liability (Tables)", "shortName": "Medical Claims Liability (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.centene.com/role/AffordableCareActTables", "longName": "9954476 - Disclosure - Affordable Care Act (Tables)", "shortName": "Affordable Care Act (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.centene.com/role/DebtTables", "longName": "9954477 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.centene.com/role/LeasesTables", "longName": "9954478 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.centene.com/role/StockholdersEquityTables", "longName": "9954479 - Disclosure - Stockholders' Equity (Tables)", "shortName": "Stockholders' Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.centene.com/role/EarningsPerShareTables", "longName": "9954480 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.centene.com/role/SegmentInformationTables", "longName": "9954481 - Disclosure - Segment Information (Tables)", "shortName": "Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "longName": "9954482 - Disclosure - Acquisitions and Divestitures - Divestiture (Details)", "shortName": "Acquisitions and Divestitures - Divestiture (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GainLossOnSaleOfBusiness", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-118", "name": "us-gaap:DerivativeAssetNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R34": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "longName": "9954483 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)", "shortName": "Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails", "longName": "9954484 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "longName": "9954485 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details)", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails", "longName": "9954486 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-140", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-140", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "longName": "9954487 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "shortName": "Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.centene.com/role/FairValueMeasurementsNarrativeDetails", "longName": "9954488 - Disclosure - Fair Value Measurements - Narrative (Details)", "shortName": "Fair Value Measurements - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-3", "name": "cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails", "longName": "9954489 - Disclosure - Goodwill and Intangible Assets - Summary of Changes in Goodwill (Details)", "shortName": "Goodwill and Intangible Assets - Summary of Changes in Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-73", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R41": { "role": "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails", "longName": "9954490 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)", "shortName": "Goodwill and Intangible Assets - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": null }, "R42": { "role": "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "longName": "9954491 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)", "shortName": "Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-73", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R43": { "role": "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails", "longName": "9954492 - Disclosure - Medical Claims Liability - Narrative (Details)", "shortName": "Medical Claims Liability - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "cnc:AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails", "longName": "9954493 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details)", "shortName": "Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-3", "name": "cnc:AffordableCareActRiskAdjustmentReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "cnc:AffordableCareActRiskAdjustmentReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.centene.com/role/AffordableCareActAdditionalinformationDetails", "longName": "9954494 - Disclosure - Affordable Care Act - Additional information (Details)", "shortName": "Affordable Care Act - Additional information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "cnc:AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cnc:AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.centene.com/role/DebtScheduleofDebtDetails", "longName": "9954495 - Disclosure - Debt - Schedule of Debt (Details)", "shortName": "Debt - Schedule of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-3", "name": "cnc:SeniorNotesTotal", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "cnc:SeniorNotesTotal", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails", "longName": "9954496 - Disclosure - Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details)", "shortName": "Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.centene.com/role/LeasesNarrativeDetails", "longName": "9954497 - Disclosure - Leases - Narrative (Details)", "shortName": "Leases - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:OperatingLeaseImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:OperatingLeaseImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails", "longName": "9954498 - Disclosure - Leases - Operating Lease Payments Over Next Five Years Excluding Circle Health (Details)", "shortName": "Leases - Operating Lease Payments Over Next Five Years Excluding Circle Health (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-3", "name": "cnc:LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearOne", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "cnc:LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearOne", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.centene.com/role/StockholdersEquityNarrativeDetails", "longName": "9954499 - Disclosure - Stockholders' Equity - Narrative (Details)", "shortName": "Stockholders' Equity - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-320", "name": "cnc:StockRepurchaseProgramIncreaseAuthorizedAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-320", "name": "cnc:StockRepurchaseProgramIncreaseAuthorizedAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails", "longName": "9954500 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details)", "shortName": "Stockholders' Equity - Share Repurchase Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:TreasuryStockValueAcquiredCostMethod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-326", "name": "us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R52": { "role": "http://www.centene.com/role/EarningsPerShareDetails", "longName": "9954501 - Disclosure - Earnings Per Share (Details)", "shortName": "Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.centene.com/role/SegmentInformationDetails", "longName": "9954502 - Disclosure - Segment Information (Details)", "shortName": "Segment Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "unique": true } }, "R54": { "role": "http://www.centene.com/role/ContingenciesDetails", "longName": "9954503 - Disclosure - Contingencies (Details)", "shortName": "Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-432", "name": "us-gaap:LossContingencyPendingClaimsNumber", "unitRef": "claim", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-432", "name": "us-gaap:LossContingencyPendingClaimsNumber", "unitRef": "claim", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cnc-20230930.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior years", "label": "Prior Year Claims and Claims Adjustment Expense", "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs." } } }, "auth_ref": [ "r608" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Domain]", "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r124", "r654" ] }, "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearFour", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails": { "parentTag": "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroup", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Four", "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Four" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r191", "r275", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r307", "r312", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r379", "r380", "r381", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r728", "r769", "r879" ] }, "us-gaap_CommercialMortgageBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommercialMortgageBackedSecuritiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Commercial mortgage-backed securities", "netLabel": "Commercial mortgage-backed securities", "terseLabel": "Commercial mortgage-backed securities", "label": "Commercial Mortgage-Backed Securities [Member]", "documentation": "Securities collateralized by commercial real estate mortgage loans." } } }, "auth_ref": [ "r797", "r803", "r804", "r837" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.centene.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r510" ] }, "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearTwo", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails": { "parentTag": "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroup", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Two", "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Two" } } }, "auth_ref": [] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r415", "r449", "r450", "r451", "r452", "r453", "r454", "r492", "r522", "r523", "r524", "r730", "r731", "r735", "r736", "r737" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Axis]", "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r192" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r124" ] }, "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification to redeemable", "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest", "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest." } } }, "auth_ref": [ "r18", "r75", "r158" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.001 par value; authorized 800,000 shares; 614,956 issued and 534,596 outstanding at September\u00a030, 2023, and 607,847 issued and 550,754 outstanding at December\u00a031, 2022", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r124", "r572", "r743" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Balance (in shares)", "periodEndLabel": "Balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r20", "r124", "r654", "r672", "r886", "r887" ] }, "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total, Fair Value", "label": "Investments, Debt Securities, Equity Securities And Other, Fair Value", "documentation": "Investments, Debt Securities, Equity Securities And Other, Fair Value" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r512" ] }, "us-gaap_LifeInsuranceCorporateOrBankOwnedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LifeInsuranceCorporateOrBankOwnedAmount", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Life insurance contracts", "label": "Life Insurance, Corporate or Bank Owned, Amount", "documentation": "This item represents the amount that could be realized under a life insurance contract or contracts owned by the Entity as of the date of the statement of financial position. Such Entity-owned life insurance policies are commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI)." } } }, "auth_ref": [ "r349", "r778" ] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets at fair value", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r98" ] }, "cnc_AcceleratedShareRepurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AcceleratedShareRepurchaseAgreementMember", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated Share Repurchase Agreement", "label": "Accelerated Share Repurchase Agreement [Member]", "documentation": "Accelerated Share Repurchase Agreement" } } }, "auth_ref": [] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "crdr": "credit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, January 1, net", "periodEndLabel": "Balance, June 30, net", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net", "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims." } } }, "auth_ref": [ "r109", "r179", "r875" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term (recorded within accounts payable and accrued expenses)", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r512" ] }, "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroup": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroup", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group", "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term debt", "terseLabel": "Long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r203" ] }, "cnc_AffordableCareActCostSharingReductionsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AffordableCareActCostSharingReductionsPayable", "crdr": "credit", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cost sharing reduction payable", "label": "Affordable Care Act Cost Sharing Reductions, Payable", "documentation": "Affordable Care Act Cost Sharing Reductions, Payable" } } }, "auth_ref": [] }, "us-gaap_ResidentialMortgageBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResidentialMortgageBackedSecuritiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Residential mortgage-backed securities", "label": "Residential Mortgage-Backed Securities [Member]", "documentation": "Securities collateralized by residential real estate mortgage loans." } } }, "auth_ref": [ "r795", "r797", "r802", "r803", "r804", "r837" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r275", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r307", "r312", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r380", "r381", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r728", "r769", "r879" ] }, "us-gaap_DepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Deposits", "verboseLabel": "Restricted deposits", "label": "Deposits [Member]", "documentation": "Amounts held on account by the entity representing a liability to the depositor. Deposits may take various forms (for example, demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits) and may be categorized in multiple ways (such as, foreign and domestic, interest and noninterest bearing)." } } }, "auth_ref": [ "r174" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r34", "r66" ] }, "cnc_A3500Million4625SeniorNotesDueDecember2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "A3500Million4625SeniorNotesDueDecember2029Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$3,500 million 4.625% Senior Notes due December 15, 2029", "label": "$3,500 Million 4.625% Senior Notes due December 2029 [Member]", "documentation": "$3,500 Million 4.625% Senior Notes due December 2029" } } }, "auth_ref": [] }, "cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "LifeInsuranceContractsAndEquityInvestmentsFairValue", "crdr": "debit", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate carrying amount of life insurance contracts and equity investments, fair value", "label": "Life Insurance Contracts And Equity Investments, Fair Value", "documentation": "Life Insurance Contracts And Equity Investments, Fair Value" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ExternalCreditRatingInvestmentGradeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExternalCreditRatingInvestmentGradeMember", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "External Credit Rating, Investment Grade", "label": "External Credit Rating, Investment Grade [Member]", "documentation": "External credit-rating that could be used to describe the current status of the payment and performance risk of credit derivatives and guarantee obligations that connote investment grade." } } }, "auth_ref": [ "r96" ] }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical claims liability", "periodStartLabel": "Balance, January 1", "periodEndLabel": "Balance, June 30", "label": "Liability for Claims and Claims Adjustment Expense", "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date." } } }, "auth_ref": [ "r109", "r179" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r491", "r492" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term (recorded within other long-term liabilities)", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r512" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "cnc_LesseeOperatingLeaseLiabilityExcludingDisposalGroupUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "LesseeOperatingLeaseLiabilityExcludingDisposalGroupUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails_1": { "parentTag": "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroup", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Excluding Disposal Group, Undiscounted Excess Amount", "documentation": "Lessee, Operating Lease, Liability, Excluding Disposal Group, Undiscounted Excess Amount" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive (loss)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r40", "r41", "r130", "r207", "r573", "r613", "r614" ] }, "us-gaap_AllOtherSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllOtherSegmentsMember", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "verboseLabel": "Other/Eliminations", "label": "Other Segments [Member]", "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items." } } }, "auth_ref": [ "r275", "r297", "r298", "r299", "r300", "r301" ] }, "us-gaap_LitigationStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationStatusDomain", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Status [Domain]", "label": "Litigation Status [Domain]", "documentation": "Status of pending, threatened, or settled litigation." } } }, "auth_ref": [ "r828" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation expense", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r13", "r65" ] }, "us-gaap_LongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermInvestments", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term investments", "label": "Long-Term Investments", "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)." } } }, "auth_ref": [ "r197" ] }, "us-gaap_PendingLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PendingLitigationMember", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pending Litigation", "label": "Pending Litigation [Member]", "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process." } } }, "auth_ref": [ "r828" ] }, "us-gaap_MinorityInterestDecreaseFromRedemptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestDecreaseFromRedemptions", "crdr": "debit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of redeemable and non-redeemable noncontrolling interest", "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests", "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests)." } } }, "auth_ref": [ "r87", "r154", "r158" ] }, "us-gaap_LitigationStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationStatusAxis", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Status [Axis]", "label": "Litigation Status [Axis]", "documentation": "Information by status of pending, threatened, or settled litigation." } } }, "auth_ref": [ "r828" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails", "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill impairment", "negatedLabel": "Impairments", "terseLabel": "Impairments", "label": "Goodwill, Impairment Loss", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r13", "r366", "r372", "r377", "r728" ] }, "cnc_MagellanSpecialtyHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "MagellanSpecialtyHealthMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Magellan Specialty Health", "label": "Magellan Specialty Health [Member]", "documentation": "Magellan Specialty Health" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r759" ] }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForLossesAndLossAdjustmentExpense", "crdr": "credit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total paid", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid", "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process." } } }, "auth_ref": [ "r11", "r23" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r297", "r298", "r299", "r300", "r301", "r307" ] }, "us-gaap_ShareRepurchaseProgramAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareRepurchaseProgramAxis", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program [Axis]", "label": "Share Repurchase Program [Axis]", "documentation": "Information by share repurchase program." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisitions, net of cash acquired", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r45" ] }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Divestiture proceeds, net of divested cash", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity." } } }, "auth_ref": [ "r44" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r728", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings attributable to Centene Corporation", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r132", "r143", "r172", "r193", "r217", "r220", "r224", "r240", "r245", "r247", "r248", "r249", "r250", "r253", "r254", "r263", "r278", "r298", "r304", "r307", "r348", "r388", "r389", "r391", "r392", "r393", "r395", "r397", "r399", "r400", "r489", "r498", "r581", "r674", "r691", "r692", "r725", "r756", "r833" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r241", "r280", "r297", "r298", "r299", "r300", "r301", "r303", "r307", "r388", "r389", "r390", "r391", "r393", "r394", "r396", "r398", "r399", "r833", "r834" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "crdr": "debit", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "12 Months or More", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r183", "r362" ] }, "cnc_StockRepurchaseProgramIncreaseAuthorizedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "StockRepurchaseProgramIncreaseAuthorizedAmount", "crdr": "credit", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase program, increase to authorized amount", "label": "Stock Repurchase Program, Increase, Authorized Amount", "documentation": "Stock Repurchase Program, Increase, Authorized Amount" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "crdr": "debit", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less Than 12 Months", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r183", "r362" ] }, "cnc_CenturionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "CenturionMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Centurion", "label": "Centurion [Member]", "documentation": "Centurion" } } }, "auth_ref": [] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r384", "r385", "r386", "r387", "r829", "r830" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/Contingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r149", "r382", "r383", "r718", "r827" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Comprehensive (earnings) attributable to noncontrolling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r10", "r86", "r90", "r219", "r221", "r229", "r554", "r585" ] }, "us-gaap_InsuranceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InsuranceAbstract", "lang": { "en-us": { "role": { "terseLabel": "Insurance [Abstract]", "label": "Insurance [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails", "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r728" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued for employee benefit plans (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r20", "r123", "r124", "r154" ] }, "us-gaap_ShareRepurchaseProgramDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareRepurchaseProgramDomain", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program [Domain]", "label": "Share Repurchase Program [Domain]", "documentation": "Name of the share repurchase program." } } }, "auth_ref": [] }, "us-gaap_DebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total debt", "label": "Debt and Lease Obligation", "documentation": "Amount of short-term and long-term debt and lease obligation." } } }, "auth_ref": [ "r170" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private equity investments", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r288", "r347", "r777", "r809" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/Debt" ], "lang": { "en-us": { "role": { "verboseLabel": "Debt", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r150", "r238", "r401", "r407", "r408", "r409", "r410", "r411", "r412", "r417", "r424", "r425", "r427" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock repurchases", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r48" ] }, "cnc_AffordableCareActAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AffordableCareActAbstract", "lang": { "en-us": { "role": { "terseLabel": "Affordable Care Act [Abstract]", "label": "Affordable Care Act [Abstract]", "documentation": "Affordable Care Act [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross margin", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r134", "r240", "r278", "r298", "r304", "r307", "r348", "r388", "r389", "r391", "r392", "r393", "r395", "r397", "r399", "r400", "r498", "r725", "r833" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Stockholders' equity:", "terseLabel": "Stockholders' equity", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r163", "r200", "r240", "r278", "r299", "r305", "r348", "r388", "r389", "r391", "r392", "r393", "r395", "r397", "r399", "r400", "r471", "r476", "r498", "r567", "r666", "r743", "r758", "r833", "r834", "r872" ] }, "us-gaap_HealthCarePremiumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HealthCarePremiumMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premium", "label": "Health Care, Premium [Member]", "documentation": "Money received from insurance for service provided for maintenance, diagnosis and treatment of physical and mental health." } } }, "auth_ref": [ "r836" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails", "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r728" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r549", "r784" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average remaining lease term", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r515", "r742" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other financing activities, net", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r766", "r783" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r35" ] }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase program, authorized amount", "label": "Stock Repurchase Program, Authorized Amount", "documentation": "Amount of stock repurchase plan authorized." } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r83", "r443", "r790", "r791", "r792", "r886" ] }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "crdr": "credit", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase program, remaining available", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "documentation": "Amount remaining of a stock repurchase plan authorized." } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r762" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Nonredeemable noncontrolling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r39", "r166", "r240", "r348", "r388", "r391", "r392", "r393", "r399", "r400", "r498", "r575", "r656" ] }, "us-gaap_PaymentsToMinorityShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToMinorityShareholders", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of noncontrolling interest", "label": "Payments to Noncontrolling Interests", "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest." } } }, "auth_ref": [ "r47" ] }, "us-gaap_IncreaseDecreaseInPremiumsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPremiumsReceivable", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Premium and trade receivables", "label": "Increase (Decrease) in Premiums Receivable", "documentation": "The change in the premium receivable balance on the balance sheet." } } }, "auth_ref": [ "r12" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r83", "r84", "r88", "r189", "r190", "r223", "r242", "r243", "r244", "r246", "r252", "r350", "r351", "r443", "r457", "r458", "r459", "r463", "r464", "r479", "r480", "r481", "r482", "r483", "r484", "r487", "r500", "r502", "r506", "r517", "r610", "r611", "r622", "r656", "r672", "r694", "r695", "r713", "r757", "r788", "r810", "r868", "r886" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r763" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One year through five years", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r799" ] }, "us-gaap_EquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities", "label": "Equity Securities [Member]", "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants." } } }, "auth_ref": [ "r58", "r753", "r754", "r755", "r888" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of services", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r136", "r550" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One year or less", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r798" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r52", "r53", "r100", "r101", "r312", "r717" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockSharesAcquired", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/StockholdersEquityNarrativeDetails", "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock repurchases (in shares)", "totalLabel": "Common stock repurchases (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r20", "r124", "r154" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Greater than ten years", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r801" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Five years through ten years", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r800" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r52", "r53", "r100", "r101", "r312", "r615", "r717" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset-backed securities", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r796", "r797" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One year or less", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r324", "r560" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One year through five years", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r325", "r561" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Five years through ten years", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r326", "r562" ] }, "cnc_ExcludingCircleHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "ExcludingCircleHealthMember", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Excluding Circle Health", "label": "Excluding Circle Health [Member]", "documentation": "Excluding Circle Health" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Greater than ten years", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r327", "r563" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset-backed securities", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r323", "r559", "r796" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r764" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r507", "r518" ] }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesAbstract", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments:", "label": "Debt Securities, Available-for-Sale [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of change in medical claims liability", "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]", "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims." } } }, "auth_ref": [ "r177" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock equivalents (as determined by applying the treasury stock method) (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r259", "r260", "r261", "r266", "r456" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized gain on cash flow hedge, net of tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r212", "r215" ] }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable noncontrolling interests", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity." } } }, "auth_ref": [ "r69", "r70", "r71", "r72" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other adjustments, net", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r143" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incurred related to:", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current year", "label": "Current Year Claims and Claims Adjustment Expense", "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs." } } }, "auth_ref": [ "r608" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive earnings (loss)", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r90", "r157", "r219", "r221", "r228", "r553", "r584" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total revenues", "terseLabel": "Revenues", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r226", "r240", "r279", "r280", "r297", "r302", "r303", "r309", "r311", "r312", "r348", "r388", "r389", "r391", "r392", "r393", "r395", "r397", "r399", "r400", "r498", "r557", "r833" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes paid", "label": "Income Taxes Paid, Net", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r51" ] }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfTreasuryStockByClassTextBlock", "presentation": [ "http://www.centene.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Treasury Stock", "label": "Class of Treasury Stock [Table Text Block]", "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock." } } }, "auth_ref": [ "r76", "r77", "r78", "r79" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September\u00a030, 2023 and December\u00a031, 2022", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r123", "r571", "r743" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r499" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase in cash, cash equivalents, and restricted cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r141" ] }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingActivitiesCashFlowStatement", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other operating activities, net", "label": "Other Operating Activities, Cash Flow Statement", "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of acquired intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r13", "r61", "r63" ] }, "us-gaap_EquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0, "order": 2.0 }, "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities", "label": "Equity Securities, FV-NI, Current", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current." } } }, "auth_ref": [ "r201", "r496", "r721" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r278", "r298", "r304", "r307", "r725" ] }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityClassOfTreasuryStockLineItems", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity, Class of Treasury Stock [Line Items]", "label": "Equity, Class of Treasury Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period", "periodEndLabel": "Cash, cash equivalents, and restricted cash and cash equivalents, end of period", "totalLabel": "Total cash, cash equivalents, and restricted cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r50", "r141", "r237" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premium and service revenues", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r279", "r280", "r297", "r302", "r303", "r309", "r311", "r312", "r446", "r447", "r550" ] }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule Of Investments And Restricted Deposits By Type [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]", "label": "Debt Securities, Available-for-Sale [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r324", "r325", "r326", "r327" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total external revenues", "label": "Revenue from Contract with Customer, Including Assessed Tax", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r279", "r280", "r297", "r302", "r303", "r309", "r311", "r312", "r446", "r447", "r550" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings", "terseLabel": "Net earnings", "verboseLabel": "Net earnings", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r193", "r217", "r220", "r233", "r240", "r245", "r253", "r254", "r278", "r298", "r304", "r307", "r348", "r388", "r389", "r391", "r392", "r393", "r395", "r397", "r399", "r400", "r470", "r473", "r474", "r489", "r498", "r557", "r579", "r623", "r674", "r691", "r692", "r725", "r740", "r741", "r757", "r782", "r833" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "cnc_AccrualForStockRepurchasesExciseTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AccrualForStockRepurchasesExciseTax", "crdr": "credit", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchases, excise tax accrual", "label": "Accrual For Stock Repurchases, Excise Tax", "documentation": "Accrual For Stock Repurchases, Excise Tax" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.centene.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "verboseLabel": "Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r255", "r267", "r268", "r269" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash and cash equivalents reclassified from (to) held for sale", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r50", "r141", "r237" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "verboseLabel": "Par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r124" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.centene.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Calculation of Basic and Diluted Net Earnings Per Common Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r794" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r760" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDivestitureOfBusinesses", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of business", "label": "Proceeds from Divestiture of Businesses", "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period." } } }, "auth_ref": [ "r44" ] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets held for sale", "label": "Disposal Group, Including Discontinued Operation, Assets", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r2", "r111", "r117", "r147", "r192", "r193" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Interest paid", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r232", "r235", "r236" ] }, "cnc_A2200Million375SeniorNotesDueFebruary2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "A2200Million375SeniorNotesDueFebruary2030Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$2,000 million 3.375% Senior Notes due February 15, 2030", "label": "$2,200 Million 3.75% Senior Notes Due February 2030 [Member]", "documentation": "$2,200 Million 3.75% Senior Notes Due February 2030" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "crdr": "debit", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest income", "label": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r322", "r357", "r358", "r359" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r187", "r204", "r205", "r206", "r240", "r258", "r262", "r264", "r266", "r272", "r273", "r348", "r388", "r391", "r392", "r393", "r399", "r400", "r429", "r430", "r432", "r435", "r442", "r498", "r617", "r618", "r619", "r620", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r654", "r675", "r693", "r708", "r709", "r710", "r711", "r712", "r765", "r786", "r793" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical", "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r745", "r746", "r747", "r749", "r750", "r751", "r752", "r790", "r791", "r867", "r883", "r886" ] }, "cnc_OperatingLeaseWeightedAverageDiscountRateExcludingDisposalGroupPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.centene.com/20230930", "localname": "OperatingLeaseWeightedAverageDiscountRateExcludingDisposalGroupPercent", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average discount rate for operating leases excluding disposal group", "label": "Operating Lease, Weighted Average Discount Rate, Excluding Disposal Group, Percent", "documentation": "Operating Lease, Weighted Average Discount Rate, Excluding Disposal Group, Percent" } } }, "auth_ref": [] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues:", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r309", "r550", "r600", "r601", "r602", "r603", "r604", "r605", "r719", "r734", "r744", "r769", "r831", "r832", "r835", "r879" ] }, "us-gaap_DerivativeAssetNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetNotionalAmount", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional amount", "label": "Derivative Asset, Notional Amount", "documentation": "Nominal or face amount used to calculate payments on the derivative asset." } } }, "auth_ref": [ "r698", "r700", "r702", "r705", "r864", "r865", "r866" ] }, "cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of unvested equity awards in connection with acquisition", "label": "Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture", "documentation": "Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r491", "r492", "r493" ] }, "us-gaap_SeniorNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorNotes", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": "cnc_SeniorNotesTotal", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior notes", "label": "Senior Notes", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders." } } }, "auth_ref": [ "r106", "r876" ] }, "us-gaap_ClassOfTreasuryStockTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfTreasuryStockTable", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Treasury Stock [Table]", "label": "Class of Treasury Stock [Table]", "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock." } } }, "auth_ref": [ "r76", "r77", "r78", "r79" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "(Earnings) attributable to noncontrolling interests", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r89", "r159", "r217", "r220", "r253", "r254", "r580", "r782" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r309", "r550", "r600", "r601", "r602", "r603", "r604", "r605", "r719", "r734", "r744", "r769", "r831", "r832", "r835", "r879" ] }, "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet", "crdr": "credit", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-duration insurance contracts, Incurred but not reported and expected development on reported claims", "label": "Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net", "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r24", "r25" ] }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current operating lease liability." } } }, "auth_ref": [ "r513" ] }, "cnc_FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$2,500 million 4.25% Senior Notes due December 15, 2027", "label": "Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member]", "documentation": "Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member]" } } }, "auth_ref": [] }, "us-gaap_PremiumsAndOtherReceivablesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsAndOtherReceivablesNet", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Premium and trade receivables", "label": "Premiums and Other Receivables, Net", "documentation": "Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities." } } }, "auth_ref": [ "r877" ] }, "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical costs", "label": "Policyholder Benefits and Claims Incurred, Net, Health", "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts." } } }, "auth_ref": [ "r878" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability." } } }, "auth_ref": [ "r513" ] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "documentation": "Different names of stock transactions and the different attributes of each transaction." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset." } } }, "auth_ref": [ "r513" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r760" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ROU assets (recorded within other long-term assets)", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r511" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r194", "r209", "r240", "r348", "r388", "r389", "r391", "r392", "r393", "r395", "r397", "r399", "r400", "r471", "r476", "r498", "r743", "r833", "r834", "r872" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r76" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "verboseLabel": "Treasury stock (in shares)", "periodStartLabel": "Treasury stock (in shares)", "periodEndLabel": "Treasury stock (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r76" ] }, "cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh", "crdr": "credit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration on disposal (up to)", "label": "Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High", "documentation": "Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High" } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Assets, Current [Abstract]", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r760" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Axis]", "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r98", "r99" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Domain]", "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r738", "r739" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r52", "r53", "r100", "r101", "r312" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost (80,360 and 57,093 shares, respectively)", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r38", "r76", "r79" ] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate securities", "label": "Corporate Debt Securities [Member]", "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment." } } }, "auth_ref": [ "r735", "r737", "r882" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "verboseLabel": "Segment Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r274", "r275", "r276", "r277", "r278", "r290", "r301", "r305", "r306", "r307", "r308", "r309", "r310", "r312" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r760" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r760" ] }, "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations", "label": "Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]", "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r6", "r22", "r192" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r384", "r385", "r386", "r387", "r829", "r830" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails" ], "lang": { "en-us": { "role": { "netLabel": "Goodwill", "periodStartLabel": "Goodwill, Balance beginning", "periodEndLabel": "Goodwill, Balance ending", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r198", "r365", "r551", "r728", "r743", "r815", "r822" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities, Current [Abstract]", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and maturities of investments", "label": "Proceeds from Sale, Maturity and Collection of Investments", "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period." } } }, "auth_ref": [ "r43" ] }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 3.0 }, "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "totalLabel": "Fair Value", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest", "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r812" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Equity", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r151", "r239", "r428", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r441", "r443", "r486", "r696", "r697", "r714" ] }, "cnc_DebtSecuritiesAvailableForSaleNumberOfPositions": { "xbrltype": "integerItemType", "nsuri": "http://www.centene.com/20230930", "localname": "DebtSecuritiesAvailableForSaleNumberOfPositions", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total investment positions", "label": "Debt Securities, Available -for-Sale, Number of Positions", "documentation": "Debt Securities, Available -for-Sale, Number of Positions" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtExtinguishmentCosts", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments for debt extinguishment", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest." } } }, "auth_ref": [ "r9" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r32", "r195", "r240", "r348", "r388", "r389", "r391", "r392", "r393", "r395", "r397", "r399", "r400", "r472", "r476", "r477", "r498", "r743", "r833", "r872", "r873" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Axis]", "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r738", "r739" ] }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations", "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r14", "r22" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Paid related to:", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]", "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.centene.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r54", "r55", "r56", "r59" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "cnc_AffordableCareActRiskAdjustmentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AffordableCareActRiskAdjustmentReceivable", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk adjustment receivable", "label": "Affordable Care Act, Risk Adjustment Receivable", "documentation": "Affordable Care Act, Risk Adjustment Receivable" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "verboseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consideration received on divestiture", "label": "Disposal Group, Including Discontinued Operation, Consideration", "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Disposal Groups, Including Discontinued Operations [Table]", "label": "Disposal Groups, Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r16", "r22", "r29", "r111", "r112", "r113", "r114", "r115", "r116", "r118", "r119", "r120", "r148" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r54", "r55", "r56", "r59" ] }, "cnc_OperatingLeaseExcludingDisposalGroupLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "OperatingLeaseExcludingDisposalGroupLiability", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails_1": { "parentTag": "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroup", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total lease liabilities", "label": "Operating Lease, Excluding Disposal Group, Liability", "documentation": "Operating Lease, Excluding Disposal Group, Liability" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term liabilities", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r187", "r204", "r205", "r206", "r240", "r258", "r262", "r264", "r266", "r272", "r273", "r348", "r388", "r391", "r392", "r393", "r399", "r400", "r429", "r430", "r432", "r435", "r442", "r498", "r617", "r618", "r619", "r620", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r654", "r675", "r693", "r708", "r709", "r710", "r711", "r712", "r765", "r786", "r793" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r507", "r518" ] }, "cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation": { "xbrltype": "sharesItemType", "nsuri": "http://www.centene.com/20230930", "localname": "TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": "us-gaap_TreasuryStockSharesAcquired", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share buybacks (in shares)", "label": "Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation", "documentation": "Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt, face amount", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r103", "r105", "r402", "r509", "r730", "r731" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r643", "r645", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r667", "r668", "r669", "r670", "r681", "r682", "r683", "r684", "r687", "r688", "r689", "r690", "r698", "r699", "r703", "r706", "r745", "r747" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r140" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r507", "r518" ] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.centene.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r490" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r137" ] }, "us-gaap_SubsidiarySaleOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockLineItems", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsidiary, Sale of Stock [Line Items]", "label": "Subsidiary, Sale of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued for employee benefit plans", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r80", "r123", "r124", "r154" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "cnc_FinanceLeaseLiabilityAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "FinanceLeaseLiabilityAndOther", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance leases and other", "label": "Finance Lease Liability And Other", "documentation": "Finance Lease Liability And Other" } } }, "auth_ref": [] }, "us-gaap_ServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ServiceMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service", "label": "Service [Member]", "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service." } } }, "auth_ref": [ "r734" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average number of common shares and potential dilutive common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r257", "r266" ] }, "us-gaap_BankTimeDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BankTimeDepositsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term time deposits", "verboseLabel": "Short-term time deposits", "label": "Bank Time Deposits [Member]", "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest." } } }, "auth_ref": [ "r175" ] }, "us-gaap_CurrencySwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrencySwapMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency Swap", "label": "Currency Swap [Member]", "documentation": "Swap involving the exchange of principal and interest in one currency for another currency." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average number of common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r256", "r266" ] }, "cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.centene.com/20230930", "localname": "FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions", "label": "Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Input Definitions [Table Text Block]", "documentation": "Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions" } } }, "auth_ref": [] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorNotesMember", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Notes", "label": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Investments, Debt and Equity Securities [Abstract]", "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireInvestments", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of investments", "label": "Payments to Acquire Investments", "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period." } } }, "auth_ref": [ "r139" ] }, "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": 1.0, "order": 4.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss", "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r812" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average discount rate for operating leases", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r516", "r742" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used in) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r234" ] }, "cnc_TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram": { "xbrltype": "percentItemType", "nsuri": "http://www.centene.com/20230930", "localname": "TreasuryStockValueAcquiredPercentageOfNotionalAmountOfProgram", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of notional amount under ASR", "label": "Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program", "documentation": "Treasury Stock, Value Acquired, Percentage Of Notional Amount Of Program" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r33", "r403" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r234" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt", "negatedLabel": "Less: current portion", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r202" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from common stock issuances", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r7" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Domain]", "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r21" ] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": "us-gaap_TreasuryStockValueAcquiredCostMethod", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax withholding", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "cnc_CircleHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "CircleHealthMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/GoodwillandIntangibleAssetsNarrativeDetails", "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Circle Health", "label": "Circle Health [Member]", "documentation": "Circle Health" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.centene.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_IntersegmentEliminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntersegmentEliminationMember", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Eliminations", "label": "Intersegment Eliminations [Member]", "documentation": "Eliminating entries used in operating segment consolidation." } } }, "auth_ref": [ "r280", "r297", "r298", "r299", "r300", "r301", "r303", "r307" ] }, "cnc_AcceleratedShareRepurchasesAgreementAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AcceleratedShareRepurchasesAgreementAmount", "crdr": "debit", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated share repurchases agreement, amount (up to)", "label": "Accelerated Share Repurchases Agreement, Amount", "documentation": "Accelerated Share Repurchases Agreement, Amount" } } }, "auth_ref": [] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings before income tax", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r131", "r171", "r278", "r298", "r304", "r307", "r557", "r578", "r725" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r125" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Centene stockholders' equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r124", "r127", "r128", "r145", "r656", "r672", "r694", "r695", "r743", "r758", "r788", "r810", "r868", "r886" ] }, "us-gaap_OtherRestrictedAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherRestrictedAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted deposits", "label": "Other Restricted Assets, Noncurrent", "documentation": "Amount of noncurrent assets that are pledged or subject to withdrawal restrictions, classified as other." } } }, "auth_ref": [ "r715", "r716" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Property, software and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r15", "r564", "r577", "r743" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.centene.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Maturity of Operating Lease Liabilities", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r871" ] }, "us-gaap_MunicipalBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MunicipalBondsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Municipal securities", "label": "Municipal Bonds [Member]", "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments." } } }, "auth_ref": [] }, "cnc_A2200Million300SeniorNotesDueOctober2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "A2200Million300SeniorNotesDueOctober2030Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$2,200 million 3.00% Senior Notes due October 15, 2030", "label": "$2,200 Million 3.00% Senior Notes Due October 2030 [Member]", "documentation": "$2,200 Million 3.00% Senior Notes Due October 2030" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r36", "r107", "r569", "r653" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r50", "r196", "r720" ] }, "us-gaap_IncomeLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperations", "crdr": "credit", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Earnings attributable to Centene Corporation", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent." } } }, "auth_ref": [ "r85", "r135", "r143", "r247", "r248", "r249", "r250", "r263", "r266" ] }, "cnc_EmployeeStockCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "EmployeeStockCompensationPlanMember", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Compensation Plan", "label": "Employee Stock Compensation Plan [Member]", "documentation": "Employee Stock Compensation Plan" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings (loss)", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity." } } }, "auth_ref": [ "r28", "r159", "r160" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from long-term debt", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r46", "r617" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r491", "r492", "r493" ] }, "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupAfterYearFive", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails": { "parentTag": "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroup", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, After Year Five", "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, After Year Five" } } }, "auth_ref": [] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets [Abstract]", "verboseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal", "crdr": "credit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on disposal", "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal", "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations." } } }, "auth_ref": [ "r378", "r785", "r825" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "periodEndLabel": "Restricted cash and cash equivalents, included in restricted deposits", "label": "Restricted Cash and Cash Equivalents", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r50", "r162", "r196", "r237", "r570" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r13", "r65" ] }, "us-gaap_AssetBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetBackedSecuritiesMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset-backed securities", "label": "Asset-Backed Securities [Member]", "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans." } } }, "auth_ref": [ "r735", "r797", "r803", "r804" ] }, "us-gaap_OtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentAssetsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Current Assets [Member]", "documentation": "Primary financial statement caption encompassing other current assets." } } }, "auth_ref": [ "r91", "r97" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign currency translation adjustments, net of tax", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r4" ] }, "cnc_RestrictedCertificatesOfDepositMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "RestrictedCertificatesOfDepositMember", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted certificates of deposit", "label": "Restricted Certificates Of Deposit [Member]", "documentation": "Restricted certificates of deposit [member]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive earnings (loss)", "terseLabel": "Other comprehensive earnings (loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r20", "r26", "r218", "r221", "r227", "r500", "r501", "r506", "r552", "r582", "r780", "r781" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r242", "r243", "r244", "r271", "r550", "r616", "r635", "r646", "r647", "r648", "r649", "r650", "r651", "r654", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r667", "r668", "r669", "r670", "r671", "r673", "r676", "r677", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r693", "r748" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in assets and liabilities", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) loss on debt extinguishment", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r13", "r67", "r68" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r34" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents [Member]", "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted earnings per common share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r231", "r247", "r248", "r249", "r250", "r251", "r258", "r264", "r265", "r266", "r270", "r488", "r489", "r556", "r587", "r723" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.centene.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "ROU Assets and Liabilities", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r870" ] }, "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicOtherDisclosuresAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average number of common shares outstanding:", "terseLabel": "Shares used in computing per share amounts:", "label": "Earnings Per Share, Basic, Other Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Line Items]", "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r514" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit facility", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r27", "r165", "r876" ] }, "us-gaap_OtherAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining asset impairment charges", "label": "Other Asset Impairment Charges", "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value." } } }, "auth_ref": [ "r785", "r826" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r241", "r280", "r297", "r298", "r299", "r300", "r301", "r303", "r307", "r388", "r389", "r390", "r391", "r393", "r394", "r396", "r398", "r399", "r833", "r834" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetImpairmentCharges", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment", "negatedLabel": "Impairment charge", "label": "Asset Impairment Charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r13", "r64" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Translation impact", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r373" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r761" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.centene.com/role/OrganizationandOperationsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Guidance Not Yet Adopted", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned revenue", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r444", "r445", "r448" ] }, "us-gaap_USTreasuryAndGovernmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USTreasuryAndGovernmentMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Treasury securities and obligations of U.S. government corporations and agencies", "label": "US Treasury and Government [Member]", "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)." } } }, "auth_ref": [ "r558", "r735", "r882" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r146" ] }, "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearThree", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails": { "parentTag": "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroup", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Three", "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Three" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r267" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liability", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r460", "r461", "r568" ] }, "us-gaap_LitigationReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationReserve", "crdr": "credit", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reserve estimate", "label": "Estimated Litigation Liability", "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs." } } }, "auth_ref": [ "r36", "r828" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Table]", "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r514" ] }, "cnc_AffordableCareActDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AffordableCareActDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/AffordableCareAct" ], "lang": { "en-us": { "role": { "terseLabel": "Affordable Care Act", "label": "Affordable Care Act Disclosure [Text Block]", "documentation": "Affordable Care Act Disclosure [Text Block]" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r34", "r241", "r402", "r403", "r404", "r405", "r406", "r408", "r413", "r414", "r415", "r416", "r418", "r419", "r420", "r421", "r422", "r423", "r509", "r729", "r730", "r731", "r732", "r733", "r787" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosures of cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r133" ] }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Contractual maturities of short-term and long-term investments and restricted deposits", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeFairValueOfDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeNet", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value, swap agreement", "label": "Derivative, Fair Value, Net", "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives." } } }, "auth_ref": [ "r497" ] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total, Amortized Cost", "label": "Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost", "documentation": "Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost" } } }, "auth_ref": [] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency swap agreement", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r210", "r211", "r497", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r660", "r661", "r698", "r701", "r703", "r704", "r706", "r707", "r722", "r747", "r884" ] }, "cnc_RatedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "RatedSecuritiesMember", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rated Securities", "label": "Rated Securities [Member]", "documentation": "Rated Securities [Member]" } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Agreement", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/StockholdersEquityNarrativeDetails", "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock repurchases", "terseLabel": "Common stock repurchases", "totalLabel": "Common stock repurchases", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r20", "r76", "r154" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r241", "r402", "r403", "r404", "r405", "r406", "r408", "r413", "r414", "r415", "r416", "r418", "r419", "r420", "r421", "r422", "r423", "r426", "r509", "r729", "r730", "r731", "r732", "r733", "r787" ] }, "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit", "crdr": "credit", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Divestitures", "label": "Goodwill, Written off Related to Sale of Business Unit", "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r371", "r728" ] }, "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearOne": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearOne", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails": { "parentTag": "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroup", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year One", "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year One" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r27", "r121", "r122", "r164", "r165", "r241", "r402", "r403", "r404", "r405", "r406", "r408", "r413", "r414", "r415", "r416", "r418", "r419", "r420", "r421", "r422", "r423", "r509", "r729", "r730", "r731", "r732", "r733", "r787" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.centene.com/role/OrganizationandOperationsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "cnc_MedicareSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "MedicareSegmentMember", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medicare", "label": "Medicare Segment [Member]", "documentation": "Medicare Segment" } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfBusiness", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) loss on divestitures", "verboseLabel": "Gain on divestiture", "label": "Gain (Loss) on Disposition of Business", "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant." } } }, "auth_ref": [ "r475", "r785" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r34", "r73", "r74", "r102", "r103", "r105", "r108", "r152", "r153", "r241", "r402", "r403", "r404", "r405", "r406", "r408", "r413", "r414", "r415", "r416", "r418", "r419", "r420", "r421", "r422", "r423", "r426", "r509", "r729", "r730", "r731", "r732", "r733", "r787" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "cnc_PremiumTaxRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "PremiumTaxRevenue", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premium tax", "label": "Premium Tax Revenue", "documentation": "Premium tax revenue, similar assessments and provider pass through payments." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "cnc_TotalPremiumAndServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "TotalPremiumAndServiceMember", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premium and service revenues", "label": "Total Premium and Service [Member]", "documentation": "Total Premium and Service" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition and purchase accounting adjustments", "label": "Goodwill, Acquired During Period", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r369", "r728" ] }, "cnc_ReturnofPremiumPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "ReturnofPremiumPayable", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Return of premium payable", "label": "Return of Premium Payable", "documentation": "Return of Premium Payable" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings per common share attributable to Centene Corporation:", "verboseLabel": "Net Income (Loss) Attributable to Parent [Abstract]", "label": "Net Income (Loss) Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r426", "r440", "r485", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r583", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r805", "r806", "r807", "r808" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r457", "r458", "r459", "r624", "r790", "r791", "r792", "r867", "r886" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r242", "r243", "r244", "r271", "r550", "r616", "r635", "r646", "r647", "r648", "r649", "r650", "r651", "r654", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r667", "r668", "r669", "r670", "r671", "r673", "r676", "r677", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r693", "r748" ] }, "us-gaap_ExternalCreditRatingByGroupingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExternalCreditRatingByGroupingDomain", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "External Credit Rating by Grouping [Domain]", "label": "External Credit Rating by Grouping [Domain]", "documentation": "External credit rating classified as investment grade or non-investment grade." } } }, "auth_ref": [ "r96" ] }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestitures" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions and Divestitures", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings." } } }, "auth_ref": [ "r110", "r156" ] }, "us-gaap_InsuranceDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InsuranceDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiability" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Claims Liability", "label": "Insurance Disclosure [Text Block]", "documentation": "The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items." } } }, "auth_ref": [ "r565", "r566", "r606", "r607" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r20", "r37", "r189", "r222", "r223", "r224", "r242", "r243", "r244", "r246", "r252", "r254", "r271", "r350", "r351", "r443", "r457", "r458", "r459", "r463", "r464", "r479", "r480", "r481", "r482", "r483", "r484", "r487", "r500", "r502", "r503", "r504", "r505", "r506", "r517", "r609", "r610", "r611", "r624", "r693" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross Unrealized Losses", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r320" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r189", "r242", "r243", "r244", "r246", "r252", "r254", "r350", "r351", "r457", "r458", "r459", "r463", "r464", "r479", "r481", "r482", "r484", "r487", "r609", "r611", "r624", "r886" ] }, "us-gaap_ExternalCreditRatingByGroupingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExternalCreditRatingByGroupingAxis", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "External Credit Rating by Grouping [Axis]", "label": "External Credit Rating by Grouping [Axis]", "documentation": "Information by external rating classified as investment grade or non investment grade." } } }, "auth_ref": [ "r57", "r478", "r811" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r12" ] }, "us-gaap_OtherComprehensiveIncomeLossTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTax", "crdr": "debit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive earning (loss), tax", "label": "Other Comprehensive Income (Loss), Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss)." } } }, "auth_ref": [ "r5", "r222", "r227", "r462", "r468", "r469", "r500", "r504", "r506", "r552", "r582" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive earnings (loss) attributable to Centene Corporation", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r42", "r219", "r221", "r230", "r555", "r586" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Unrealized Gains", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r319" ] }, "us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Held-to-Maturity, Unrealized Loss Position, Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r52", "r53", "r100", "r101", "r312", "r717" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Change in unrealized gain (loss) on investments", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax", "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r213", "r215", "r346" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Change in unrealized gain (loss) on investments, net of tax", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r213", "r215", "r346" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r92", "r93", "r94", "r95", "r643", "r645", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r667", "r668", "r669", "r670", "r681", "r682", "r683", "r684", "r687", "r688", "r689", "r690", "r698", "r699", "r703", "r706", "r722", "r745", "r747" ] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term investments", "label": "Short-Term Investments", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r168", "r169", "r779" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r104", "r173", "r225", "r282", "r508", "r678", "r756", "r885" ] }, "us-gaap_OperatingLeaseImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ROU impairment", "label": "Operating Lease, Impairment Loss", "documentation": "Amount of loss from impairment of right-of-use asset from operating lease." } } }, "auth_ref": [ "r869" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r52", "r53", "r100", "r101", "r312", "r717", "r767" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r20", "r189", "r222", "r223", "r224", "r242", "r243", "r244", "r246", "r252", "r254", "r271", "r350", "r351", "r443", "r457", "r458", "r459", "r463", "r464", "r479", "r480", "r481", "r482", "r483", "r484", "r487", "r500", "r502", "r503", "r504", "r505", "r506", "r517", "r609", "r610", "r611", "r624", "r693" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Change in unrealized gain (loss) on investments, tax effect", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax", "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r5", "r214" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Earnings (Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r3", "r19", "r41", "r480", "r483", "r517", "r609", "r610", "r780", "r781", "r782", "r790", "r791", "r792" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r208", "r743" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r60", "r62" ] }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Losses", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total investments", "label": "Investments, Fair Value Disclosure", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method." } } }, "auth_ref": [ "r491" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax expense", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r184", "r186", "r253", "r254", "r286", "r462", "r465", "r588" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_UnamortizedDebtIssuanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnamortizedDebtIssuanceExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Debt issuance costs", "label": "Unamortized Debt Issuance Expense", "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset." } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities", "label": "Debt Securities, Available-for-Sale, Amortized Cost [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1", "crdr": "credit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current year", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year", "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs." } } }, "auth_ref": [ "r23" ] }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleTable", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule Of Investments And Restricted Deposits By Type [Table]", "terseLabel": "Debt Securities, Available-for-sale [Table]", "label": "Debt Securities, Available-for-Sale [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r324", "r325", "r326", "r327" ] }, "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments", "crdr": "debit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Less: Reinsurance recoverable", "periodEndLabel": "Plus: Reinsurance recoverable", "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments", "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer." } } }, "auth_ref": [ "r109", "r179", "r874", "r880", "r881" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1", "crdr": "credit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior years", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years", "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs." } } }, "auth_ref": [ "r23" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Positions from which gross unrealized losses were generated", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions", "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r182", "r361" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "crdr": "debit", "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total incurred", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims", "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process." } } }, "auth_ref": [ "r178" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r181", "r727", "r813" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Investments And Restricted Deposits By Type [Axis]", "verboseLabel": "Financial Instrument [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r352", "r353", "r354", "r355", "r356", "r360", "r363", "r364", "r426", "r440", "r485", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r583", "r727", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r805", "r806", "r807", "r808" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions", "crdr": "credit", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions and divestitures", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions", "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported." } } }, "auth_ref": [] }, "cnc_AffordableCareActReinsurancePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AffordableCareActReinsurancePayable", "crdr": "credit", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Risk adjustment payable", "label": "Affordable Care Act Reinsurance Payable", "documentation": "Affordable Care Act Reinsurance, Payable" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.centene.com/20230930", "localname": "ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term and long-term investments and restricted deposits by investment type", "label": "Short Term And Long Term Investments And Restricted Deposits By Investment Type [Table Text Block]", "documentation": "Short-term and long-term investments and restricted deposits by investment type" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level II", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r415", "r449", "r454", "r492", "r523", "r730", "r731", "r735", "r736", "r737" ] }, "cnc_AssetImpairmentChargesNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AssetImpairmentChargesNetOfTax", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Impairment charge, net of tax", "label": "Asset Impairment Charges, Net Of Tax", "documentation": "Asset Impairment Charges, Net Of Tax" } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r760" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r31", "r240", "r348", "r388", "r389", "r391", "r392", "r393", "r395", "r397", "r399", "r400", "r472", "r476", "r477", "r498", "r652", "r724", "r758", "r833", "r872", "r873" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level I", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r415", "r449", "r454", "r492", "r522", "r735", "r736", "r737" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r141", "r142", "r143" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments and repurchases of long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r49", "r620" ] }, "cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration": { "xbrltype": "durationItemType", "nsuri": "http://www.centene.com/20230930", "localname": "InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years)", "label": "Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration", "documentation": "Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "cnc_AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AffordableCareActRiskAdjustmentAndReinsurancePreTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AffordableCareActAdditionalinformationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Risk adjustment and reinsurance pre-tax benefit", "label": "Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)", "documentation": "Affordable Care Act, Risk Adjustment And Reinsurance, Pre-Tax Expense (Benefit)" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.centene.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r760" ] }, "cnc_AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "crdr": "credit", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs", "label": "Amounts Recorded As An Adjustment to Premium Revenues Related to Minimum HBR and Return of Premium Programs", "documentation": "Amounts Recorded As An Adjustment To Premium Revenues Related To Minimum HBR and Return Of Premium Programs" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r123", "r429" ] }, "us-gaap_LossContingencyPendingClaimsNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyPendingClaimsNumber", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pending claims", "label": "Loss Contingency, Pending Claims, Number", "documentation": "Number of pending claims pertaining to a loss contingency." } } }, "auth_ref": [ "r829", "r830" ] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "crdr": "credit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities held for sale", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r2", "r111", "r117", "r147", "r192", "r193" ] }, "cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes", "crdr": "debit", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": "us-gaap_TreasuryStockValueAcquiredCostMethod", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share buybacks", "label": "Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes", "documentation": "Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level III", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r415", "r449", "r450", "r451", "r452", "r453", "r454", "r492", "r524", "r730", "r731", "r735", "r736", "r737" ] }, "cnc_TermLoanCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "TermLoanCreditAgreementMember", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan Facility", "label": "Term Loan Credit Agreement [Member]", "documentation": "Term Loan Credit Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "parentTag": "us-gaap_TreasuryStockSharesAcquired", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax withholding (in shares)", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "cnc_SeniorNotesTotal": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "SeniorNotesTotal", "crdr": "credit", "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total senior notes", "label": "Senior Notes, Total", "documentation": "Senior Notes, Total" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CertificatesOfDepositMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CertificatesOfDepositMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Certificates of deposit", "label": "Certificates of Deposit [Member]", "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured." } } }, "auth_ref": [ "r17", "r749", "r750", "r751", "r752" ] }, "us-gaap_LeaseContractualTermDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseContractualTermDomain", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease Contractual Term [Domain]", "label": "Lease Contractual Term [Domain]", "documentation": "Contractual term of lease arrangement." } } }, "auth_ref": [ "r768" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r199" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r123", "r654" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r13", "r155", "r185", "r466", "r467", "r789" ] }, "cnc_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposalNetOfTax", "crdr": "credit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on disposal, net of tax", "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Net Of Tax", "documentation": "Disposal Group, Not Discontinued Operation, Gain (Loss) On Disposal, Net Of Tax" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued expenses", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r12" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r123", "r654", "r672", "r886", "r887" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic earnings per common share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r231", "r247", "r248", "r249", "r250", "r251", "r256", "r258", "r264", "r265", "r266", "r270", "r488", "r489", "r556", "r587", "r723" ] }, "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupYearFive", "crdr": "credit", "calculation": { "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails": { "parentTag": "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroup", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.centene.com/role/LeasesOperatingLeasePaymentsOverNextFiveYearsExcludingCircleHealthDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Five", "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Year Five" } } }, "auth_ref": [] }, "us-gaap_GoodwillTransfers": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillTransfers", "crdr": "debit", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reallocation", "label": "Goodwill, Transfers", "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r821" ] }, "us-gaap_LeaseContractualTermAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseContractualTermAxis", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease Contractual Term [Axis]", "label": "Lease Contractual Term [Axis]", "documentation": "Information by contractual term of lease arrangement." } } }, "auth_ref": [ "r768" ] }, "cnc_A2200Million250SeniorNotesDueMarch2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "A2200Million250SeniorNotesDueMarch2031Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$2,200 million 2.50% Senior Notes due March 1, 2031", "label": "$2,200 Million 2.50% Senior Notes due March 2031 [Member]", "documentation": "$2,200 Million 2.50% Senior Notes due March 2031" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities, redeemable noncontrolling interests and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r129", "r167", "r576", "r743", "r788", "r810", "r868" ] }, "cnc_MedicaidSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "MedicaidSegmentMember", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medicaid", "label": "Medicaid Segment [Member]", "documentation": "Medicaid Segment" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillImpairmentLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLossNetOfTax", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill, impairment, net of tax", "label": "Goodwill, Impairment Loss, Net of Tax", "documentation": "Amount after tax of loss recognized that results from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [] }, "cnc_PremiumTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "PremiumTaxExpense", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Premium tax expense", "label": "Premium Tax Expense", "documentation": "Premium tax expense, similar assessments and provider pass through payments." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense):", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeNonoperating", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Investment and other income", "label": "Investment Income, Nonoperating", "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations." } } }, "auth_ref": [ "r138" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r123", "r429" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reclassification adjustment, net of tax", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax", "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities." } } }, "auth_ref": [ "r8", "r130", "r216", "r346" ] }, "cnc_RestrictedCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "RestrictedCashEquivalentsMember", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash equivalents", "label": "Restricted Cash Equivalents [Member]", "documentation": "Restricted Cash Equivalents [Member]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.centene.com/role/OrganizationandOperationsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r291", "r292", "r293", "r294", "r295", "r296", "r311", "r726" ] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.centene.com/role/OrganizationandOperations" ], "lang": { "en-us": { "role": { "verboseLabel": "Organization and Operations", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r144" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "cnc_A1300Million2625SeniorNotesDueAugust2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "A1300Million2625SeniorNotesDueAugust2031Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$1,300 million 2.625% Senior Notes due August 1, 2031", "label": "$1,300 Million 2.625% Senior Notes due August 2031 [Member]", "documentation": "$1,300 Million 2.625% Senior Notes due August 2031" } } }, "auth_ref": [] }, "cnc_A2300Million245SeniorNotsDueJuly2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "A2300Million245SeniorNotsDueJuly2028Member", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$2,300 million 2.45% Senior Notes due July 15, 2028", "label": "$2,300 Million 2.45% Senior Nots due July 2028 [Member]", "documentation": "$2,300 Million 2.45% Senior Nots due July 2028" } } }, "auth_ref": [] }, "cnc_AffordableCareActMinimumMedicalLossRatio": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AffordableCareActMinimumMedicalLossRatio", "crdr": "credit", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Minimum medical loss ratio", "label": "Affordable Care Act Minimum Medical Loss Ratio", "documentation": "Affordable Care Act, Minimum Medical Loss Ratio" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r126", "r154", "r574", "r612", "r614", "r621", "r655", "r743" ] }, "cnc_ApixioMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "ApixioMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Apixio", "label": "Apixio [Member]", "documentation": "Apixio" } } }, "auth_ref": [] }, "cnc_CommercialSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "CommercialSegmentMember", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsSummaryofChangesinGoodwillDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commercial", "label": "Commercial Segment [Member]", "documentation": "Commercial Segment" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r81", "r82", "r455" ] }, "cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "GainLossOnExtinguishmentOfDebtIncludingCashPortion", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Debt extinguishment", "label": "Gain (Loss) on Extinguishment of Debt , Including Cash Portion", "documentation": "Gain (Loss) on Extinguishment of Debt , Including Cash Portion" } } }, "auth_ref": [] }, "cnc_AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "AffordableCareActRiskAdjustmentNetReceivableIncreaseDecrease", "crdr": "debit", "presentation": [ "http://www.centene.com/role/AffordableCareActAdditionalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk adjustment, increase to net receivables", "label": "Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease)", "documentation": "Affordable Care Act, Risk Adjustment, Net Receivable Increase (Decrease)" } } }, "auth_ref": [] }, "us-gaap_InvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsMember", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investments [Member]", "documentation": "Assets held for their financial return, rather than for the entity's operations." } } }, "auth_ref": [] }, "cnc_SpanishAndCentralEuropeanBusinessesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "SpanishAndCentralEuropeanBusinessesMember", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Spanish and Central European Businesses", "label": "Spanish and Central European Businesses [Member]", "documentation": "Spanish and Central European Businesses" } } }, "auth_ref": [] }, "cnc_LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.centene.com/20230930", "localname": "LesseeOperatingLeaseLiabilityToBePaidExcludingDisposalGroupRemainderOfFiscalYear", "crdr": "credit", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Remaining lease payments in 2023 excluding disposal group", "label": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Remainder of Fiscal Year", "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Excluding Disposal Group, Remainder of Fiscal Year" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued expenses", "label": "Accounts Payable and Accrued Liabilities, Current", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r30" ] }, "cnc_InvestmentSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.centene.com/20230930", "localname": "InvestmentSecuritiesMember", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Securities", "label": "Investment Securities [Member]", "documentation": "Investment Securities" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r415", "r449", "r450", "r451", "r452", "r453", "r454", "r522", "r523", "r524", "r730", "r731", "r735", "r736", "r737" ] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net earnings per common share attributable to Centene Corporation:", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "crdr": "debit", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Less Than 12 Months", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r183", "r362", "r727" ] }, "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities", "crdr": "debit", "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Medical claims liabilities", "label": "Increase (Decrease) in Health Care Insurance Liabilities", "documentation": "The increase (decrease) in health care insurance liability balances during the period." } } }, "auth_ref": [ "r12" ] }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits" ], "lang": { "en-us": { "role": { "verboseLabel": "Short-term and Long-term Investments, Restricted Deposits", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "documentation": "The entire disclosure for investments in certain debt and equity securities." } } }, "auth_ref": [ "r161", "r176", "r180", "r188", "r313", "r314", "r494", "r495" ] }, "cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.centene.com/20230930", "localname": "ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "presentation": [ "http://www.centene.com/role/AffordableCareActTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of net receivables (payables) related to the Affordable Care Act Programs", "label": "Schedule Of Receivables (Payables) Related To The Affordable Care Act Programs [Table Text Block]", "documentation": "Schedule of Receivables (Payables) Related to the Affordable Care Act Programs" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "crdr": "debit", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, 12 Months or More", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r183", "r362", "r727" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-14" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481047/942-405-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4D" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4E" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(3)", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-29" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "320", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(12)(c)", "Section": "S99", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(16)(c)", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "14", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "15", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-24" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4K" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.16)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-20/tableOfContent" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.13)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "940", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//940-320/tableOfContent" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.13,16)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481160/942-230-45-1" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "b.", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481160/942-230-45-1" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//942-320/tableOfContent" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(cc)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//946-320/tableOfContent" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-7" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1403", "Paragraph": "(b)", "Publisher": "SEC" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2A" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "325", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481612/325-30-25-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3A" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3B" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-5" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-11" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1B" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4K" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//944/tableOfContent" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479838/944-20-50-7" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(4)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479584/944-310-50-3" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(4)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479584/944-310-50-3" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-4" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480602/954-210-50-2" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r726": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r727": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r728": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r729": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r730": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r731": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r732": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r733": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r734": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r735": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r738": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r739": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r740": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r741": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r765": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r782": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r783": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r784": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r785": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r786": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r787": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r788": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r789": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479838/944-20-50-5" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(13)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479616/944-310-45-6" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479584/944-310-50-2" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" } } } ZIP 72 0001071739-23-000209-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001071739-23-000209-xbrl.zip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end